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ABSTRACT 
Introduction 
 
Cardiovascular disease is one of the most common causes of morbidity and mortality 
worldwide, and globally has contributed to more than 17 million deaths in a year. 
Coronary heart disease (CHD) alone is responsible for one in seven deaths in the US, 
and the mortality rate is expected to rise by 10% per year over the next 20 years. One 
of the invasive treatments for CHD is coronary artery bypass grafting (CABG), which 
aims to improve cardiac tissue perfusion by grafting another blood vessel to bypass 
the narrowed or blocked coronary artery. Currently the artery conduit is the standard 
choice for this procedure, however, the main concern for the use of artery conduits is 
that they have a high probability of inducing perioperative vasospasm. Therefore, it is 
crucial to maintain functionality of the conduit during harvest, pressure testing, storage 
and implantation. 
 
The current strategy to prevent artery vasospasm involves a range of anti-spasmodic 
agents. Some of the most commonly used vasodilators in the surgical setting include 
Ca2+ antagonists (diltiazem, verapamil), nitrates (nitroglycerin, glyceryl trinitrate), and 
phosphodiesterase inhibitors (papaverine). However, the results remain 
unsatisfactory. Accordingly, the search for a vasorelaxation agent to reduce graft 
spasm remains an ongoing pursuit, which if successful may also be applicable to 
vascular surgery and neurosurgery. The aim of this thesis is to explore the use of 
adenosine and lidocaine combination as a potential vasodilator to improve arterial 
grafting using in vitro models. 
  
Methods 
In this thesis, vascular reactivity was assessed using two different in vitro methods: 1) 
Isometric force measurements for the isolated male rat aortic ring studies, and 2) 
Pressured myography for the isolated guinea pig mesenteric artery studies. Isometric 
force measurements of vasoreactivity were used as the basis for Chapters 3, 4 and 5; 
and for Chapter 6 after static cold storage. The pressure myography system was only 
used in Chapter 5. 
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Chapter 3 investigates the relaxation effect of adenosine as a single drug on rat aorta 
as well as its possible mechanisms of action. In this chapter, aortic rings were freshly 
harvested from adult male Sprague Dawley rats and equilibrated in an organ bath 
containing oxygenated, modified Krebs Henseleit (KH) solution (11 mM glucose, pH 
7.4, 37°C). Isolated rings were pre-contracted sub-maximally with 0.3 µM 
norepinephrine (NE), and the effect of increasing concentrations of adenosine (1 to 
1000 µM) was examined.  The effect of antagonists on adenosine relaxation, such as 
NG-nitro-L-arginine methyl ester (L-NAME), indomethacin, 4-aminopyridine (4-AP), 
glibenclamide, 5-hydroxydecanoate (5-HD), ouabain, 8-(3-chlorostyryl) caffeine (CSC) 
and 8-[4-[4-(4-chlorobenzyl)piperazide-1-sulfonyl)phenyl]]-1-propylxanthine (PSB-
0788) were examined in intact and denuded aortic rings. Rings were dilated with 100 
µM papaverine after each experiment to confirm viability.  
In Chapter 4, lidocaine effects and mechanisms of action on rat aorta vasorelaxation 
were examined. Incremental concentrations of lidocaine (1 to 1000 µM) were 
administered and tested against 0.3 µM NE pre-contracted rat aorta. The effects of 
antagonists L-NAME, indomethacin, 4-AP, glibenclamide, 5-HD, ouabain, CSC and 
PSB-0788 were also examined against lidocaine relaxation. As in Chapter 3, rings 
were tested for viability after each experiment with maximally dilating 100 µM 
papaverine.   
Chapter 5 focused on the effect of the combination of adenosine and lidocaine on rat 
aortic ring relaxation compared to each drug alone. Rings were pre-contracted sub-
maximally with 0.3 µM norepinephrine, and the effects of increasing AL, A or L (up to 
1.0 mM) were examined in intact and denuded rings. In this Chapter 5, the 
vasorelaxation effect of AL as a combination was further explored in the mesenteric 
artery of guinea pig. This study used the pressure myograph system to examine 
mesenteric conduit relaxation and the vascular dilatory response to adenosine, 
lidocaine and AL during luminal and abluminal administration. This methodology is 
often used to investigate small vessel function (diameter >60 μM) under near 
physiological conditions of pressure and flow by measuring vessel diameter and flow 
in time. Mesenteric artery segments were isolated from guinea pigs and mounted in an 
arteriograph containing KH solution and pressurized to 60 mmHg. Arteries were pre-
constricted with 10-8 M vasopressin and AL, A or L was administered luminally or 
abluminally. Diameters were measured using video-microscopy. 
Chapter 6 explores the potential use of AL as an additive in a vessel preservation 
solution. In this chapter, thoracic aortic vessels were harvested from 300-350 g 
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Sprague Dawley rats and transferred to a container with pre-cooled KH solution. 
Vessel segments were cleaned and cut in 3-mm length rings and stored at 4°C for six 
days in one of the following preservation solutions: 1) Krebs Henseleit (KH), 2) 
modified KH (low Ca2+/high Mg2+), 3) modified KH + adenosine-lidocaine (KH+AL), or 
4) modified KH + AL and melatonin and insulin (KH+ALMI). After 6-day storage, 
physiological (contraction and relaxation) function of the preserved aortic rings was 
measured using an isometric force transducer. Contraction was induced by 
norepinephrine (NE; 0.3 μM) and potassium chloride (KCl; 60 mM). Vessel relaxation 
in response to acetylcholine (ACh; 10-6-10-3 M) and sodium-nitroprusside (SNP; 10-6-
10-3 M) was tested after preconstriction with 0.3 μM NE. At the end of each experiment, 
rings were maximally dilated with 100 μM papaverine to confirm viability of the vessels. 
 
Results 
Adenosine induced a dose-dependent, triphasic relaxation response, and the 
mechanical removal of the endothelium significantly decreased adenosine relaxation 
above 10 μM. Interestingly, endothelial removal significantly reduced the 
responsiveness (defined as % relaxation per μM adenosine) by two-thirds between 10 
and 100 μM, but not in the lower (1-10 μM) or higher (>100 μM) ranges. In intact rings, 
L-NAME, but not indomethacin, significantly reduced relaxation, suggesting a role of 
nitric oxide (NO) but not prostacyclin in adenosine endothelium-dependent relaxation. 
Antagonists of voltage-dependent Kv (4-AP), sarcolemmal KATP (glibenclamide) and 
mitochondrial KATP channels (5-HD) led to significant reductions in adenosine 
relaxation in both intact and denuded rings, with the Na+/K+-ATPase antagonist 
ouabain having little or no effect. Adenosine-induced relaxation appeared to involve 
the A2a receptor, but not the A2b subtype. In contrast to adenosine, lidocaine relaxation 
in intact rings was biphasic between 1 to 10 µM (Phase 1) and 10 to 1000 µM (Phase 
2). Mechanical removal of the endothelium resulted in further relaxation, and at lower 
concentrations ring sensitivity (% relaxation per µM lidocaine) significantly increased 
3.5 times compared to intact rings.  The relaxing factor(s) responsible for enhancing 
lidocaine relaxation did not appear to be NO- or prostacyclin-dependent, as L-NAME 
and indomethacin had little or no effect on intact ring relaxation.  In denuded rings, 
lidocaine relaxation was completely abolished by Kv channel inhibition and significantly 
reduced by antagonists of the MitoKATP channel, and to a lesser extent the SarcKATP 
channel. Curiously, A2a subtype receptor antagonism significantly inhibited lidocaine 
relaxation above 100 µM, but not the A2b receptor. In combination, adenosine and 
 xiii 
lidocaine (AL) increased aortic relaxation from 21 to 100% (0.1-1.0 mM) and relaxation 
was endothelium-independent. Although adenosine alone was also a potent relaxant 
of aortic rings, unlike AL relaxation, it was partially endothelium-dependent.   
Further investigation of AL effects on mesenteric artery showed that increasing luminal 
administration of AL in intact mesenteric artery segments produced a potent 
endothelium-independent dilation up to 90% (p<0.05). Adenosine dilation was 
endothelium-independent but not lidocaine, which produced 33% dilation only after 
endothelial removal.  Extra-luminal AL and A led to 76% and 80% dilation in intact 
segments respectively, whereas L resulted in constriction (10-17%).  
When exploring the potential use of AL as a preservation solution with 6-day cold 
storage in Chapter 6, it was found that AL addition in modified KH solution resulted in 
100% recovery of NE contractile function in rat aorta, which was superior compared to 
KH solution alone (89% recovery). However, there was no further recovery in the KCl 
response over modified KH (76% recovery). A similar result was also shown with ALMI 
in modified KH, which led to 100% and 86% of contractile function recovery in response 
to NE and KCl, respectively. Furthermore, AL but not ALMI addition in modified KH 
significantly improved relaxation function compared to standard KH, with 93% recovery 
compared to 79% with modified KH alone after six days of storage. Maximal SNP 
relaxation following 6-day cold storage with either modified KH alone, modified KH with 
AL or with ALMI recovered 100%. 
 
Conclusions 
Adenosine is a potent vasodilator of aortic rings. Adenosine relaxation in NE-
precontracted rat aortic rings was triphasic and endothelium-dependent above 10 μM, 
and relaxation involved endothelial nitric oxide (not prostanoids) and a complex 
interplay between smooth muscle A2a subtype and voltage-dependent Kv, SarcKATP 
and MitoKATP channels. In contrast, lidocaine relaxation is not as potent as adenosine 
relaxation, but it appears to be significantly enhanced by endothelial removal, which 
did not appear to be NO- or prostacyclin-dependent. The unknown factor(s) 
responsible for enhanced relaxation was significantly reduced by Kv channel inhibition, 
MitoKATP channel inhibition, and A2a subtype inhibition indicating a potential role for 
crosstalk in lidocaine’s vasoreactivity. When combined, AL can dilate aortic rings and 
mesenteric artery segments by up to 90% regardless of whether the endothelium is 
intact. This may have potential translational significance of AL to improve conduit 
 xiv 
protection in cardiac surgery, and other major surgeries where varying degrees of 
endothelial damage, vasoconstriction or vasospasm are known to occur. In addition, 
AL has a potential role as an adjuvant in preservation solutions since it improved 
vascular function after 6-day cold storage. AL addition in modified KH solution 
significantly improved NE-induced vascular contractility and ACh-induced relaxation 
compared to standard KH solution. This may indicate that AL improved endothelial 
preservation during storage, which was not achieved with standard preservation 
solution. 
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CHAPTER 1  
 
INTRODUCTION AND LITERATURE REVIEW 
 
 
 
Cardiovascular disease is one of the major causes of morbidity and mortality 
worldwide, and globally has contributed to more than 17 million deaths in a year (Roth, 
et al., 2015). In the USA, coronary heart disease (CHD) alone is responsible for one in 
seven deaths with a mortality rate of ~370,213 per year (Mozaffarian, et al., 2016). 
More than 600,000 US citizens experience a new coronary attack each year, and 
around 300,000 will have a recurrent attack (Mozaffarian, et al., 2016). CHD is 
expected to increase by 10% per year over the next 20 years, with a projected overall 
cost increase from $273 billion in 2010 to $818 billion in 2030 (Heidenreich, et al., 
2011).  
 
A common treatment for CHD is coronary artery bypass grafting (CABG) and there are 
more than one million procedures being performed each year globally (DeFrances, et 
al., 2008). CABG comprises the surgical attachment of a healthy artery or vein graft 
from the body, which bypasses the blocked portion of the coronary artery and creates 
a new path for oxygen-rich blood to be delivered to the heart muscle. Surgeons can 
bypass multiple coronary arteries during one surgery.  As CABG surgery enters its 
fourth decade, the access to grafts and their perioperative protection remains a 
concern (Goldman, et al., 2004b; Magee, et al., 2008a). 
 
The two major vessel types for bypass surgery are the arterial graft (internal thoracic 
or radial artery) and saphenous vein grafts (Shi, et al., 2015). While arterial grafts have 
higher patency rates than saphenous vein grafts which are more prone for intimal 
hyperplasia (Sur, et al., 2014), an ongoing problem is their increased tendency to 
spasm early in 4-10% of cases during the perioperative period (Cuminetti, et al., 2017; 
El Tecle, et al., 2016; Watanabe, et al., 2013). Therefore, there is an unmet need to 
improve arterial graft protection from spasm during harvest, pressure testing, storage 
and implantation (Goldman, et al., 2004b; He & Taggart, 2016a). 
A range of anti-spasmodic agents has been examined in the literature to address 
arterial conduit dysfunction (Attaran, et al., 2008). Some of the most commonly used 
vasodilators in the surgical setting include phosphodiesterase inhibitors (papaverine), 
nitrates (nitroglycerin, glyceryl trinitrate), and Ca2+ antagonists (diltiazem, verapamil) 
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(El Tecle, et al., 2016; Erdem, et al., 2015; Huh, et al., 2016). Unfortunately, despite 
decades of investigations there remains no effective treatment based on translational 
research and clinical trials (Yagami, et al., 2013; Yildiz, et al., 2013). Accordingly, the 
search for a vasorelaxation agent to reduce graft spasm remains an ongoing pursuit, 
which if successful may also be applicable to vascular surgery and neurosurgery.  
 
This chapter will provide a brief review on the structure of the arterial blood vessel wall 
and known mechanisms of vasospasm, and the ongoing search for pharmacological 
vasodilators that may provide alternative solutions to overcome graft spasm. 
 
1.1 The structure and function of arterial blood vessels 
Along with central nervous system (CNS) control of blood flow through arterial 
baroreceptors and direct innervation through the arterial tree (Thomas, 2011), several 
local factors influence the regulation of local blood flow including: 1) structural 
characteristics of the vasculature and wall structure (London & Pannier, 2010), 2) the 
intrinsic ability of the vascular endothelium and vascular smooth muscle to respond to 
various stimuli (Flammer, et al., 2012; Triggle, et al., 2012b), and 3) the role of ion 
channels in the regulation of vascular tone (Jackson, 2000).   
1.1.1 Structural characteristics of the vasculature and wall structure 
The vascular system is built from a vessel network comprising arteries, veins and 
capillaries (Ardalani, et al., 2014). The arteries deliver oxygen (O2)-rich blood from the 
heart to the entire body, through the aorta, small arteries and arterioles (Ardalani, et 
al., 2014). The large arteries such as the aorta and carotid arteries are comprised of 
smooth muscle and elastic layers, and called elastic arteries (Rhodin, 1980; Wagenseil 
& Mecham, 2009). As the main arteries approach the organs, the size and diameter of 
the vessels decreases, the vessel wall becomes thinner, less elastic and mostly 
comprises the smooth muscle layer (muscular arteries) (Rhodin, 1980; Wagenseil & 
Mecham, 2009). In the aorta and large arteries, the contraction of smooth muscles 
largely contributes to vessel compliance, which is one of the key determinants of 
afterload. Meanwhile, the narrower small arteries and arterioles are largely responsible 
for peripheral vascular resistance regulation through contraction or relaxation of 
vascular smooth muscle, and are known as the resistance arteries (Martinez-Lemus, 
2012; Touyz, et al., 2013).  
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The veins, on the other hand, are thinner-walled vessels compared to arteries (Touyz, 
et al., 2013). The dynamic nature of venous tone predominantly affects the capacity of 
systemic and regional circulation and therefore these are termed capacitance vessels.  
Ventricular filling and therefore preload is affected by venous blood pressure and the 
rate of venous return (Touyz, et al., 2013). The exchange between the O2 and 
metabolic CO2 content of the blood and tissues occurs in the vast capillary network, 
which is supported by a single continuous endothelium layer with endothelial cell 
junctions acting as the pore system in tunica intima (Karnovsky, 1968). Arterioles 
together with capillaries, post capillary venules and muscular venules are called the 
microcirculation (Rhodin, 1980).  
1.1.2 Layers of the vessel wall 
In general, a blood vessel wall consists of three distinct layers: tunica intima, tunica 
media and tunica adventitia (Hurlimann, et al., 2002) and is considered a dynamic 
structure that plays an important role in vascular contraction. 
 
Tunica intima lies at the innermost side of the vessel and gets exposed directly to the 
lumen and consists of one continuous single layer of endothelial cells and basal lamina 
(Martinez-Lemus, 2012). Endothelial cells are organised in longitudinal orientation with 
thickness of approximately 0.5 μm (Rhodin, 1980). A subendothelial layer can be found 
in the aorta and large arteries, which contains a heterogeneous structural population 
including collagenous bundles, elastic fibrils, smooth muscles and fibroblasts 
(Orekhov, et al., 2014).  
 
Tunica media (middle layer) contains smooth muscle cells with layers of elastic lamina, 
which are connected together with a network of collagenous fibrils (Martinez-Lemus, 
2012). Elastic lamina contains elastin that contributes to extensibility and recoil 
function of the vessel wall, which is particularly important to deal with pulsatile pressure 
(Keeley, 2013). The number of elastic laminae gradually decreases, while the smooth 
muscle percentage increases along the arterial system and becomes a major 
constituent in small arteries. In contrast, only a small number of smooth muscle cells 
are found in small veins and venules (Wagenseil & Mecham, 2009).  
 
Tunica adventitia is the outermost layer of the vessel wall including the external elastic 
lamina, terminal nerve fibers, and connective tissues, which mostly comprises of 
fibroelastic tissues and macrophages (Eichmann & Brunet, 2014; Hurlimann, et al., 
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2002; Majesky, et al., 2011; Martinez-Lemus, 2012). The thickness of tunica adventitia 
may vary between vessels. In medium and large-sized veins, tunica adventitia 
contributes to 60% to 75% of the vessel wall, while only 10% is found in the wall of 
large arteries (Rhodin, 1980). 
1.1.3 The endothelium  
The endothelium is a single cell layer forming a continuous lining to all blood vessels 
in the body (Aird, 2007a, 2007b). In an adult human, the endothelial layer consists of 
around 1013 cells in total (Galley & Webster, 2004). As a multifunctional barrier, the 
vascular endothelium is dynamic and adaptive in response to spatial and temporal 
changes to meet regional demands (DeMaio, et al., 2004; Mack, et al., 2009). Indeed, 
endothelial cells have a specific phenotypic (structural and functional) heterogeneity 
that depends on the vascular size or site (Aird, 2007a, 2007b).  
 
The physiological roles of the endothelium involve the complex balance between 
secretory, synthetic, metabolic, immunologic and haemostatic functions (Eliseyeva, 
2013). Endothelial cells may serve as an endocrine “organ” by releasing vasoactive 
substances including nitric oxide, prostacyclin and endothelin, as well as factors 
involved in vasculogenesis and angiogenesis such as fibroblast growth factors, 
vascular endothelial growth factors, angiopoietins and matrix metalloproteinases 
(Adams & Alitalo, 2007; Triggle, et al., 2012b). The endothelium also mediates immune 
and inflammatory reactions by activating signaling processes that are involved in 
leukocyte recruitment and extravasation or activation of T-cell memory (Pober & 
Sessa, 2007). Furthermore, endothelial cells can activate the coagulation system and 
downregulate anti-coagulation factors during pathological conditions such as sepsis 
and trauma (Levi, et al., 2002).  
 
The endothelium plays a major role in regulation of vascular tone by adjusting the 
diameter of the vascular wall through the release of vasoactive substances (Triggle, et 
al., 2012b; Vanhoutte, et al., 2017). Based on these “vasoactions”, endothelium-
released mediators are classified into three different categories: endothelium-derived 
relaxing factors (EDRFs), endothelium-derived hyperpolarizing factors (EDHFs), and 
endothelium-derived contracting factors (EDCFs) (Aird, 2007a, 2007b).  
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1.1.3.1 Endothelium-derived relaxing factors (EDRFs) 
1.1.3.1.1 Nitric oxide  
In early 1980s, Furchgott and Zawadzki showed precontracted vascular rings were 
relaxed in response to acetylcholine and the relaxation required the presence of an 
active endothelium and was independent of prostaglandins (Furchgott, 1984). This 
endothelium-dependent vasodilator was later identified as nitric oxide (NO). NO is a 
lipophilic free radical with single unpaired electron and has a short half-life of less than 
five seconds (Heinrich, et al., 2013; Kang, 2014). As the key signaling molecule in 
vascular homeostasis, NO has important roles beyond vasorelaxation, which include 
cell proliferation, platelet aggregation and adhesion, as well as low density lipoprotein 
oxidation (Kang, 2014).   
 
NO is regulated by the expression and activation of endothelial NO synthase (eNOS) 
that converts amino acid L-arginine to NO (Moncada, et al., 1991) Endothelial NO 
synthase (eNOS) is constitutively expressed in all endothelial cells and its activities are 
closely related to intracellular Ca2+ level (Figure 1.1) (Koo, et al., 2013). An increase in 
intracellular Ca2+ level allows interaction with protein calmodulin (CaM) to form 
Ca2+/CaM complex that facilitates eNOS detachment from caveolin (Cav-1) leading to 
eNOS activation (Busse & Mulsch, 1990; Koo, et al., 2013; Michel, et al., 1997). Shear 
stress and most NO agonists, including bradykinin, acetylcholine (ACh), adenosine 
triphosphate (ATP), substance P, and thrombin, induce NO release by stimulating Ca2+ 
discharge from intracellular storage in the endoplasmic reticulum to trigger eNOS 
activation (Moncada & Higgs, 2006). In contrast, substances that reduce the 
intracellular Ca2+ level can prevent Ca2+/CaM-provoked eNOS activation and reduce 
NO production (Thebault, et al., 2011).  Apart from intracellular store release, 
increased intracellular Ca2+ level can also be achieved through Ca2+ entry from the 
extracellular space (Zhang & Gutterman, 2011). Although the mechanisms are still 
unclear (Huang, et al., 2011), Ca2+ entry to endothelial cells presumably involves store 
operated Ca2+ entry channels (SOCs) (Sundivakkam, et al., 2013). Recent evidence 
suggest that SOCs are predominantly expressed as transient receptor potential (TRP) 
channels in endothelial cells, including TRPV4, TRPC4 and TRPC6 (Zhang & 
Gutterman, 2011) (Sundivakkam, et al., 2013). In addition, several studies also 
reported Orai1 and Ca2+-release activated Ca2+ channels (ICRAC) contributed to 
transient Ca2+ entry in endothelial cells (Li, et al., 2011).  
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Activation of eNOS may also be stimulated through Ca2+-independent pathways. This 
can be accomplished at transcriptional and post-translational levels (Triggle, et al., 
2012b). At the transcriptional level, up-regulation of eNOS expression may occur due 
to biomechanical stimulation, such as shear stress, involving activation of key 
transcriptional proteins such as activator protein (AP)-1 and Kruppel-like factor (KLF)-
2 (Boo, et al., 2002; Koo, et al., 2013). Meanwhile, post-translational modification 
includes eNOS phosphorylation at certain regulatory sites (Ser 617, Ser 635, Ser 1177, 
Ser 1179, Thr 495) (Triggle, et al., 2012b), which is activated via protein kinases, 
including protein kinase A (PKA), protein kinase B (AKT), AMPK and calmodulin-
dependent protein kinase II (Bae, et al., 2003; Butt, et al., 2000; Dudzinski & Michel, 
2007). 
 
After being released from the endothelium, NO diffuses to smooth muscle cells and 
binds to soluble guanylyl cyclase (sGC) on its heme and non-heme sites (Tsai & Kass, 
2009). NO binding to sGC heme center catalyzes the conversion of guanosine 
triphosphate to cGMP up to several-hundred fold (see Fig. 1.1) (Martin, et al., 2012; 
Oppermann, et al., 2011). cGMP subsequently reduces intracellular Ca2+ level through 
several mechanisms: 1) blocking inositol triphosphate (IP)3-sensitive intracellular Ca2+ 
release (Carrasco, et al., 2004), 2)  removal of intracellular Ca2+ via calcium pump (Yao 
& Huang, 2003), 3) halting extracellular Ca2+ influx (Tsai & Kass, 2009), and  4) 
stimulating Ca2+ re-uptake (Cornwell, et al., 1991; Martínez-Ruiz, et al., 2011). 
Reduction in intracellular Ca2+ decreases the myosin light chain kinase (MLCK) and/or 
increases myosin light chain phosphatase (MLCP) activities, leading to 
dephosphorylation of the 20-kDa regulatory light chain of myosin (MLC20) (Morgado, 
et al., 2012). As a result, tonic contraction of VSMC is abrogated and leads to 
vasorelaxation.   
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Figure 1.1 Endothelial nitric oxide production and it actions in the vascular smooth 
muscle cell. ACh= acetylcholine; BK= bradykinin; ATP= adenosine triphosphate; ADP= 
adenosine diphosphate; SP= substance P; SOCa2+= store-operated Ca2+ channel; ER= 
endoplasmic reticulum; NO= nitric oxide; sGC= soluble guanylyl cyclase; cGMP= cyclic 
guanosine-3’, 5-monophosphate; MLCK= myosin light chain kinase. *When Ca2+ stores of the 
endoplasmic reticulum are depleted, a signal is sent to SOCa2+ channel which allows 
extracellular Ca2+ into the endothelial cell. 
 
 
 
1.1.3.1.2 Prostacyclin  
The production and release of NO is an important, but not the sole mechanism of 
endothelial-derived vasoregulation (Evgenov, et al., 2006; Kang, 2014). Prostacyclin 
(PGI2) was firstly identified (as PGX) by Moncada and coworkers in 1970s as a 
vasoactive substance that depended on an active vascular endothelium (Moncada, et 
al., 1976). PGI2 is a lipophilic metabolite synthesized from arachidonic acid, which 
easily diffuses through the endothelial membrane to act as an anticoagulant and local 
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vasorelaxant (Parkington, et al., 2004). Similar to NO, PGI2 is also released in 
response to shear stress, hypoxia, mild oxidative stress, bradykinin, serotonin, and 
growth factors (Kang, 2014; Toniolo, et al., 2013).  
 
PGI2 synthesis is dependent on cyclooxygenase (COX) enzyme, of which two isoforms 
are currently recognized, COX-1 and COX-2 (Kirkbya, et al., 2013). The COX-1 
enzyme is expressed constitutively and mainly involved in physiological conditions and 
serves the ‘housekeeping’ function in endothelial cells. In contrast, COX-2 is an 
inducible form of COX that is increasingly expressed in pathological conditions, 
including during inflammation, angiogenesis and malignancy (Crofford, 1997; Félétou, 
et al., 2011). However, whether prostacyclin production is majorly dependent on the 
COX-1 or COX-2 isoform has not been settled yet (Kirkbya, et al., 2013). Ruan, et al. 
(2011) and others postulate the dominant role of COX-2 over COX-1 in prostacyclin 
biosynthesis, pointing out the potential risk of COX-2 inhibitor use for vascular disease 
development (Skarke & FitzGerald). Nonetheless, in physiological conditions, COX-1-
dependent PGI2 synthesis is apparently more important (Kirkbya, et al., 2013), and this 
theory has been supported by experimental studies using immunohistochemistry 
(Belton, et al., 2000; Kawka, et al., 2007; Mitchell, et al., 2006). 
 
After its release, PGI2 binds to prostanoid receptors in vascular smooth muscle cells 
and activates adenylate cyclase and stimulates cyclic adenosine monophosphate  
(cAMP) (Billington & Penn, 2003). An increase in cAMP subsequently activates protein 
kinase A, leading to vascular smooth muscle relaxation (Fetalvero, et al., 2007; 
Stitham, et al., 2004). Nevertheless, compared to NO, the role of PGI2 as an 
endothelium-derived relaxing factor (EDRF) is less pronounced (Araújo, et al., 2011; 
Vanhoutte, et al., 2017). Verma and colleagues (2001) showed that blocking PGI2 
formation through COX-2 inhibition did not impede endothelial-dependent relaxation in 
healthy volunteers. However, PGI2 contribution in endothelium-dependent vasodilation 
becomes more important when the NO level is diminished during pathological states 
(Sandoo, et al., 2010a) or reduced due to ageing (Eisenach, et al., 2014). In this state, 
PGI2 plays a compensatory role to NO, and hence, chronic and acute inhibition of NO 
synthesis may lead to upregulation of COX-dependent PGI2 production (Beierwaltes, 
2002; Beverelli, et al., 1997). 
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1.1.3.2 Endothelium-derived hyperpolarizing factors (EDHFs) 
In 1980s, Chen et al. first demonstrated that the endothelium could hyperpolarize 
independent of EDRF. The existence of endothelium-derived hyperpolarizing factors 
(EDHFs) is postulated based on the fact that endothelium-dependent relaxation can 
be partially or totally resistant to NO (eNOS) or COX inhibition (Garland, et al., 2011; 
Triggle, et al., 2012b). The contribution of EDHFs becomes more pronounced as the 
vessel size decreases (Shimokawa, et al., 1996), and hence, they play important roles 
in coronary, renal and small arterial vessel tone regulation (Garland, et al., 2011; 
Quilley, et al., 1997; Urakami-Harasawa, et al., 1997). Along the same lines, eNOS 
expression in the mesenteric arteries decreases as the vessels becomes smaller, 
indicating a lesser role for NO function in these small resistant arteries. Indeed, in 
eNOS knock-out mice, EDHFs play a predominant role in endothelium-dependent 
vasodilation as a compensatory mechanism in the absence of endothelial NO 
(Chataigneau, et al., 1999; Waldron, et al., 1999).  Recently, Spilk and colleagues 
(2013) have proposed a significant role of EDHFs in human skeletal muscle 
vasodilation during hypoxia (Spilk, et al., 2013).   
 
The specific mediator of EDHF regulation remains controversial and includes 
epoxyeicosatrienoic acid (EET), a cytochrome P450 of arachidonic acid (Archer, et al., 
2003; Eckman, et al., 1998), myoendothelial gap junction (Sandow & Hill, 2000), 
potassium ions (Quignard, et al., 1999), and hydrogen peroxide (H2O2) (Matoba, et al., 
2002; Shimokawa, 2010). However, instead of a single agent, it is clearer now that 
EDHFs incorporate complex processes involving a number of molecules (Giles, et al., 
2012). Zhang and Gutterman (2011) proposed that endothelial hyperpolarization 
predominantly involves two principal pathways, the classic pathway and the second 
pathway. 
 
In the classic pathway, EDHFs are thought to induce vascular hyperpolarization 
through the activation of Ca2+-activated K+ channels (SKCa, IKCa) located in endothelial 
cells (Dora & Garland, 2013). The hyperpolarization is then conducted to vascular 
smooth muscle cells through myoendothelial gap junctions (Garland, et al., 2011; 
Zhang & Gutterman, 2011). K+ efflux via SKCa and IKCa raises extracellular K+ level 
between endothelial cells and smooth muscle cells, which subsequently activates KIR, 
KATP or Na+/K+ ATPase (Bełtowski & Jamroz-Wiśniewska, 2014). This process in turn 
hyperpolarizes smooth muscle cells decreasing Ca2+ influx via voltage-gated Ca2+ 
channels, and leads to vasorelaxation (Bełtowski & Jamroz-Wiśniewska, 2014). The 
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EDHF pathway is dependent on increased endothelial intracellular Ca2+, particularly to 
activate the endothelial KCa channels considering these channels are not voltage 
dependent but depend on [Ca2+]i elevation (Crane, et al., 2003). Again, the increase of 
endothelial [Ca2+]i can be accessed from intracellular store release or via extracellular 
entry through TRP channels (Zhang & Gutterman, 2011).  
 
In the second pathway, alternatively, endothelial hyperpolarization may occur 
insensitive to SKCa and IKCa blockage (Edwards, et al., 2010). This pathway is thought 
to involve endothelial releasing factors such as cytochrome P450-derived EET and 
superoxide anion metabolite, H2O2 (Zhang & Gutterman, 2011). EET appears to 
activate non-classical BKCa and KATP channels in human or rat vasculatures (Larsen, 
et al., 2006; Lu, et al., 2006). Similar to the classic pathway, hyperpolarization via EET 
is also a Ca2+-dependent process (Zhang & Gutterman, 2011), especially because 
EET synthesis by cytochrome P450 requires an increase in Ca2+ level to stimulate the 
release of arachidonic acid (Griffith, 2004). Meanwhile, H2O2, so far, has been linked 
to activation of BKCa, KATP, Kir, and Kv channels, dependent on the vessel type 
(Edwards, et al., 2010). EET and H2O2 are found to co-exist in some vascular beds, 
such as porcine and human coronary artery, as well as rabbit mesenteric arteries 
(Larsen, et al., 2008) (Weston, et al., 2005; Zhang, et al., 2007).  
 
1.1.3.3 Endothelium-derived contracting factors (EDCFs) 
 
1.1.3.3.1 Endothelin-1 (ET-1) 
 
Two years after the discovery of EDRF by Furchgott and Zawadzki, the presence of 
endothelium-derived contracting factors (EDCFs) was first recognized (De Mey & 
Vanhoutte, 1982; De Mey & Vanhoutte, 2014). After purification and sequencing, 
Yanagisawa and coworkers (1988) identified one of the contracting factors as 
endothelin-1 (ET-1) (Rubanyi, 2011). ET-1 is a peptide consisting of 21-aminoacids 
(Yanagisawa, et al., 1988), generated from a 38 amino acid precursor, proendothelin-
1 after its conversion to big endothelin-1 by endothelin converting enzymes (ECEs) 
(De Mey & Vanhoutte, 2014; Grover, et al., 1992; Haynes & Webb, 1994).  
 
ET-1 effects are elicited through its binding to two different types of endothelin 
receptors (Arai, et al., 1990; Sakurai, et al., 1990), namely endothelin-A (ETA) and 
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endothelin-B (ETB) (Barton, 2011; Ohkita, et al., 2012). The ETA subtype, mostly 
expressed in vascular smooth muscle, is known to primarily mediate vasoconstriction, 
whereas ETB may have biphasic actions dependent on the localization of the receptors 
(Barton, 2011; Faraci & Heistad, 1998). The activation of ETB receptors in vascular 
smooth muscle induces a profound vasoconstriction (Ohkita, et al., 2012), especially 
in the arteriolar resistance and venous capacitance vessels (Haynes & Webb, 1994), 
or in disease states such as atherosclerosis and ischaemic heart disease (Dimitrijevic, 
et al., 2009; Iwasa, et al., 1999). While present in endothelial cells, ETB activation 
appears to facilitate EDRF and EDHF release leading to vasorelaxation, as well as to 
contribute to ET-1 clearance (Mazzuca & Khalil, 2012).  
 
ET-1 is released continuously from endothelial cells and, to a lesser extent, from 
vascular smooth muscle cells, to maintain vascular tone (Thorin & Webb, 2010). As 
the most potent endogenous vasoconstrictor, ET-1 vasoregulation is interconnected 
with NO in several ways: 1) exogenous or endogenous NO inhibits ET-1 production 
and release (Junbao, et al., 1999; Mitsutomi, et al., 1999; Rapoport, 2014b), 2) 
increased NO level reduces response and sensitivity to ET-1 (Chen, et al., 2003), 3) 
eNOS inhibition leads to increased ET-1 dependent vasoconstriction (Hilgers & De 
Mey, 2009; Rapoport, 2014a), 4) blocking ETA receptors leads to upregulation of 
eNOS expression and increased NO activity (Barton, et al., 1998; Taner, et al., 2001), 
and 5) ET-1 binding to ETA reduces eNOS expression and activity (Wedgwood & 
Black, 2005). This close ET-1/ NO interaction becomes the Yin and Yang of vascular 
function (Marasciulo, et al., 2006). Indeed, alteration of this balance is evidently 
important in vascular dysfunction (Bourque, et al., 2011) and the pathogenesis of 
cardiovascular diseases (Böhm & Pernow, 2007; Félétou, et al., 2012; Tanaka, et al., 
2013). Recently, De Mey and Vanhoutte (2014) speculated about the presence of 
mechanisms beyond endothelial NO that may also interact with ET-1 regulation in 
vascular tone, and these include the sensorimotor neurotransmitter calcitonin gene-
related peptide (CGRP). However, at this stage, available data supporting this 
contention are still limited. 
 
1.1.3.3.2 COX-derived prostanoids  
In addition to endothelial peptides (endothelin-1), moment-to-moment vascular tone is 
also regulated by contracting factor prostanoids derived from COX (Vanhoutte, 2011). 
Tang et al. (2005) showed that the EDCF activity was abolished in the aorta of COX-
1, but not COX-2, knockout mice. Furthermore, inhibition of COX-1 (and not COX-2) 
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was shown to prevent endothelium-dependent vasoconstriction in diabetic rats (Shi, et 
al., 2007), and the genomic expression of COX-1 increased in spontaneously 
hypertensive rats (Tang & Vanhoutte, 2008). These data suggest a predominant role 
of COX-1 in EDCF-mediated vasoconstriction (Vanhoutte, 2011). 
 
After being released from endothelial cells, COX-derived contracting prostanoids 
diffuse to the adjacent vascular smooth muscle and activate the thromboxane-
prostanoid (TP) receptors (Shi & Vanhoutte, 2014). The TP receptors are 
predominantly stimulated by thromboxane A2, but may also be by a high level of 
endoperoxides (PGH2) (Vanhoutte, 2011), COX-2 derived PGF2 during ageing (Wong, 
et al., 2009), and paradoxically, PGI2, as seen in spontaneously hypertensive rats 
(Félétou, et al., 2009). The activation of TP receptors stimulates production of IP3 and 
DAG via activation of phospholipase C (Dorn & Becker, 1993; Suzuki, et al., 2012), 
which increases the intracellular free Ca2+ through the opening of voltage-dependent 
and independent channels and leads to vasoconstriction (Suzuki, et al., 2012). In 
addition, Liu et al. (2009) demonstrated that TP-evoked vasoconstriction could be 
achieved by averting eNOS activity via the RhoA/Rho-kinase pathway in rat carotid 
artery, which was also confirmed in rat aorta (Chan, et al., 2009). This Ca2+-
independent pathway of TP-evoked vasoconstriction may also be important in vascular 
dysfunction and warrants further investigation (Liu, et al., 2009). 
 
1.1.4. The vascular smooth muscle cells (VSMCs) 
The VSMCs comprise the contractile fibers (actin-myosin) normally located in the 
tunica media layer of blood vessels (Shinohara, et al., 2012). The existence of VSMC 
heterogeneity has been uncovered ranging from contractile to synthetic/proliferative 
phenotypes (Beamish, et al., 2010). The modulation of VSMC phenotypes depends on 
the development state or pathophysiological conditions. For example, the contractile 
phenotype is mostly expressed in healthy and mature VSMCs, while in developing 
arteries, the synthetic/proliferative phenotype is more dominant (Shinohara, et al., 
2012). During pathological conditions, the VSMC phenotype can reversibly swift to be 
more proliferative and migratory while losing its contractility function (Alford, et al., 
2011). The many factors that trigger the switching (phenotype modulation) have been 
proposed and these include extracellular matrix (Qin, et al., 2000), platelet-derived 
growth factor (PDGF) and transforming growth factors (TGF) (Hirschi, et al., 1998; 
Thomas, et al., 2009), angiotensin II (Kim, et al., 2005), microRNAs (Cheng, et al., 
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2009; Davis, et al., 2009), and collagen isotypes (Orr, et al., 2009). However, at this 
stage, it is still difficult to conclude the actual mechanism of this phenomenon due to 
contradictory findings between laboratories (Alexander & Owens, 2012).   
 
Like the endothelium, VSMCs have numerous other vascular functions and these 
include angiogenesis, immune and chemokine regulation (Hayes, et al., 1998; Ma, et 
al., 2007). However, the foremost role of VSMC is to regulate vascular tone and blood 
pressure to maintain adequate systemic and regional perfusion (Rensen, et al., 2007). 
This is achieved by maintaining the balance between the cellular signaling pathways 
mediating force generation (contraction) and release (relaxation). The contraction and 
relaxation of VSMCs involves 3 distinctive mechanisms: 1) regulation of intracellular 
free Ca2+ ([Ca2+]i) level, 2) modulation of VSMC-Ca2+ sensitivity and 3) actin filament 
regulation (Akata, 2007a, 2007b; Hirano, 2007). These mechanisms will now be 
discussed in more detail. 
.  
1.1.4.1 Contraction of VSMCs 
The contraction of VSMCs is largely dependent on increases in intracellular [Ca2+]i 
levels in VSMC. The basal vascular tone is maintained at [Ca2+]i levels around 10-9 M, 
while VSMC contraction is initiated when [Ca2+]i is elevated to 10-6 M (Koledova & 
Khalil, 2006). The two to three orders of magnitude [Ca2+]i increase is generally 
achieved in two ways: 1) via Ca2+ influx from the extracellular compartment, and 2) 
through Ca2+ release from intracellular stores in the sarcoplasmic reticulum (Khalil, 
2010) (see Figure 1.2). The first mechanism is the major source of [Ca2+]i increase, 
which occurs through various Ca2+ channels or Ca2+ exchangers on membrane cells 
(Horowitz, et al., 1996). Accordingly, the use of Ca2+ channel blockers inhibits vascular 
contraction or can lead to vasodilation (Cauvin, et al., 1983; Timmermans, et al., 1983). 
The release of Ca2+ from the sarcoplasmic reticulum is believed to occur in response 
to activation of inositol triphosphate (IP3) or ryanodine (Ry) receptors (Rainbow, et al., 
2009).  In addition,  [Ca2+]i can be increased by the simultaneous activation of a Ca2+-
induced Ca2+ release (CICR) mechanism (Breemen & Saida, 1989). This phenomenon 
has been observed in skinned cardiac cells from adult human, dog, cat, rabbit, and 
frog (Fabiato & Fabiato, 1978). 
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Figure 1.2 Mechanisms of VSMC contraction. 
 
In VSMCs, [Ca2+]i interacts with specific Ca2+-binding proteins, calmodulin (CaM), 
which serves as a critical sensor for Ca2+ regulation (Koledova & Khalil, 2006). The 
Ca2+/CaM complex activates 20-kDa myosin light chain (MLC20) kinase, which leads 
to MLC20 phosphorylation (Van Lierop, et al., 2002), which not only facilitates myosin 
monomers to gather into filaments but also enhances the actin-activated Mg2+-ATPase 
activity (Horowitz, et al., 1996). This process facilitates the actin-myosin binding 
leading to VSMC contraction (see Figure 1.2).  
 
However, Ca2+-dependent MLC phosphorylation is not the sole mechanism in VSMC 
contraction. Itoh and colleagues (1993) suggest other mechanisms that increase the 
myofilament force by changing the sensitivity to Ca2+ over a range of [Ca2+]i levels (Itoh, 
et al., 1993) or different states of MLC20 phosphorylation (Khalil & van Breemen, 1990) 
(Khalil, 2010). Ca2+ sensitization of myosin is believed to be modulated by the ratio of 
myosin light-chain kinase (MLCK) to myosin light chain phosphatase (MLCP) activity 
(Somlyo & Somlyo, 2003) (see Figure 1.2).   
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In addition to changing Ca2+ sensitization, Gunst and Zhang (2008) proposed another 
mechanism of increasing smooth muscle contraction involving polymerization of actin 
filaments (Gunst & Zhang, 2008). Actin polymerization is now recognized as an 
essential mechanism for tension development beyond actin-myosin interaction (Gunst 
& Zhang, 2008). Several reports have shown that pharmacological inhibition of actin 
polymerization leads to reduced VSMC contractile responses (Adler, et al., 1983; 
Saito, et al., 1996; Shaw, et al., 2003). Recent studies by Moreno-Dominguez and 
colleagues have suggested the involvement of ROK and PKC pathways in regulation 
of actin filament polymerization (Moreno-Domínguez, et al., 2013). 
 
1.1.4.2 Relaxation of Vascular Smooth Muscle Cells (VSMCs) 
Endothelium-derived NO initiates VSMC relaxation by activating the soluble guanylyl 
cyclase to generate cyclic guanosine monophospate (cGMP) (Qin, et al., 2007). 
However, the intracellular events that occur downstream after cGMP formation 
remains controversial (Qin, et al., 2007).  One downstream target is the activation of 
cGMP-dependent protein kinase (PKG) (Burgoyne, et al., 2012; Lincoln, et al., 2001; 
Sausbier, et al., 2000; Schlossmann, et al., 2003) which can lead to vascular relaxation 
(Feil, et al., 2003; Pfeifer, et al., 1998).   
 
The general consensus of VSMC relaxation, including the NO/cGMP/PKG pathways, 
is mediated by at least four major mechanisms: 1) decreases in [Ca2+]i level, 2) calcium 
desensitization, 3) thin filament regularization (actin depolymerization), and 4) 
hyperpolarization of VSMC membrane (Morgado, et al., 2012). VSMC membrane 
hyperpolarization is mostly mediated by PKG-modulation of K+ channel activity in 
membrane cells (Morgado, et al., 2012). K+ channel blockade results in membrane 
depolarization leading to increased Ca2+ influx through voltage-gated Ca2+ channels; 
in contrast, K+ opening leads to reduced Ca2+ influx (Brayden, 1996).  The role of the 
specific K+ channels in vessel tone regulation will now be discussed.   
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1.1.5 Role of potassium (K+) channels and Na+/K+-ATPase in vascular tone 
 
1.1.5.1 Role of K+ channels in vascular tone 
 
K+ channels in the plasma membrane have profound effects on the regulation of 
vascular tone by regulating K+ outflow, leading to smooth muscle cell hyperpolarization 
(Dick & Tune, 2010). Hyperpolarization triggers the closing of voltage-dependent Ca2+ 
channels (VDCC), reducing Ca2+ influx and resulting in vascular relaxation. 
Conversely, blocking K+ channel causes smooth muscle cell depolarization, triggers 
VDCC opening, increases intracellular Ca2+ and leads to vasoconstriction (Dick & 
Tune, 2010).  
 
K+ channels are divided into three main families based on their different molecular 
structures. The number of transmembrane (TM) segments in their subunits divide K+ 
channels into 1) 2TM, 2) 4TM and 3) 6TM classifications (Tang, et al., 2004). These 
three main families of K+ channels are further divided into subclasses of K+ channels 
(Sandhiya, 2009):  
• 2TM family: these K+ channels are also known as inward-rectifier K+ channels 
(KIR). Adenosine 5’-triphospate-sensitive K+ channel (KATP) is one of the 
examples of this family.  
• 4TM family: these channels have two pore domains in their α-subunits. The 
channels include: TWIK, TREK, TASK, TALK, THIK and THRESK. 
• 6TM family: in this family there are voltage-activated K+ (Kv) channels and Ca-
activated K+ (KCa) channels. There are three types of KCa channels: Small-
conductance KCa (SKCa) channels, Intermediate-conductance KCa (IKCa) 
channels, and Large-conductance KCa (BKCa) channels. 
 
Among the wide variety of K+ channels, the major ones that play an important role in 
vascular reactivity and blood flow regulation are: Kv, KATP, KIR and Kca (Ko, et al., 2008).  
 
 
 1.1.5.1.1 ATP-sensitive K+ (KATP) channels 
 
ATP-sensitive potassium (KATP) channels were first discovered in the heart 30 years 
ago (Nichols, et al., 2013; Noma, 1983). KATP channels are believed to link cell 
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metabolism to membrane excitability and are involved in a wide range of physiological 
processes including control of vascular tone, hormone secretion and protection of 
cardiac and neuronal cells against ischaemic injuries (Nichols, et al., 2013). The KATP 
channel is a large hetero-octamer of nearly 950 kDa, and is composed of four KIR 6.1 
or 6.2 as α-subunits, and four sulphonylurea receptor (SUR) proteins as β-subunits 
(Ko, et al., 2008). Adenosine 5’-triposphate (ATP) inhibits the channels by binding to 
the α-subunit, while adenosine diphosphate (ADP) activates the channels by binding 
to the SUR domain (Nelson & Quayle, 1995). SUR was so-named from the β-subunits 
of the channels being sensitive to the K+-channel blocker, sulphonylurea (Ocaña, et 
al., 2004). Potassium channel openers such as pinacidil and levocromakalim also can 
activate the channels via these SUR subunits. In addition to vascular smooth muscle, 
KATP channels are found in heart (Zingman, et al.),  brain (Ballanyi, 2004), pancreas 
(Remedi & Koster, 2010), skeletal muscle (Banas, et al.), and vascular endothelium 
(Figura, et al., 2009; Martin, et al., 2013). 
 
The presence of KATP channels on vascular smooth muscle and endothelium have 
been reported in a number of different vascular beds including the aorta (Tang, et al., 
2005), coronary (Duncker, et al., 1993) and mesenteric artery (Nelson, 1990). As 
mentioned above their primary role is the regulation of vascular tone (Daut, et al., 1994; 
Nichols, et al., 2013). Endogenous vasodilators such as calcitonin gene related 
peptide, prostacyclin, and adenosine are known to activate KATP channels via protein 
kinase A stimulation (Mannhold, 2004). Kuo and co-workers (1995) specifically 
showed that adenosine increased flow-induced relaxation in swine coronary artery by 
activating KATP channels in endothelium, which in turn release NO. They further found 
that flow-induced relaxation by adenosine was inhibited by 10-6 M sulfonylurea 
glibenclamide (Kuo & Chancellor, 1995). Endogenous vasoconstrictors, including 
endothelin-1, norepinephrine, and vasopressin, on the other hand, are shown to inhibit 
KATP channels (Park, et al., 2005; Tan, et al., 2007; Tsuchiya, et al., 2002). While 
endothelin-1 and vasopressin-induced vasoconstriction involve blocking KATP channels 
via PKC-coupled reactions (Park, 2005; Tsuchiya, 2002), Tan and coworkers showed 
that norepinephrine inhibition of KATP channels is mediated by α2-adrenoceptor, 
possibly through inhibition of PKA activity (Tan, et al., 2007).  
 
Pharmacological modulation of KATP channels is largely studied using K+ channel 
openers (KCOs) (Mannhold, 2004). KCOs such as cromakalim, levcromakalim, 
minoxidil, nicorandil, pinacidil and diazoxide cause KATP channels to become less 
sensitive to ATP inhibition, leading to increased K+ efflux, hyperpolarization and 
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relaxation (Brayden, 2002; Mannhold, 2004).  This effect to relax the vessel and 
increase flow can be blocked by 0.5-10 µM glibenclamide (Waldron & Cole, 1999), but 
not by KCa channel inhibitors (such as iberiotoxin and apamin) or low concentration of 
tetraethylammonium (TEA) (Brayden, 2002). In addition, KATP channels can be 
activated in pathophysiological states, including hypoxia (Quayle, et al., 2006), septic 
shock (Buckley, et al., 2006), acidosis (Xu, et al., 2001), as well as during ischaemic-
reperfusion to provide cellular protection (Okorie, et al., 2011). 
 
 
1.1.5.1.2 Voltage-activated K+ (Kv) channels 
 
Mammalian voltage-activated K+ channels (Kv) were first cloned by Tempel and co-
workers in 1988, a decade after Hodgkin and Huxley (1952) unveiled the electrical 
basis of cellular signaling (Jan & Jan, 2012). They are transmembrane proteins that 
enable the movement of K+ ions down an electrochemical gradient (Pardo & Stuhmer, 
2014). As voltage-gated channels, the shift between opening and closing of Kv 
channels is dependent on transmembrane voltage (Jensen, et al., 2012). Jensen and 
colleagues (2012) further showed at the atomic level conformational shifting of Kv 
channels can be stimulated by altering the transmembrane voltage below 
(hyperpolarization) or higher than 0 mV (depolarization). The activation of Kv channels 
increases outward K+ currents and hyperpolarizes the smooth muscle cells, reduces 
Ca2+ entry via closing of voltage-dependent Ca2+ channels (VDCC), and causes 
vasodilation. In contrast, Kv channel inhibition will cause cell depolarization, open the 
VDCC, increase [Ca2+]I, and cause vasoconstriction (Makino, et al., 2011).  
 
Kv channels are also recognized as delayed rectifier K+ channels due to their delayed 
activation kinetics during the action potential. The term ‘rectifier’ comes from an 
electronic term when a circuit component conducts current on one direction compared 
to the other (Resta & Becchetti, 2010). The Kv channel consists of four polypeptides 
with each containing six transmembrane segments (S1-S6). The first four membranes 
are thought to control the channel’s pore opening and closing, with S4 being the 
voltage sensor of the channel (Miller, 2000). Each α-subunit is linked to additional β-
subunits that determine the channel characteristics. The β-subunit was found to modify 
the inactivation kinetics of the Kv channel by accelerating the process (Pongs, et al., 
1999; Torres, et al., 2007), and post-translational modification of the β-subunit by PKC 
phosphorylation plays a pivotal role in Kv channel’s inactivation and voltage sensitivity 
(David, et al., 2012; Niwa & Nerbonne, 2010). 
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It is believed that there are multiple Kv channel subtypes expressed in smooth muscle 
cells as a number of investigators have reported differences in voltage-dependence 
activation (Jan & Jan, 2012), sensitivity against inhibitors (Marzian, et al., 2013), as 
well as differences in gating properties (Niwa & Nerbonne, 2010). For example, tissue 
expression of Kv1.5, Kv2.2 and Kvβ4 subunits have been reported in smooth muscle of 
canine artery (Ko, et al., 2008), while Kvα1.2, Kvα1.5, Kvβ1.1, Kvβ1.2, Kvβ 2.1 and others 
have been reported in rat pulmonary artery (Cox, 2005; Standen & Quayle, 1998; 
Yuan, et al., 1998). 
 
The presence of the Kv channel and its properties in vascular smooth muscle and 
endothelial cells have been studied using the inhibitor 4-aminopyridine (4-AP) (Cox, 
2005; Ko, et al., 2008). 4-AP (0.5 – 5 mM) is the most selective known inhibitor for 
almost all Kv channels subtypes, except Kv7  (Martelli, et al., 2013; Novakovic, et al., 
2012; Yuan, et al., 1998). 4-AP inhibits Kv channels in both open and closed forms, 
and it is believed that the 4-AP blocking site on the channel is at the internal side of 
the membrane cell (Bouchard & Fedida, 1995; Claydon, et al., 2007).  
 
Kv channels are abundantly expressed in vascular smooth muscle cells (Ko, et al., 
2010) including rat mesenteric (Lu, et al., 2002), rat pulmonary artery (Michelakis, et 
al., 2002), rat kidney (Carrisoza-Gaytán, et al., 2010) and also rat aorta (Palacios, et 
al., 2013). In contrast, there are fewer reports of the presence of Kv channels in 
vascular endothelium. However, Jow and colleagues (1999) reported the presence of 
K+ outward current in vascular endothelium, which could be blocked by 4-AP, and this 
implied the presence of Kv channels in cultured human capillary endothelial cells. A 
more recent study by Millar and coworkers (2008) also showed the expression of Kv 
channels in endothelium of brain vasculatures (Millar, et al., 2008).    
 
 
1.1.5.2 Role of Na+/K+-ATPase in vascular tone 
 
Potassium regulation in vascular tissue also arises from regulation of the Na+/K+ pump 
(Vedovato & Gadsby, 2014).  Although, Na+/K+-ATPase is an integral protein that 
functions as an ion transporter like ion channels, it is categorized as an ion active pump 
since it is energized by ATP hydrolysis (Morth, 2011). When activated, channels permit 
ions to flow down their electrochemical gradients, whilst pumps actively push ions 
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against these gradients (Gadsby, 2009). The Na+/K+ pump expels three Na+ ions out 
for two K+ ions into the cell at the expense of ATP (Vedovato & Gadsby, 2014). The 
Na+/K+-ATPase function is important to maintain the high potassium and low sodium 
concentrations inside the cell, however, its activity decreases during aging (Maurya & 
Prakash, 2013). The Na+/K+-ATPase consists of two (α and β) subunits. The α-subunit 
acts as the binding site for cations, ATP or the inhibitor (ouabain); and also regulates 
the catalytic and transport function of the enzyme. Whereas, the β-subunit is believed 
to play an important role in maintaining the normal activity of the enzyme (Morth, et al., 
2009). 
 
In vascular tissue, Na+/K+-ATPase is found in smooth muscle cells in rat (Oguchi, et 
al., 1993), canine (Allen, et al., 1986) as well as rabbit aorta (Gupta, et al., 1994).  The 
presence of the Na+/K+ pump has also been reported in isolated human endothelial 
cells (Duran, et al., 2010). If the pump is activated the difference in pumping three Na+ 
ions out compared to two K+ ions pumped in leads to vascular smooth muscle 
membrane hyperpolarization which decreases intracellular Ca2+ availability, and 
relaxes the smooth muscle cells (Lockette, et al., 1980), thus reducing vessel lumen 
size. In addition to its ion-pumping function, the Na+/K+ATPase role as a signal 
transducer has been recognised to mediate multiple protein-protein complexes 
(Reinhard, et al., 2013). 
 
1.2 Mechanism of vasospasm  
Vasospasm refers to a temporary condition in which an arterial blood vessel spasms 
or constricts which can reduce blood flow and lead to ischaemia (Moukarbel & 
Weinrauch, 2012). Vasospasm occurs in the coronary arteries (Lanza & Crea, 2010), 
cerebral arteries (Siasios, et al., 2013), ocular arteries (Gasser, 1989) and mesenteric 
arteries (White & Hassoun, 2013). The cause of arterial vasospasm is believed to 
involve at least one of three mechanisms: 1) endothelial dysfunction, 2) hyperactivity 
of VSMC to vasoconstrictive stimuli, and 3) sympathetic nerve dysfunction (Lanza, et 
al., 2011).  
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1.2.1 Endothelial dysfunction 
 
As discussed previously, the endothelium plays a crucial role in modulating vessel tone 
by releasing EDRFs (NO and PGI2), EDHF, and EDCFs (endothelin-1) to maintain 
basal tone (Sandoo, et al., 2010a). However, endothelial injury leads to an imbalance 
between these vasoactive mediators and vascular tone (Lanza, et al., 2011). 
Endothelial injury leads to reduced NO, PGI2 and EDHF release, and increases 
endothelin-1 production leading to impaired vasodilation and pronounced 
vasoconstriction (Virdis, et al., 2010), causing  vasospasm (Moukarbel & Weinrauch, 
2012).  
 
The vascular endothelium has other important functions such as vessel wall 
remodeling (Rudic, et al., 1998), regulation of inflammatory mediators (Harrison, et al., 
2006) and anti-thrombotic factors (Vanhoutte, 2009; Wu & Thiagarajan, 1996). An 
imbalance between growth-inhibitors and growth-promoting factors, the pro- and anti-
inflammatory mediators, the pro- and anti-coagulation factors, as well as the excessive 
reactive oxygen species (ROS) can occur from endothelial injury (Rajendran, et al., 
2013). Chronic endothelial dysfunction is associated with atherosclerosis (Bonetti, et 
al., 2003; Davignon & Ganz, 2004), essential hypertension (Perticone, et al., 2001), 
peripheral vascular disease (Vita & Hamburg, 2010) and stroke (Roquer, et al., 2009). 
Oxidative stress is thought to be the common denominator of endothelial dysfunction 
(Chrissobolis, et al., 2010; Schulz, et al., 2011; Shrestha, et al., 2018). Elevated ROS 
not only directly inactivates NO but also impairs its synthesis (Landmesser, et al., 
2006). In addition to oxidant stress, a range of factors can also contribute to endothelial 
dysfunction (Félétou & Vanhoutte, 2006). These include aging (Herrera, et al., 2010), 
smoking (Lavi, et al., 2007), dyslipidaemia (Guardamagna, et al., 2009), 
hyperhomocyteinemia (Jin, et al., 2007), and hypertension (Versari, et al., 2009). 
Recently, it has been reported that accumulated chemotherapy may also induce 
arterial stiffness and endothelial dysfunction (Taniguchi, et al., 2014). Medical 
interventions do not necessarily improve endothelial function, but they may recover 
part of these factors or symptoms (Félétou, et al., 2011; Flammer, et al., 2012). 
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1.2.2 Vascular Smooth Muscle Cell (VSMC) hyperactivity  
 
It has been revealed that VSMC could provoke extreme responses to agents leading 
to vasospasm in a range of pathological conditions (Lacolley, et al., 2012). Spasmodic 
agents may include catecholamines, serotonin, vasopressin, and also EDCF including 
COX-derived prostanoids (thromboxane A2) and endothelin-1 (Hoenicka, et al., 2011; 
Sung, et al., 2009). 
 
Vascular hyper reactivity has been demonstrated in human Prinzmetal's angina or 
coronary artery spasm (Okumura, et al., 1996), human diabetes  (Fleischhacker, et al., 
1999; Guo, et al., 2005) and in spontaneously hypertensive rats (de Oliveira Salgado 
& Krieger, 1982). The in vivo mechanism for abnormal vascular reactivity remains 
unknown. In diabetic and hypertensive animal models, Oliveira and colleagues have 
implicated the COX system (de Oliveira Salgado & Krieger, 1982; Guo, et al., 2005), 
and Kadokami and colleagues has suggested enhanced Ca2+ sensitivity mediated by 
increased Rho-kinase or protein kinase C activities in abnormal coronary artery spasm 
(Kadokami, et al., 1996; Kandabashi, et al., 2000). 
 
 
1.2.3 Sympathetic nerve innervation 
 
Apart from endothelial dysfunction and vascular hyper-reactivity, increased 
sympathetic tone has also been implicated as one of the triggers of vasospasm 
(Brunet, et al., 2014). Increased sympathetic stimulation can lead to elevated 
catecholamines, serotonin and vasopressin, leading to prolonged vasoconstriction 
(Guyenet, 2006). Immunohistochemical studies demonstrated that sympathetic nerves 
mainly project to the tunica adventitia and the border between the adventitia and tunica 
media of the vessels (Reddy, et al., 2011). The density of sympathetic fiber innervation 
is apparently dissimilar in large elastic and small resistance arteries (Brunet, et al., 
2014). Large elastic aorta are poorly innervated (Storkebaum & Carmeliet, 2011), while 
very dense innervation is predominantly observed in skin and mesenteric arteries, and 
hence, these are more vulnerable to sympathetic stimulation (Luff, et al., 2005; 
Ruocco, et al., 2002). Barry and colleagues (2007) further showed that sympathetic 
innervation is evident in the adventitia of coronary, radial, ulnar and epigastric, but not 
in internal thoracic arteries (ITA), which may partly explain the better patency of ITA 
(Barry, et al., 2007; He, 1999). However, more recently, Reddy and coworkers (2011) 
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found the presence of a sympathetic nerve area in ITA of men and women. However 
there is no direct contact between the VSMCs and sympathetic nerves which may 
contribute to the low incidence of spasm in ITA conduits (Reddy, et al., 2011).  
 
 
1.3 The importance of pharmacological vasodilation and vascular 
protection in cardiac surgery 
 
As the prevalence of cardiovascular diseases grows worldwide, there is an increasing 
need to find new vasoactive agents (single or in combination) to maintain improved 
supply-demand balance in the heart (Gulati & Simari, 2009) and to ensure sufficient 
ventricular-arterial coupling and tissue oxygen supply following cardiac and major 
surgery (Ky, et al., 2013). This thesis will address three different vascular conditions 
that continue to challenge surgeons, cardiologists and post-operative intensive care 
unit (ICU) specialists.  
 
 
1.3.1 Preventing Arterial Graft Spasm  
 
Internal mammary or radial arterial conduits are commonly used for CABG as they are 
easily accessible and have relatively low occlusion rates at around 8-10% after the first 
year (Desai, et al., 2004; Tatoulis, et al., 1999), and 13-15% after 8-10 years (Buxton, 
et al., 2009; Goldman, et al., 2004b). A potential limitation of arterial grafts is their high 
susceptibility of vasospasm during graft preparation (Gao, et al., 2013; Watanabe, et 
al., 2013), and peri-operative spasm which occurs in around 10% of cases (Ajani & 
Yan, 2007; Velez, et al., 2001). Vasospasm may contribute to early myocardial 
ischaemia and myocardial infarction (Kaul & Ito, 2004). 
 
Current dilators used in cardiac surgery to help overcome perioperative spasm are 
papaverine, calcium channel blockers (diltiazem and verapamil), organic nitrates 
(glyceryl-trinitrate and nitroglycerine), selective phospodiesterase III inhibitors 
(levosimendan), K+ channel openers (levokromakalim, diazoxide, minoxidil sulphate), 
and alpha-adrenoceptor antagonist (phenoxybenzamine), lidocaine, and more recently 
the Rho-kinase inhibitor fasudil (Watanabe, et al., 2013; Yildiz, et al., 2013). The 
problem is many of these vasodilators have not been standardized and their use varies 
from surgeon to surgeon.  
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For example, topical papaverine, a phosphodiesterase inhibitor (Yildiz, et al., 2013) is 
very common but it is acidic and short-lived in effect (Murakami, et al., 2009), and there 
is growing evidence that papaverine may lead to endothelial dysfunction (Dipp, et al., 
2001; Gao, et al., 2002; He, 1998; Mayranpaa, et al., 2004). Gao and colleagues have 
shown that papaverine induces apoptosis and endothelial damage in canine and 
human internal thoracic or radial arteries especially at high concentrations (Gao, et al., 
2002).  Mayranpaa has also shown reduced endothelial viability in the presence of 
papaverine in cultured human coronary endothelial cells (Mayranpaa, et al., 2004). 
Since the integrity of endothelial cells is crucial for normal vascular function and post-
graft patency, alternative strategies to prevent and protect spasm have been sought 
(Gao, et al., 2002). To this end, in 2013, Watanabe and colleagues showed that fasudil 
had a very potent vasodilatory effect on the internal thoracic artery compared with 
conventional papaverine and it resulted in increased graft free flow (Watanabe, et al., 
2013).  The group concluded that the Rho-kinase inhibitor may be a useful graft dilating 
agent in cardiac surgery, however it remains to be globally adopted. In summary, 
despite decades of investigating numerous pharmacological agents to relax arterial 
conduits for CABG surgery, there remains a need for alternate topical agents that are 
effective, safe and affordable.  
 
 
1.3.2 Reducing Mesenteric Artery Vasoconstriction and Spasm  
 
Vasoconstriction and/or spasm of the superior mesenteric artery that delivers blood to 
the intestine from the lower part of the duodenum through two-thirds of transverse 
colon, as well as the pancreas, can be life-threatening following cardiac surgery or 
other major surgery (Oldenburg W, 2004). Reduced blood flow can lead to acute 
mesenteric ischaemia (AMI).  Although relatively rare, AMI arises from vasospasm, 
occlusion, and/or sudden hypoperfusion of the mesenteric vasculature (Oldenburg, et 
al., 2004).  
 
The clinical consequences of AMI can be catastrophic, including sepsis, bowel 
infarction, and death (Berland & Oldenburg, 2008). Based on autopsy data from the 
1970-1980s, 12.9 per 100.000 population have been diagnosed with this condition 
(Acosta & Björck, 2014). Despite its low incidence, the mortality rate ranges from 70% 
to 100% (Schütz, et al., 1998), and appears to be on the rise in the past few years 
(Berland & Oldenburg, 2008). The condition can be due to low cardiac output, 
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increased sympathetic tone causing mesenteric artery vasoconstriction, or embolic or 
thrombotic occlusion (Eker, et al., 1999; Imanaka, et al., 2006). 
 
The management of AMI is difficult and there are few drug therapies to alleviate the 
condition. One method for non-occlusive AMI is continuous intravenous infusion of 
papaverine (Kahn, 2011; Oshikata, et al., 2013). However, as mentioned above, the 
use of papaverine has been associated with side effects including cardiac 
tachyarrhythmias (Kahn, 2011). This would complicate its use in patients with 
underlying cardiac disease and, therefore, finding an alternative could play an 
important role in improving AMI survival rate.  In summary, acute non-occlusive 
mesenteric ischaemia currently has no clear-cut effective management and has a poor 
prognosis as a result of low cardiac output, and it can be aggravated by on- or off-
pump coronary artery bypass grafting (Katz, et al., 2006). 
 
 
1.3.3 Vascular Relaxation and Protection during Isolated Vessel 
Preservation 
 
Vessel banking is becoming a popular experimental tool to provide vessel conduits for 
cardiovascular, vascular surgery or reconstructive surgery when they are otherwise 
limited options (Zatschler, et al., 2009). Some of the problems with the current storage 
solutions and technologies are damage to endothelial cells which may promote low 
perfusion and graft vasculopathy (Wille, et al., 2008; Winkler, et al., 2016). 
 
The main problem of vessel banking is the maintenance of vascular quality and 
function following extended storage and rewarming (Garbe, et al., 2011). Although cold 
storage (0-4oC) down-regulates tissue metabolism and provides some protection 
against endothelial damage, most of the damage occurs during the rewarming phase 
(Wille, et al., 2008; Zatschler, et al., 2009). Isolated aortic rings in cold storage with 
traditionally used high potassium depolarizing preservation solution such as University 
of Wisconsin (UW), Euro Collins (EC), and histidine-tryptophan-ketoglutarate (HTK) 
solution have failed to protect with contractility and relaxation loss after 72 hours of 
storage (Corner, et al., 2003). The loss of contractile function of up to 40% is seen as 
early as 36-hours after cold storage using UW and Perfadex solution; and while Krebs 
solution could protect the contractility function, it also leads to 86% loss of endothelial-
induced relaxation over similar time periods (Ingemansson, et al., 1995).   
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Endothelial injury is believed to be the key factor of vascular dysfunction following 
isolated vessel or ring ischaemic preservation, since endothelial cells are vulnerable 
to oxidative stress (Kutchai & Geddis, 2001). As endothelial cells and smooth muscle 
interactions have key roles in optimal contraction-relaxation regulation and long-term 
patency (Davies & Hagen, 1995; Thatte & Khuri, 2001), endothelial dysfunction in cold 
high potassium depolarization storage solutions has been shown to lead to loss of 
relaxation, increased risk of atherosclerosis and intimal hyperplasia as well as reduced 
graft patency (Dobson, et al., 2013a; Wilbring, et al., 2011). Therefore, improved 
preservation solutions are required to maintain endothelial viability of isolated vessels 
during preservation and rewarming period if vessel banking is going to be clinically 
useful. 
 
 
1.4 Potential alternative vasoactive agent for vasospasm 
prevention/dilation and vascular preservation 
 
As already discussed, the major drawbacks with current antispastic strategies and 
vascular protection include less potency, insufficient endothelial protection and 
adverse effects on cardiac function. Finding a novel drug strategy may improve 
vascular outcomes. The topic of this present thesis is to explore the potential use of 
adenosine and lidocaine (AL) solution as a vasodilatory agent to prevent vasospasm 
and improve vascular preservation. What follows is a brief introduction into the 
properties of each drug followed by a summary of the work carried out on AL in cardiac 
surgery, as an anti-ischaemic and anti-inflammatory; and finally, the hypothesis to be 
tested in isolated blood vessels.  
 
1.4.1 Adenosine 
Adenosine is a naturally occurring purine nucleoside released from metabolically 
active cells mostly as a response to stress conditions such hypoxia or ischaemia 
(Berne, 1980; Layland, et al., 2014; Peart & Headrick, 2007). It is formed either from 
adenosine monophosphate (AMP) dephosphorylation by 5'-nucleotidase or from S-
adenosylhomocysteine (SAH) hydrolysis by SAH hydrolase (see Figure 1.3) (Linden, 
2005; Obata, 2002; Sala-Newby, et al., 1999). Obata (2002) showed that 
dephosphorylation of AMP is the major source of adenosine in hypoxic and ischaemic 
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rat heart. 
 
 
 
Figure 1.3 Sources of extracellular adenosine.  
Intracellular hydrolysis of adenine nucleotides or S-adenosylhomocysteine (SAHC) yields 
adenosine that is released via specific nucleoside transporters (NT) or nonspecifically upon cell 
membrane damage. In the extracellular space, adenine nucleotides are hydrolyzed by 
ectoapyrase (CD39) and ecto-5’-nucleotidase (CD73). Adenosine binds to specific G-protein-
coupled receptors, namely the adenosine receptors (AdoRs), which initiate various cellular 
responses (Carsten P Schepp and Jörg Reutershan, 2008). 
 
 
Adenosine has many physiological functions including: 1) rapidly and reversibly slows 
heart rate and contraction (negative chronotropism and inotropism) (Belardinelli, et al., 
1995; Headrick, et al., 2003; Peart & Headrick, 2007) 2) slows atrioventricular 
conduction (negative dromotropism) (Canyon & Dobson, 2004; Wagner, et al., 1994), 
3) possesses coronary vasodilatory properties (Vasu, et al., 2013), 4) has 
preconditioning and anti-ischaemic properties involving activation of survival kinases 
via adenosine A1 activation (Downey, et al., 2007; Hausenloy & Yellon, 2006; Vinten-
Johansen, et al., 2005), 5) angiogenesis (Ernens, et al., 2015; Feoktistov, et al., 2003), 
6) regulates activity in the sympathetic nervous system (Sousa, et al., 2014) , 7) 
modulates inflammation (Antonioli, et al., 2014; DeOliveira, et al., 2017), and 8) has 
antithrombotic properties (Fuentes & Palomo, 2015). Adenosine has been called the 
retaliatory metabolite because it helps to regulate the oxygen supply and demand of 
heart and many other tissues and organs (Ådén, et al., 2003; Alders, et al., 2015; Peng, 
et al., 2016).  Adenosine actions and signaling is mediated by four G-protein–coupled 
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adenosine receptors (AR): A1, A2a, A2b, and A3 (Headrick, et al., 2003; Peart & 
Headrick, 2007; Sheth, et al., 2014).  The four receptors involved and their role in 
regulating vascular relaxation and vascular tone in coronary vessels will now be 
discussed.  
 
 
1.4.1.1 Adenosine physiological effects: the role of adenosine receptors 
 
Adenosine receptors are a class of membrane-bound purinergic receptors called P1 
receptors which are preferentially activated by adenosine in contrast to P2Y receptors 
that are preferentially activated by ATP (Jacobson & Gao, 2006). There are four main 
types of adenosine receptors (AdoRs), namely adenosine A1, adenosine A2a, 
adenosine A2b, and adenosine A3 receptors (Sheth, et al., 2014). The AdoRs 
classification is based on the effect of different inhibitors, modulators with different 
affinities for adenosine involving G-protein coupled pathways (Bruns, et al., 1986; 
Calker, et al., 1979; Eltzschig, et al., 2009b).  The distribution of the AdoR subclasses 
throughout the body is diverse as shown in Table 1.1. 
 
The A1 receptors are highly expressed in nervous system and less so in skeletal 
muscle, spleen, liver and kidney (Fredholm, et al., 2000). The A2a receptors are 
dominantly found in striatum, spleen, thymus, olfactory bulb as well as leucocytes 
(Linden, 2001). In contrast, the A2b receptors are abundantly distributed in caecum, 
colon, bladder, lung, eye and blood vessels, but also found in adipose tissue, adrenal 
glands, brain, kidney, and liver at low level (Fredholm, et al., 2000). 
Table 1.1 the adenosine receptor distributions and related effects 
(Fredholm et al., 2000) 
Type A1 A2a A2b A3 
Species of 
cloning 
Man, rat, 
mouse, dog, 
cow, rabbit, 
guinea pig, 
chicken 
Man, rat, 
mouse, dog, 
guinea pig 
Man, rat, 
mouse, chicken 
Man, rat, 
mouse, dog, 
sheep, chicken 
Organs with 
high expression 
Brain, spinal 
cord, eye, 
adrenal gland, 
atria 
Spleen, thymus, 
leukocytes, 
blood platelets, 
striatoplallidals 
GABA-nergic 
neurons, 
olfactory bulb 
Caecum, colon, 
bladder 
Testis (rat), 
mast cells (rat) 
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Effects of G-
protein coupling 
ê cAMP 
é IP3/DAG 
(PLC) 
éarachidonate 
(PLA2) 
é choline (PLD) 
é cAMP 
é IP3 
é cAMP 
é IP3/DAG 
(PLC) 
ê cAMP 
é IP3/DAG 
(PLC) 
Definition: é increase; ê decrease of concentration 
 
 
Historically, the intracellular signaling pathways of AdoRs are associated with the 
modulation of adenylyl cyclase activation, leading to either higher or lower intracellular 
cAMP levels (Fredholm, et al., 2000).  However, other intracellular pathways are 
involved (see fig. 1.4), including phospholipase C (PLC), potassium channels, calcium 
channels and mitogen-activated protein kinases (MAPKs) (Jacobson & Gao, 2006).  
 
 
 
 
 
Figure 1.4 Adenosine receptor signaling pathways.  
Activation of the A1 and A3 adenosine receptors (AdoRs) inhibits adenylyl cyclase activity 
through activation of pertussis toxin-sensitive Gi proteins and results in increased activity of 
phospholipase C (PLC) via Gβγ subunits. Activation of the A2a and A2b AdoRs increases adenylyl 
cyclase activity through activation of Gs proteins. Activation of the A2a AdoRs to induce 
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formation of inositol phosphates can occur under certain circumstances, possibly via the 
pertussis toxin-insensitive Gα15 and Gα16 proteins. A2b AdoRs-induced activation of PLC is 
through Gq proteins. All four subtypes of AdoRs can couple to mitogen-activated protein kinase 
(MAPK), giving them a role in cell growth, survival, death and differentiation. CREB, cAMP 
response element binding protein; DAG, diacylglycerol; IP3, inositol 1,4,5-trisphosphate; PI3K, 
phosphatidylinositol 3-kinase; PIP, phosphatidylinositol-4,5-bisphosphate; PK, protein kinase; 
PLD, phospholipase D; NF-&B, nuclear factor-&B. (Jacobson & Gao, 2006) 
 
 
A1 receptor stimulation occurs from the inhibition of adenylate cyclase, indirect 
activation of potassium channels, indirect inactivation of calcium channels, alteration 
of inositol phosphates, or inactivation of phospholipase A2 (Linden, 2001). Thus, in 
general, the A1 receptor activation is mostly related to adenosine’s inhibitory effects on 
physiological processes such as negative chronotropic, dromotropic, and inotropic 
(Shryock & Belardinelli, 1997) and antiadrenergic effects (Burgdorf, et al., 2001) or 
even attenuation of norepinephrine-provoked adenylyl cyclase activation in 
cardiomyocytes (Belardinelli, et al., 1995). Accordingly, adenosine’s role in maintaining 
the oxygen supply-demand ratio is believed to be mostly mediated by activation of A1 
receptors (Babich, et al., 2015) 
 
As mentioned previously, the A2 receptors are subdivided into A2a and A2b receptors 
based on differences in affinity to adenosine (Fredholm, et al., 2000). The A2a receptors 
have a higher affinity for adenosine compared to that of the A2b receptors (Olanrewaju, 
et al., 2000). The activation of the two A2 receptors also involves cyclic AMP-dependent 
pathways including phospholipase C (Offermanns & Simon, 1995), P-type of Ca2+ 
channels (Umemiya & Berger, 1994), and MAPK (Fredholm, et al., 2000). However, in 
contrast to the inhibitory action of A1 receptors, the effect of A2 receptors is 
predominantly stimulatory.  In isolated cardiomyocytes, for example, they have positive 
inotropic, chronotropic and dromotropic actions (Dobson & Fenton, 1997; Stein, et al., 
1994) and believed partly due to coronary vasodilation and induced stretching of 
myocardium, which are largely associated with A2a rather than A2b receptor stimulation 
(Dobson & Fenton, 1997). In the central nervous system, an excitatory role of A2a 
AdoRs on glutamate, GABA and acetylcholine activity has also been recognized 
(O'regan, et al., 1992). This is supported by the fact that A2a AR-/- knockout mice 
persistently showed declined exploratory behaviour, which implies a depressed central 
nervous system (Ledent, et al., 1997).  
 
Unfortunately, the physiological function of A2b receptors has been difficult to assess. 
Several reports indicate a link between A2b receptors with MAPK activation as well as 
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HMC-1 mast cells (Gao, et al., 1999; Linden, et al., 1999), which may suggest a role 
of A2b receptors in the proliferation and differentiation of vascular smooth muscle cells, 
cell growth and proliferation (Jackson, et al., 2011; Jonzon, et al., 1985). However, 
these functions are also related to the adenosine A3 receptor subtype (Hinze, et al., 
2012).  It is thought that the lack of progress in understanding the physiological effects 
of A2b activation most likely results from the lower affinity of A2b towards adenosine and 
adenosine derivatives (Beukers, et al., 2000; Gao, et al., 2004). Fredholm (2001,2010) 
revealed that adenosine binding to A2b was 30-80 less potent than the other subtypes 
(Fredholm, 2010; Fredholm, et al., 2000). Thus, a higher level of adenosine is required 
to activate A2b and a lower level of adenosine may be inadequate to trigger A2b receptor 
activity (Eckle, et al., 2008a; Eckle, et al., 2008b; Grenz, et al., 2008).  Interestingly, it 
has been recently shown that in A2a genetic depleted mice, that the A2b receptors could 
be up-regulated to substitute A2a receptor function (Teng, et al., 2008). 
 
Typically, the physiological concentration of adenosine is maintained about 1 µM, 
which is hardly sufficient to activate A2b receptors (Hasko, et al., 2008). Consequently, 
most A2b receptor activation is found in pathological conditions, during which the 
generation of adenosine is elevated (Eckle, et al., 2007; Eltzschig, et al., 2009a; 
Fredholm, 2007). 
 
The A3 receptors appear to signal in a similar way to A1 receptors, involving inhibition 
of adenylyl cyclase activity and/or stimulation of inositol 1,4,5-triphosphate as well as 
phospholipase C activity (Nishat, et al., 2012). Due to their likeness in signaling 
pathways, the A3 receptor-induced physiological effects are more or less equal to those 
of A1 receptors (Ramkumar, 2000), especially in the cardiovascular system (Mubagwa 
& Flameng, 2001).  The effects of A3 receptor activation include cytoprotection, 
attenuation of pathophysiological intracellular calcium influx, reduced oxygen-derived 
radical formation, and inhibition of lipid peroxidation (Emanuelov, et al., 2010; 
Shneyvays, et al., 2000). Unlike the A1 receptors, A3 receptors experience more rapid 
phosphorylation along with desensitization (Palmer, et al., 1996; Palmer & Stiles, 
2000).  It seems that A3 receptor depalmitoylation increases their vulnerability to G 
protein-coupled receptor-induced phosphorylation (Palmer & Stiles, 2000). 
 
 
 
1.4.1.2 Role of Adenosine in Vascular Tone 
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Adenosine and its analogs are involved in the regulation of vascular tone to varying 
degrees (Berne, 1980). A2a and/or A2b AdoRs are involved in adenosine-mediated 
vascular relaxation of coronary and aortic beds (Tabrizchi & Bedi, 2001), whereas A1 
AdoR involvement in the regulation of vascular tone is less clear. Adenosine’s action 
on isolated rings from the pulmonary artery (Biaggioni, et al., 1989; McCormack, et al., 
1989) and renal vasculature (Marraccini, et al., 1996; Martin & Potts, 1994) are further 
complicated by it displaying a biphasic response in relaxation and contraction, which 
appears to be concentration-dependent. Despite decades of research, the role of the 
different adenosine receptor subtypes in vascular tone is still a matter of debate 
(reviewed by Tabrizchi and Bedi, 2001). 
 
 
1.4.1.2.1 Adenosine-induced vasoconstriction 
 
Using A1 AdoR-knockout A1 AdoR mice, Tawfik and colleagues showed that the 
activation of A1 AdoRs caused a contraction in isolated aortic rings (Tawfik, et al., 
2005). According to the authors, the A1 AdoRs interact with Gi- or Go-regulatory 
proteins, which leads to inhibition of adenylate cyclase and a decrease in cAMP levels, 
as well as protein kinase A (PKA) activity, that appears to contribute to the adenosine-
evoked vasoconstriction. Another study by Hansen and colleagues showed 
vasoconstriction involved Gi-proteins and activation of phospholipase C (Hansen, et 
al., 2003). Shim et al., also reported that adenosine-induced vasoconstriction can be 
independent of a decrease in cAMP levels (Shim, et al., 2002). These differences may 
be related to differences in distribution of adenosine receptors between tissues (Sheth, 
et al., 2014). 
 
 
1.4.1.2.2 Adenosine-induced vasodilation 
 
The general consensus is that adenosine-induced vasodilation is exerted through the 
activation of the A2 AdoRs (Fahim, et al., 2001). While A2a is thought to be predominant 
receptor subtype, A2b may also play a role (Hinschen, et al., 2003; Shryock, et al., 
1998). For example, a study using isolated guinea pig hearts shows that the A2a AdoRs 
were involved in coronary vasodilation (Belardinelli, et al., 1998); whereas, other 
studies suggest that vasodilation is mediated by activation of the A2b AdoRs in human 
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small coronary arteries (Kemp & Cocks, 1999). The involvement of both A2a and A2b 
AdoRs in vasodilation is also supported by the finding that both subtypes are present 
on either or both endothelial and vascular smooth muscle cells (Olanrewaju & Mustafa, 
2000). However, since the A2b AdoRs have a lower affinity compared to the A2a AdoRs 
for adenosine, it is believed that the activation of the A2b receptors require high local 
concentrations of adenosine to result in vasodilation (Fredholm, et al., 2000).  
 
In addition, further complexity arises as large coronary arteries are less sensitive to 
adenosine than smaller ones and epicardial micro vessels are less responsive than 
those located in epicardium (Harder, et al., 1979; Quillen & Harrison, 1992).  
 
 
1.4.1.3 Contribution of endothelium to adenosine-induced vasodilation 
 
The vasodilatory effect of adenosine has been linked to endothelial NO production by 
endothelial cells (Li, et al., 1995). This has been confirmed when endothelial NO 
synthesis is inhibited (Okumura, et al., 1992; Vials & Burnstock, 1993) or by removal 
of the endothelium (Iwamoto, et al., 1994; Rose'Meyer & Hope, 1990). 
 
The possible mechanisms for NO-induced adenosine relaxation include the following: 
1) Activated endothelial A2a receptors are coupled to KCa channels (Hein, et al., 1999) 
which leads to K+ efflux and Ca2+ influx and activates eNOS with subsequent NO 
synthesis and release (Ray & Marshall, 2006b). The production of NO leads to 
increased cGMP level which results in vascular relaxation (Olanrewaju & Mustafa, 
2000). In addition, increased intracellular cAMP stimulates cAMP-dependent protein 
kinase A (PKA) activation, which, in turn, facilitates the phosphorylation of eNOS (Ray 
& Marshall, 2006b). 2) ATP-dependent potassium (KATP) channels have been shown 
to be activated by endothelial adenosine receptors, which leads to increased influx of 
Ca2+ and NO release (Leipert, et al., 1992).  
 
Another mechanism of adenosine’s action is independent of the endothelium (Sato, et 
al., 2005). In a study using denuded human coronary arteries, relaxation was shown 
by activation of KCa channels in vascular smooth muscle which leads to adenylate 
cyclase activation (Sato, et al., 2005). Samples for this study were taken from patients 
with heart disease who probably have altered endothelial function. A separate study 
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on healthy adults has verified the importance of the endothelium in the vasorelaxant 
effect of adenosine in humans (Smits, et al., 1995).  
 
 
1.4.1.4 Contribution of K+ channels and Na+/K+-ATPase to adenosine-
induced vasodilation 
 
Activation of vascular smooth muscle KATP channels in thoracic aorta (Kleppisch & 
Nelson, 1995), mesenteric arteries (Quayle, et al., 1995) and gallbladder (Zhang, et 
al., 1994a), are also involved in adenosine-evoked vasodilation (Tabrizchi & Bedi, 
2001).  KATP channels trigger the formation of cAMP and increase the activity of PKA 
(Brayden, 2002). In addition, the relaxation of rat aorta is found to be mediated, at least 
in part, by the activation of Na+/K+-ATPase, which is exerted through A2a AdoR 
activation (Grbović & Radenković, 2003). Inhibition of the large-conductance calcium-
activated potassium (KCa) channels in dog coronary arteries may attenuate adenosine–
induced relaxation, suggesting their role in the vasodilator effect of adenosine (Cabell, 
et al., 1994).  
 
 
1.4.2 Lidocaine  
 
Lidocaine was developed in 1943 as part of a chemical search for compounds with 
cocaine-like anaesthetic properties but without the toxic and addictive side-effects of 
cocaine (Bryce-Smith, 1960; Gordh, et al., 2010; Heavner, 2007). Lidocaine acts as a 
Class 1B local anaesthetic and cell membrane stabilizer by blocking voltage-
dependent sodium (Na+) fast channels (Rosen & Danilo, 1980). In addition to its Class 
1B anaesthetic function, lidocaine has been used as an intravenous antiarrhythmic 
agent that is widely used in the treatment and prevention of ventricular arrhythmias 
(Turan, et al., 2000). Moreover, its function as a vasodilator has been identified, even 
though it’s underlying mechanisms have not been completely elucidated (Gherardini, 
et al., 1998a). Lidocaine also has non-Na+ channel dependent effects which may 
involve N-type voltage-gated Ca2+ channels (Hiruma, et al., 2008), Kv channels 
(Trellakis, et al., 2006), KATP channels  (Kinoshita, et al., 2004), pore domain K 
channels TREK1 inhibition (Nayak, et al., 2009), and mitoKATP channels (Tsutsumi, et 
al., 2001), and believed to be responsible for its neuroprotection, anti-oxidant and anti-
inflammatory effects (Lahat, et al., 2008; Lee, et al., 2010; Niiyama, et al., 2005; 
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Tsutsumi, et al., 2001; Wang, et al., 2013). Lidocaine is also cardioprotective in cardiac 
surgery (Hinokiyama, et al., 2003; Kim, et al., 2014; Lee, et al., 2011) by preventing 
ATP depletion (Fried, et al., 1995; Soliman, et al., 2012) and exerting anti-apoptotic 
actions during ischaemia (Kaczmarek, et al., 2009). Of relevance to this thesis, 
lidocaine is reported to have vasodilatory effects but this remains very controversial 
(Kinoshita, et al., 2001a; Kinoshita, et al., 2004).   
 
 
1.4.2.1 Lidocaine structure, metabolism and excretion 
 
Lidocaine is a cationic amino amide drug that consists of a lipophilic end, 2,6-xylidine 
and connected to a hydrophilic end (diethylglycine) through an aminoamide link 
(Sweeney & Bromilow, 2006). Lidocaine metabolism greatly depends on microsomes 
in the liver. Studies on hepatic homogenates have shown that cytochrome P450 
(CYP1A2) is involved in lidocaine degradation into monoethylglycinexylidide by N-de-
ethylation through an oxidation process (Sweeney & Bromilow, 2006).  Hydrolysis then 
takes place to convert the previous metabolite into 2,6-xylidine and other degradation 
products. Elimination of lidocaine and its metabolites occurs mainly through kidneys, 
and only a small amount is excreted via the intestines. Keenaghan and Boyes (1972) 
showed that more than 65% of lidocaine and the metabolites was found in the rat urine 
when administered either orally or intravenously, while only 0.5% accounts for 
intestinal elimination if lidocaine was administered orally, and none were found in the 
faeces if given intravenously.  
 
 
1.4.2.2 Lidocaine effect on vascular tone  
 
Lidocaine has been demonstrated to have biphasic vascular actions. It can produce 
either vasoconstriction or vasodilation in a concentration-dependent manner (Evans, 
et al., 1997c; Johns, et al., 1985).  
 
 
1.4.2.2.1 Lidocaine-induced vasoconstriction 
 
Preliminary studies have observed lidocaine-mediated vasoconstriction when 
administered intradermally especially at low concentration (Aps & Reynolds, 1976; 
Jorfeldt, et al., 1970). This is in line with an in vitro study showing a vasoconstrictive 
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effect of lidocaine in isolated human arteries (Gherardini, et al., 1995). The dose 
suggested for lidocaine-induced vasoconstriction is below 1.5 x 10-3 M. The 
vasoconstrictive effect of lidocaine is thought to be related to its interaction with KATP 
channels since lidocaine may impair relaxation induced by KATP channel activation 
(Kinoshita, et al., 1999). It is suggested that lidocaine causes an increase in adenosine 
triphosphate (ATP) (Perlmutter, et al., 1990a), therefore, with increased level of ATP, 
KATP -sensitive channels will be closed and depolarised (Rang, et al., 2003). However, 
it seems that KATP channel is not the only pathway involved in the lidocaine 
vasoconstriction effect.  Alteration of membrane potential as well as modulation of 
adrenergic action have been proposed by previous studies (Fleisch & Titus, 1973; 
Fukuda, et al., 1980).  
 
 
1.4.2.2.2 Lidocaine-induced vasodilation 
 
Lidocaine at high concentration produces relaxation on blood vessels (Johns, et al., 
1985). This has been confirmed by in vitro studies using human radial and internal 
mammary artery rings (Gherardini, et al., 1995; Jernbeck & Samuelson, 1993). 
Although one study showed a lidocaine vascular effect on human veins (Gherardini, et 
al., 1996), vasodilation effects of lidocaine mainly affect arterioles (Turan, et al., 2000). 
It is suggested that the vasodilation action of lidocaine was initiated at the 
concentration 30 µg/ml and was maximal at 2000 µg/ml (Perlmutter, et al., 1990c). 
 
It is believed that the lidocaine dilation action results partly from inhibition of the 
sympathetic adrenergic neurotransmission in the vascular wall (Hogan, et al., 1998). 
The other mechanism suggested is a direct effect of lidocaine on vascular smooth 
muscle, since lidocaine is able to block Ca2+ influx required for contraction (Zhang, et 
al., 1994b). Several reports have demonstrated that lidocaine inhibits Ca2+ entry 
through voltage and receptor gated channels as well as blocks the release of Ca2+ from 
intracellular stores (del Pozo, et al., 1997; Tanaka, et al., 2002). Consequently, 
lidocaine may attenuate transphosphorylation of myosin in the smooth muscle cells 
that fails the vascular smooth muscle constriction (Aberg & Wahlstrom, 1972). 
Regardless of a report showing weakened lidocaine-induced relaxation on 
endothelium intact arteries (Jernbeck & Samuelson, 1993), the lidocaine 
vasorelaxation effect is apparently independent of vascular endothelium (Gherardini, 
et al., 1996). This in accordance with another paper by Turan et al. (2000) who reported 
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that removal of the endothelium did not significantly modify the lidocaine-induced 
relaxations.  
 
 
1.4.2.2.3 Lidocaine modifies effects of other vasoactive agents  
 
Lidocaine may differentially modify the vascular action of other agents. For example, 
lidocaine can inhibit noradrenaline-induced contractions, but it potentiates the caffeine-
induced contraction in the vascular smooth muscle of rabbit aorta (Karaki, et al., 1987). 
There is evidence that lidocaine inhibits endothelium-dependent relaxation induced by 
methacholine but not endothelium-independent vasodilation induced by sodium 
nitroprusside in rat isolated thoracic aorta (Johns, 1989). Several studies report that 
lidocaine is capable of impairing the relaxation mediated by KATP -sensitive channels 
(Kimoto, et al., 2005; Kinoshita, et al., 2003a; Kinoshita, et al., 2004), supporting the 
role of KATP channels in the vasoconstriction effect of lidocaine. These studies 
observed attenuated relaxation with lidocaine at concentrations up to 100 mM, 
suggesting that higher concentrations are required to achieve vasodilation. 
Additionally, a recent finding showed that pH changes are possible to modify 
vasoactivity of lidocaine (Kinoshita, et al., 2001a). One possible explanation could be 
that lidocaine acts through KATP channel activation, and changes in pH may result in 
the alteration of the ionization of ATP-sensitive K+ protein (Kinoshita & Katusic, 1997).  
 
 
1.4.3 Adenosine and lidocaine (AL) in combination  
 
As mentioned previously, adenosine and lidocaine separately possess vascular 
actions, but their vasoactive effects as a combination (AL) have not been studied. It is 
the interest of this thesis to examine AL vasodilatory effect on isolated vessels and 
explore its potential use in vascular preservation. Current literatures have 
demonstrated AL benefits in cardiac surgery, as an anti-ischaemic and anti-arrhythmic 
agent, and in heart preservation solution. These benefits will be discussed in the 
following section.  
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1.4.3.1 AL in cardiac surgery 
 
AL as a drug combination was first introduced as a cardioplegia by Dobson and Jones 
(2004). This formulation was based on the understanding that adenosine acts as a 
KATP opener, increasing K+ efflux which can reduce the action potential duration in the 
heart, while lidocaine is a sodium fast channel blocker that works synergistically with 
adenosine by blocking the inward fast Na+ current (Dobson, 2004). The adenosine-
lidocaine combination arrests the heart just at the polarized state, at or near its resting 
membrane potential (Dobson, 2004). The main advantages of arresting the heart at or 
near resting membrane potential include: 1) less cellular activities leading to better 
energy preservation during ischaemia (Dobson, 2004), 2) less electrolyte and 
metabolic imbalances, thus, limiting cellular injuries (Cohen, et al., 1995; Snabaitis, et 
al., 1997), 3) less unwanted and toxic metabolites (ROS, lactate, ion H+) are generated 
(Boutilier, 2001), and 4) reduced neutrophil activities, and hence reduced inflammatory 
reactions (Dobson, 2010). 
 
The safety and efficacy of AL as a cardioplegia in high-risk patients of cardiac surgery 
has been demonstrated (Dobson, et al., 2013a). O'Rullian, et al. (2008) reported a 
successful ±10-hour operation using AL for re-operative aortic and mitral valve 
replacement without systemic hyperkalaemia, haemodilution or significant tissue 
oedema on a 4-times redo elderly patient. Promising results were also demonstrated 
in the study by Jin, et al. (2008) using high (HPAL) and moderate (MPAL) K+ 
concentrations with AL cardioplegia during hypothermia in randomized paediatric 
congenital heart patients. Jin and co-workers found no significant differences in arrest 
time, cardiopulmonary bypass (CPB) time, haematocrit value or fluid output compared 
to high potassium (HP) cardioplegia application. All three groups retrieved 
spontaneous rhythm after cross clamp removal, no temporary pacing support during 
operation, and there were no deaths or post-operative complications. However, AL 
with only 10mM K+ (MPAL) cardioplegia resulted in higher systolic and pulse pressures 
after CPB, lower serum Troponin I value after 12-hour operation, reduced use of 
inotropes post-operatively, and less postoperative hospital time compared to other 
groups. In 2013, a randomised clinical trial showed that AL with magnesium and insulin 
in CABG patients led to significantly lower troponin and plasma lactate level, improved 
myocardial protection and cardiac index, less blood product requirement, and shorter 
ICU stays compared to patients who received the conventional Buckberg solution 
(Onorati, et al., 2013b).  
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1.4.3.2 AL as an anti-ischaemic and anti-arrhythmic agent 
 
In addition to cardiac surgery, AL has been shown to offer protection against 
ischaemia-reperfusion injury in animal models. (Canyon & Dobson, 2004, 2006). In the 
in vivo rat model, Canyon and Dobson (2004) showed that after 30 min of regional 
myocardial ischaemia, AL administration significantly improved survival with no 
deaths, compared to 58% mortality in control animals. AL treatment also significantly 
reduced myocardial infarct size, but this benefit was not conferred with either 
adenosine or lidocaine alone (Canyon & Dobson, 2004). The authors further showed 
that if the A1 agonist 2-Chloro-N6-cyclopentyladenosine (CCPA) was used instead of 
adenosine and combined with lidocaine the infarct size fell to below 10%, similar to 
preconditioning (Canyon & Dobson, 2005). It is suggested that the anti-ischaemic 
effect of AL was associated with preservation of left ventricular high-energy phosphate 
(PCr and ATP) during ischaemia, indicating a downregulation of myocardial 
metabolism with AL (Canyon & Dobson, 2006). Lowering oxygen/energy demand 
appears to limit pathological milieu during ischaemia and following reperfusion 
(Dobson, et al., 2013a).  
 
Consistent with reduced infarct size, AL administration in the acute myocardial 
ischaemic model led to a 90% reduction in ventricular arrhythmias. In contrast, 
adenosine or lidocaine alone did not significantly reduce the arrhythmic events 
(Canyon & Dobson, 2004). The mechanism of AL’s anti-arrhythmic action is unclear 
but may relate to synergistic effects of adenosine and lidocaine as both agents have 
anti-arrhythmic actions (Bush, et al., 1989; Dobson, et al., 2013a). Adenosine activates 
potassium channel (IK+ADO, Ach) opening leading to hyperpolarization and more stable 
myocardial excitability (Wilbur & Marchlinski, 1997). In addition, adenosine has an anti-
adrenergic effect to counteract the stimulatory effects of catecholamines (Ely & Berne, 
1992; Hayes, 2003). Whereas, lidocaine shortens the action potential by its inhibition 
of voltage-dependent Na+ fast channels in cardiac myocytes (Ruiz-Meana, et al., 
1999), and through its interaction with sarcolemmal Ca2+ (Lu, et al., 1999; Wilbur & 
Marchlinski, 1997). Prolonged hyperpolarization with adenosine or shortening the 
action potential with lidocaine may paradoxically become arrhythmogenic (Pelleg, et 
al., 2002; Starmer, et al., 1991), but the AL combination may “clamp” the membrane 
potential into a more polarized state compared to either adenosine or lidocaine alone 
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(Dobson & Jones, 2004). More recently, AL superiority to prevent fatal arrhythmias 
compared to each drug alone has also been shown following asphyxial cardiac arrest 
(Djabir & Dobson, 2013) and haemorrhagic shock in rats (Letson & Dobson, 2011b). 
The anti-ischaemic and anti-arrhythmic action of AL may find great utility if used as a 
vasodilator during cardiovascular surgery. 
 
 
1.4.3.3 AL in heart preservation solution 
 
AL cardioprotection has also been demonstrated in isolated rat heart preservation after 
six to eight hours of cold storage (Rudd & Dobson, 2009, 2011a, 2011b). In 2009, 
Rudd and Dobson showed that isolated rat hearts preserved in AL solution for six hours 
had significantly higher functional recovery compared to Celsior solution (68% vs 47% 
cardiac output). More prolonged (8-hour) cold storage with AL plus melatonin and 
insulin led to 78% recovery of full cardiac function compared to 4-25% recovery in 
those preserved in histidine-tryptophan-ketoglutarate (HTK) or Celsior solution. It is 
suggested that the AL combination stabilizes membrane polarity, reducing Na+ and 
Ca2+ loading, and therefore limiting cellular damage and myocardial dysfunction during 
cold storage and reperfusion (Rudd & Dobson, 2011b). In accordance with this, no 
detectable troponin T and significantly lower lactate levels were found in AL-preserved 
hearts regardless of the prolonged cold static storage (Rudd & Dobson, 2011a, 2011b). 
Currently, the safe period for human heart storage is four to five hours (Rudd & 
Dobson, 2009). Thus, it would be interesting to examine if AL solution may offer the 
same protection in prolonged vascular preservation. 
 
 
1.4.3.4 AL as an anti-inflammatory agent 
 
AL protective effects appear to involve inhibition of the inflammatory response. Shi et 
al. (2012) showed that in vitro, AL combination reduced multiple polymorphonuclear 
neutrophil (PMN) activities to a greater extent compared to each drug alone. AL anti-
inflammatory actions include suppression of superoxide generation, expression of 
adhesion molecules (CD11 and CD18), and PMN adherence and transmigration (Shi, 
et al., 2012). In accordance with this, AL potent anti-inflammatory effects have been 
reported in an in vivo model of ventricular fibrillation-induced cardiac arrest (Granfeldt, 
et al., 2013). Granfeldt and colleagues (2013) showed that resuscitation with AL not 
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only significantly improved cardiac function but also diminished leucocyte superoxide 
production following cardiac arrest in pigs. AL anti-inflammatory effects could be 
imperative to improve arterial graft protection when used as a vasodilator or to prevent 
endothelial dysfunction during vascular preservation. 
 
 
1.5 General aim and hypothesis 
 
The aim of this thesis is threefold: 
1.  To investigate the vasodilatory effects of adenosine (A), lidocaine (L) and 
adenosine-lidocaine (AL), and possible mechanisms of adenosine (A) and 
lidocaine (L) relaxation in isolated rat thoracic aortic rings. 
2. To investigate the vasodilatory effects of A, L and AL on segments of guinea 
pig second order mesenteric arteries, with the future goal to reduce secondary 
complications from gut ischaemia during cardiac surgery. 
3. To investigate the effect of AL and AL with antioxidants on six-day cold storage 
using rat thoracic aortic rings for future vessel preservation. 
 
The following hypotheses will be tested: 
1. Adenosine will relax precontracted isolated rat aortic rings dependent on 
endothelium. The relaxation may involve EDRF, Kv channels, KATP channels, Na+/K+-
ATPase, A2a and A2b adenosine receptors (Chapter 3). 
2. Lidocaine will relax precontracted isolated rat aortic rings independent of 
endothelium. The relaxation may involve EDRF, Kv channels, KATP channels, Na+/K+-
ATPase, A2a and A2b adenosine receptors (Chapter 4). 
3. Adenosine-lidocaine (AL) will relax precontracted isolated rat aortic rings 
independent of endothelium. The relaxation will be greater than A or L alone (Chapter 
5). 
4. A, L and AL will relax guinea pig mesenteric artery. Adenosine relaxation will be 
endothelium-dependent while L and AL will be endothelium-independent. Luminal and 
abluminal administration of A, L and AL will give the same relaxation on isolated 
mesenteric artery (Chapter 5). 
5. AL and antioxidants can preserve isolated rat thoracic aortic rings for 6-day cold 
storage (Chapter 6).  
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CHAPTER 2  
MATERIALS AND METHODS 
2.1 INTRODUCTION 
This thesis employed two in vitro methods to assess vascular reactivity: 1) Isometric 
force measurements for the isolated male rat aortic ring studies, and 2) Pressured 
myography for the isolated guinea pig mesenteric artery studies. This chapter will detail 
the experimental protocols including animal housing, anaesthesia and vessel 
preparation, drugs used, compositions and concentrations, and the method of 
statistical analysis.  
2.2 ISOMETRIC FORCE MEASUREMENT 
Isometric force measurements of vasoreactivity were used in Chapters 3, 4 and 5; and 
for Chapter 6 after static cold storage.  
Isometric force measurement is useful in detecting the spasmogenic or vasodilatory 
effect of substances as well as their possible mechanisms of action on vascular 
segments. This technique requires basic pharmacological equipment, i.e. a force 
transducer, a water-jacketed organ bath and a data acquisition system. A schematic 
diagram and photograph of the experimental set-up are shown in Figures 2.1 and 2.2, 
respectively.   
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Figure 2.1 Diagram of isometric force measurement experimental setup. 
The ring vessel was stretched between the triangle stirrups. One end was fixed on an L-shape 
brace and the other end was connected to a transducer. Ring tension changes recorded by the 
transducer were then sent to a PowerLab (ADInstrument) and portrayed on a computer.  
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Figure 2.2 Photograph of the experimental setup for isometric force measurement. 
  
2.2.1 Animal and drug preparation 
Male Sprague Dawley rats (300-350g) from James Cook University breeding colony 
were fed ad libitum and housed in a 12-hour light/dark cycle.  On the day of the 
experiment rats were anaesthetised with Na-thiopentone (100 mg/kg). Animals were 
treated in accordance with the Guide for the Care and Use of Laboratory Animals 
published by the US National Institutes of Health (NIH Publication No. 85-23, revised 
1996). The studies were approved by James Cook University Animal Ethics Committee 
with approval number A1535. Lidocaine hydrochloride was sourced as a 2% solution 
from the local Pharmaceutical Suppliers (Lyppard, Queensland).  All other chemicals, 
including adenosine (A9251 >99% purity), were purchased from Sigma Aldrich (Castle 
Hill, NSW). 
  
Force transducer 
Organ bath 
PowerLab 
Monitor 
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2.2.2 Aortic ring preparation and organ bath tension measurements 
2.2.2.1 Aortic ring preparation 
Rat isolated aortic rings are well recognized in the literature as a robust model to 
investigate the vasoactive effects of substances, or their analogues (Grbović & 
Radenković, 2003; Prentice & Hourani, 2000; Tawfik, et al., 2005). 
 
Rats were anaesthetized as described in Section 2.2.1 and the thoracic cavity was 
opened and the thoracic aorta was removed and placed in an ice-cold solution of 
oxygenated Krebs Henseleit solution (118 mM NaCl, 4.7 mM KCl, 1.2 mM Na2PO4, 0.5 
mM MgCl2, 1.12 mM CaCl2, 25 mM NaHCO3, 0.03 mM EDTA) pH 7.4 with 11 mM 
glucose. 
 
The rat thoracic aorta was carefully cleaned by dissecting the surrounding fat and 
connective tissue and cut into short segments of around 3-cm long. Isolated rings of 
3-4 mm width were then cut from the segments (Broughton, et al., 2010; Wang, et al., 
1996).  
 
In those experiments that required the endothelium to be removed (denuded rings), 
this was achieved using the method of Broughton, et al. (2010) by gently rubbing the 
inside of the ring with a thin, smooth, stainless-steel rod. Successful removal of the 
endothelium was assessed by testing the aortic ring for a vasodilatory response to 10 
µM acetylcholine (ACh) (Vo, et al., 2005) as detailed in section 2.2.2.3 Endothelium 
function testing. At the end of each experiment, the rings were tested for viability by 
being maximally dilated with 100 µM papaverine (Grbović & Radenković, 2003; 
Grbović, et al., 2000b). 
2.2.2.2 Aortic ring equilibration 
Freshly prepared aortic rings (3-mm long) were equilibrated for 60 minutes in a 
standard 10 ml volume organ bath (Radnotti Glass, ADinstruments, NSW, AUS) filled 
with Krebs Henseleit (pH 7.4) containing 118 mM NaCl, 4.7 mM KCl, 1.2 mM KH2PO4, 
1.2 mM MgCl2, 2.5 mM CaCl2, 25 mM NaHCO3 and 0.03 mM EDTA with 11 mM 
glucose. The organ bath was continuously bubbled with 95% O2 and 5% CO2 at 37°C 
for 15 minutes (zero tension). The rings were vertically mounted on small stainless-
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steel triangles, stirrups and connected to an isometric force transducer (PANLAB, 
distributed by ADInstruments as MLT 0201/RAD, NSW, AUS) coupled to a computer-
based data acquisition system (PowerLab, ADInstruments) and data recording 
software LabChart 7 (ADInstruments Pty Ltd., Castle Hill, Australia).   
 
The ring tension was manually adjusted to 1.5 g and equilibrated for 60 min.  A tension 
of 1.5 g was chosen from the literature and preliminary studies showing that an 
optimum contraction was achieved at this tension following norepinephrine (NE) 
administration. During 60 min equilibration, the solution was changed at 15 minutes 
intervals. The aortic rings were then washed with freshly prepared Krebs Henseleit 
buffer pH 7.4 and the tension was readjusted to 1.5 g tension. Each preparation was 
sub-maximally contracted using 3 µl of 0.1 mM NE (0.3 µM final concentration) (Evans, 
et al., 1997a; Zerkowski, et al., 1993) and those aortic rings that failed to contract were 
discarded (Figure 2.3).  
2.2.2.3 Endothelium function testing  
When the increase of tension reached plateau level after 0.3 µM of NE administration, 
10 µl of 10 mM acetylcholine (10 µM final concentration) was applied to confirm the 
presence or absence of an intact endothelium in all preparations (Vo, et al., 2005). It 
is well-established that acetylcholine (ACh) will induce a rapid relaxation of pre-
contracted rings if the endothelium is intact, and will have little or no effect if the 
endothelium is denuded (or damaged) leaving the rings in a contracted state (Furchgott 
& Zawadzki, 1980). In this thesis, aortic rings were considered intact if the relaxation 
induced by 10 µM ACh was greater than 80%, and the aortic ring was assumed to be 
denuded if relaxation was less than 10% (Vo, et al., 2005). As mentioned above, in 
endothelium-denuded ring experiments, aortic rings were stripped by gently rubbing 
the intimal surface of the vessel segment with a thin, smooth stainless-steel probe 
(Broughton, et al., 2010). After evaluation of endothelial function using ACh, organ 
baths were emptied and the rings were washed three times with Krebs Henseleit 
solution then left for another 30 min equilibration prior to experiments (Lewis, et al., 
2008) (Figure 2.3).     
2.2.2.4 Concentration-dependent relaxation experiments 
After 30 min equilibration, the ring tension was adjusted back to 1.5 g and then NE (0.3 
µM) was re-applied. Before each experiment, the rings were contracted at least two 
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times until a reproducible contractile response was obtained. Each experiment started 
after 10-15 min stabilisation of tension because pilot studies showed that the increase 
in tension and plateau from 0.3 µM of NE was reached at 10 min and remained at this 
plateau level for over 60 min, the time course of each experiment. Adenosine, lidocaine 
or adenosine-lidocaine (AL) combination was added to the organ bath in a 
concentration-dependent manner (see 2.2.3 Drug concentrations used in the studies) 
and the change in tension of pre-contracted rings was assessed. At the end of each 
experiment, the rings were maximally dilated with 100 µM papaverine (Grbović, et al., 
2000b) (Figure 2.3).  
2.2.3 Drug concentrations used in the studies    
Adenosine, lidocaine or AL aliquots were freshly prepared in distilled water and made 
in three final concentrations; 1, 10 and 20 mM. Adenosine alone, lidocaine alone or AL 
concentration-response curves for intact and denuded aortic rings were obtained by 
cumulatively adding adenosine, lidocaine or AL 1, 5, 10, 50, 100, 500 and 1000 µM 
(final concentrations) into a 10 mL organ bath containing NE pre-contracted rings and 
the tension was measured (Figure 2.3). The AL concentration-response curves were 
obtained by adding the same concentrations in combination of adenosine and 
lidocaine. The volume of adenosine, lidocaine or AL added in the organ bath for each 
examined-concentration was the same.  
2.2.4 Examination of adenosine or lidocaine mechanisms using specific 
inhibitors  
In order to investigate the possible mechanisms of action of adenosine, lidocaine and 
AL relaxation in aortic rings (Chapters 3, 4 and 5), a number of specific drugs were 
employed to investigate the roles of an intact endothelium, endothelium-derived 
relaxation factors (EDRFs), potassium channels, Na+/K+ ion pump, and adenosine 
receptors. Isolated aortic rings were preincubated with the antagonists for 20-30 min 
before being contracted with NE followed by adenosine or lidocaine incremental dosing 
administration. Involvement of factors, channels, pumps and/or receptors would be 
indicated if their selective antagonists led to a significant reduction or abolishment of 
adenosine- or lidocaine-induced relaxation. These antagonists are outlined below. 
1. The role of endothelium and EDRFs was examined using  
100 µM NG-nitro-L-arginine Methyl Ester (L-NAME) and 10 µM indomethacin. 
L-NAME is a nitric oxide synthase (NOS) inhibitor leading to inhibition of nitric 
 48 
oxide (NO) production, while indomethacin is a cyclooxygenase (COX)-1 
inhibitor that inhibits prostacyclin (PGI2) release (Ilkka & Bengt Saltin, 2011). L-
NAME and indomethacin were prepared in distilled water and applied in 
endothelium-intact rat aortic rings only. 
2. The role of potassium channels was investigated using the following K+ channel 
blockers: 
• 1 mM 4-aminopyridine (4-AP), a specific voltage K+ (Kv) channel 
blocker. 4-AP was dissolved in distilled water. 
• 10 μM glibenclamide, a non-selective ATP-sensitive K+ (KATP) channel 
blocker. Glibenclamide was dissolved in 100% dimethyl sulphoxide 
(DMSO).  
• 1 mM 5-hydroxydecanoate (5-HD), a specific mitochondrial ATP-
sensitive K+ (mitoKATP) channel inhibitor. 5-HD was dissolved in distilled 
water. 
• The role of Na+/K+-ATPase was investigated using 100 μM ouabain, a 
Na+/K+-ATPase inhibitor. Ouabain was dissolved in distilled water. 
3. The role of adenosine receptors was investigated using 100 μM 8-(3-
chlorostyryl) caffeine (CSC) and 10 μM 8-[4-[4-(4-chlorobenzyl)piperazide-1-
sulfonyl)phenyl]]-1-propylxanthine (PSB 0788). CSC and PSB 0788 are highly 
selective for adenosine A2a and A2b receptors, respectively (Borrmann, et al., 
2009; Daly & Jacobson, 1995). CSC and PSB 0788 were dissolved in 
100% DMSO.  
 
 
 
 
 
 
 
 
 
 
Figure 2.3 Diagram of experimental protocols of isometric force measurement. 
* Inhibitors such as L-NAME, Indomethacin, 4-AP, 5-HD, Ouabain, CSC and PSB-0788 were 
only applied during experiments evaluating relaxation mechanisms of adenosine, lidocaine or 
AL.  
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2.3 PRESSURE MYOGRAPH SYSTEM 
A pressure myograph system was the method used to examine mesenteric conduit 
relaxation in Chapter 5 and the vascular dilatory response to adenosine, lidocaine and 
AL during luminal and abluminal administration. The experimental design is based on 
the study of Doughty, et al. (1999). This methodology is often used to investigate small 
vessel function (diameter >60 μM) under near physiological conditions of pressure and 
flow by measuring vessel diameter and flow in time (Lu & Kassab, 2011). 
2.3.1 Animal and drug preparation 
Male guinea pigs (250-300 g) obtained from Flinders University were fed ad libitum 
and housed in a 12-hour light/dark cycle. Animals were treated in accordance with the 
Australian Code for the Responsible Conduct of Research at Flinders University. The 
ethics approval number for this study was 734/09. Lidocaine hydrochloride was 
sourced as a 2% solution (ilium) from the local Pharmaceutical Suppliers (Lyppard, 
Queensland).  All other chemicals, including adenosine (A9251 >99% purity) and 
Arginine Vasopressin (AVP, >95%), were purchased from Sigma Aldrich (Castle Hill, 
NSW).  
 
Animals were anaesthetised using ether then decapitated. A laparotomy was 
performed and the second order mesenteric arteries were dissected out according to 
the method of Ellis, et al. (2009). 
2.3.2 Vessel isolation 
Second order mesenteric artery branches were dissected and carefully transferred into 
physiological Krebs Henseleit solution (119 mM NaCl, 4.7 mM KCl, 1.18 mM KH2PO4, 
1.17 mM MgSO4.7H2O, 2.5 mM CaCl2, 22.8 mM NaHCO3 and 0.026 mM EDTA) pH 
7.4 with 5.5 mM glucose and continuously bubbled with 95% O2 and 5% CO2 (Ellis, et 
al., 2009). The artery segment was carefully cleaned to remove fat and connective 
tissue then cut into at least 1 mm in lengths.  
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2.3.3 Vessel mounting in pressure myograph 
The artery segment was mounted on transparent glass cannulae in a warm chamber 
filled with Krebs Henseleit solution and continuously bubbled with 95% O2 and 5% CO2 
at 37oC. Both ends of the segments were fixed on the cannulae with suture (Kenny, et 
al., 2002). The transmural pressure was maintained using two reservoirs mounted on 
a column and connected to the cannulae. A pressure tranducer at one end of the artery 
allowed continual measurement of the intraluminar pressure. One of the reservoirs was 
filled with Krebs Henseleit gassed continuously with 5% CO2 in 95% O2 which 
constantly flowed through the artery throughout the experiment to give an intraluminal 
pressure of 60 mmHg and luminal flow of 100 µl/min (Kenny, et al., 2002). Before the 
experiments were carried out, arteries were tested for leaks by clamping on tubes at 
both ends of the cannulae. If there was no decrease in pressure detected on the 
transducer for 15 seconds, then arteries were deemed leak-free. Arteries with leaks 
were discarded. The outer artery diameter was continuously measured through a 
NIKON TMS inverted microscope, which was portrayed using a video monitor 
(Doughty, et al., 1999) (Figure 2.4, Figure 2.5).  
 
Arteries were allowed to equilibrate for 30 min, then were constricted with 10-8 M AVP. 
AVP was used in the mesenteric artery experiments as the vasoconstrictor instead of 
NE since AVP produces greater maximum contraction on mesenteric arteries than NE 
(Karashima, 1981). Some of the artery segments were left intact and some were 
denuded using pumped air through the vessel (see section 2.3.4). Removal of 
endothelium was confirmed using 10-5 M ACh. Arteries that did not relax >10% of AVP-
precontracted tone, were considered endothelium-denuded. Arteries were then 
washed with Krebs Henseleit solution and left for 30 minutes for re-equilibration. 
Following 30 min equilibration, precontraction was induced by 10-8 M AVP (Lei, et al., 
1993).  
 
After tension stabilisation with AVP precontraction, the arteries then were exposed to 
adenosine, lidocaine or adenosine-lidocaine (AL) intraluminally or extraluminally in a 
concentration-dependent manner and the change in outer artery diameter was 
assessed. At the end of each experiment, the vessels were washed with calcium-free 
physiological solution containing 1 mM ethylene glycol tetraacetic acid (EGTA) to 
determine the maximal dilation of the vessels (Sokoya, et al., 2006a). 
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2.3.4 Endothelium removal 
After the mesentery artery was mounted, pressurized and checked for leaks, the 
denuding process commenced. One end of the cannulae tube (inflow) was connected 
to a 10 ml syringe attached to a pump machine and the other end (outflow) was 
opened. Air was then perfused into the lumen using the pump with a flow rate of 1000 
µl/min. When 5 ml air had been infused, the outflow was clamped and the intraluminal 
pressure increased rapidly. When the lumen pressure reached 70 mmHg, flow rate 
was reduced to 2 µl/min and the vessel left pressurized for 10 minutes. The pump was 
then turned off and inflow to the Krebs Henseleit solution was opened. The outflow 
tube was opened to let the air bubbles out. When the vessel was free from air bubbles, 
the outgoing flow is switched to flowmeter. The denuded vessel was then left to 
equilibrate for 30 minutes.  
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Figure 2.4 A schematic of experimental protocol using pressure myograph. 
Ring vessel was mounted between the glass canulae. Transmural pressure was created by 
adjusting the height of the pressure reservoir and waste reservoir. Outer artery diameter was 
continuously measured through an inverted microscopy connected to a monitor. Drugs were 
delivered intraluminary through pressure reservoir and extraluminary through KH reservoir then 
pumped into the organ bath. Endothelium was removed by injecting high-pressured air into the 
vessel. 
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Figure 2.5 Pressure myograph system.
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2.4 PRESERVATION WITH STATIC COLD STORAGE 
The potential use of AL as an additive in vessel preservation solution was studied in 
Chapter 6. The aim was to examine if AL could improve preservation of vessel 
physiological function after six days of static cold storage. The physiological functions 
of the preserved vessels were measured using isometric force transducer (see Section 
2.2; Figures. 2.1 and 2.2).  
2.4.1 Animal and drug preparation 
Animal and drug preparation were described in section 2.2.1.  
2.4.2 Vessel preparation 
Thoracic aortic vessels were harvested from 300-350 g male Sprague Dawley rats and 
transferred to a container with pre-cooled KH solution (118 mM NaCl, 4.7 mM KCl, 1.2 
mM KH2PO4, 1.2 mM MgCl2, 2.5 mM CaCl2, 25 mM NaHCO3 and 0.03 mM EDTA with 
11 mM glucose). Vessel segments were cleared from surrounding adipose and 
connective tissue and cut in 3 mm length rings and stored at 4°C for six days in one of 
the following preservation solutions: 1) Krebs Henseleit (KH), 2) modified KH (low 
Ca2+/high Mg2+), 3) modified KH + adenosine-lidocaine (KH+AL), or 4) modified KH + 
AL and melatonin and insulin (KH+ALMI) solutions. Due to light sensitivity of melatonin, 
vessels stored in ALMI were covered with aluminium foil during storage.  
2.4.3 Composition of preservation solutions 
• KH: 118 mM NaCl, 4.7 mM KCl, 1.2 mM NaH2PO4, 2.5 mM CaCl2,1.2 mM 
MgCl2, 25 mM NaHCO3, 0.03 mM Na-EDTA and 11 mM glucose. 
• Modified KH: 118 mM NaCl, 4.7 mM KCl, 1.2 mM NaH2PO4, 0.22 mM CaCl2, 
2.6 mM MgCl2, 25 mM NaHCO3, 0.03 mM Na-EDTA and 11 mM glucose. 
• Modified KH + AL: modified KH + 0.4 mM adenosine and 1 mM lidocaine. 
• Modified KH +ALMI: modified KH + 0.4 mM adenosine and 1 mM lidocaine + 
0.1 mM melatonin and 0.01 IU/ml insulin. 
The AL composition was obtained from a previous study performed by Rudd and 
Dobson (2011b). The composition of A and L (400 µM and 1000 µM) which were twice 
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the AL cardioplegia, were used in their other study (Rudd & Dobson, 2011a) previously. 
The use of double concentrations of A and L in heart preservation, recovered a 
superior cardiac output (CO), heart rate, and developing pressure after eight hours 
cold storage (Rudd & Dobson, 2011b). 
 
2.4.4 Vessel physiological function testing   
After six days storage, the vessel rings were transferred to an organ bath filled with KH 
solution, gently warmed to 37°C, and subjected to function testing. Physiological 
(contraction and relaxation) function of the preserved aortic rings were measured using 
an isometric force transducer (PANLAB, distributed by ADInstruments as MLT 
0201/RAD, NSW, AUS) as described in Section 2.2. Contraction was induced by 
norepinephrine (NE; 0.3 μM) and potassium chloride (KCl; 60 mM) to examine the 
receptor and non-receptor-induced contraction, respectively. Vessel relaxation in 
response to acetylcholine (ACh; 10-6-10-3 M) and sodium-nitroprusside (SNP; 10-6-10-
3 M) was tested after preconstriction with 0.3 μM norepinephrine to assess 
endothelium-dependent and endothelium-independent relaxation, respectively (Veres, 
et al., 2015). At the end of each experiment, rings were maximally dilated with 100 μM 
papaverine to confirm viability of the vessels (Grbović, et al., 2000b) and the relaxation 
value would be used as a comparison to ACh and SNP relaxation. ACh is believed to 
act on muscarinic receptors which are G-protein-coupled receptors to produce 
relaxation via endothelial-derived NO production (Chataigneau, et al., 1999), whereas 
SNP is an NO donor that induces vascular smooth muscle relaxation mainly through 
the activation of the soluble guanylate cyclase (sGC), and an increase in cyclic GMP 
(cGMP), although cGMP-independent mechanisms have also been reported 
(Cogolludo, et al., 2001). 
 
 
2. 5. STATISTICAL ANALYSIS  
 
Values are reported as mean ± SEM. All data was tested for normality using 
Kolmogorov-Smirnov test, then tested for homogeneity of variances followed by one-
Way ANOVA and coupled with Bonferroni post hoc test for individual data point 
comparisons. 
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CHAPTER 3. ADENOSINE RELAXATION IN ISOLATED RAT 
AORTIC RINGS AND POSSIBLE ROLES OF SMOOTH MUSCLE KV 
CHANNELS, KATP CHANNELS AND A2A RECEPTORS 
Abstract:  
 
Introduction: An area of ongoing controversy is the role of adenosine to regulate 
vascular tone in conduit vessels that regulate compliance, and the role of nitric oxide 
(NO), potassium channels and receptor subtypes involved.  The aim of this chapter was 
to investigate adenosine relaxation in rat thoracic aortic rings, and the effect of inhibitors 
of NO, prostanoids, Kv, KATP channels, and A2a and A2b receptors.  
 
Methods: Aortic rings were freshly harvested from adult male Sprague Dawley rats and 
equilibrated in an organ bath containing oxygenated, modified Krebs Henseleit solution 
(11 mM glucose, pH 7.4, 37°C). Isolated rings were pre-contracted sub-maximally with 
0.3 µM norepinephrine (NE), and the effect of increasing concentrations of adenosine 
(1 to 1000 µM) were examined.  The drugs L-NAME, indomethacin, 4-aminopyridine (4-
AP), glibenclamide, 5-hydroxydecanoate, ouabain, 8-(3-chlorostyryl) caffeine and PSB-
0788 were examined in intact and denuded rings. Rings were tested for viability after 
each experiment.  
 
Results: Adenosine induced a dose-dependent, triphasic relaxation response, and the 
mechanical removal of the endothelium significantly deceased adenosine relaxation 
above 10 μM. Interestingly, endothelial removal significantly decreased the 
responsiveness (defined as % relaxation per μM adenosine) by two-thirds between 10 
and 100 μM, but not in the lower (1-10 μM) or higher (>100 μM) ranges. In intact rings, 
L-NAME significantly reduced relaxation, but not indomethacin. Antagonists of voltage-
dependent Kv (4-AP), sarcolemma KATP (glibenclamide) and mitochondrial KATP 
channels (5-HD) led to significant reductions in relaxation in both intact and denuded 
rings, with ouabain having little or no effect. Adenosine-induced relaxation appeared to 
involve the A2a receptor, but not the A2b subtype.  
 
Conclusions: It was concluded that adenosine relaxation in NE-precontracted rat 
aortic rings was triphasic and endothelium-dependent above 10 μM, and relaxation 
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involved endothelial nitric oxide (not prostanoids) and a complex interplay between 
smooth muscle A2a subtype and voltage-dependent Kv, SarcKATP and MitoKATP 
channels.  The possible in vivo significance of the regulation of arterial compliance to 
left ventricular function coupling is discussed. 
 
  
 58 
3.1 INTRODUCTION 
Adenosine is a ubiquitous endogenous mediator that is activated in response to cellular 
ischaemic or hypoxic or shear stress (Burnstock & Ralevic, 2013; Ely & Berne, 1992; 
Fredholm, et al., 2001; Jacobson & Gao, 2006; Mustafa, et al., 2009). Adenosine 
exerts it cellular effects by binding to four major subtypes of the G-protein-coupled 
receptors; A1, A2a, A2b, and A3 which activate intracellular survival kinase pathways in 
a cell- and tissue-specific manner (Burnstock & Ralevic, 2013; Fredholm, et al., 2001; 
Headrick, et al., 2013; Jacobson & Gao, 2006). Through receptor-modulation and 
downstream signaling pathways adenosine alters coronary and peripheral vascular 
tone, cardiac function, brain and central nervous system signaling, sleep, the state of 
natural hibernation, ischaemic preconditioning, post-conditioning, inflammation, 
coagulation, angiogenesis, and cell proliferation and remodelling (Burnstock & Ralevic, 
2013; Dobson, et al., 2013a; Headrick, et al., 2013; Mustafa, et al., 2009). 
 
An area of ongoing controversy is the role of adenosine to regulate vascular tone in 
the arterial tree, and the receptor subtypes involved.  The subtype A2a appears to be 
the predominant receptor in arterial vasodilation in mouse, rat, guinea pig, pigs and 
humans, however, the A2b receptor has also been reported to dilate human coronary 
arteries (Kemp & Cocks, 1999), and possibly rat coronary arteries (Headrick, et al., 
2013). In the guinea pig, A2b appears to predominate in the thoracic aorta to induce 
relaxation (Martin, et al., 1993) and both A2a and A2b in the rat (Lewis & Hourani, 1997; 
Lewis, et al., 1994a; Ponnoth, et al., 2009). In addition, there is ongoing debate on the 
relative importance of an intact endothelium to adenosine relaxation in these vessels, 
and the role of nitric oxide (NO) and interplay between voltage-dependent 
transmembrane Na+, K+ and Ca2+ fluxes and signaling pathways.  In the thoracic aorta, 
adenosine relaxation has been reported to be fully dependent (Lewis, et al., 1994a; 
Newman, et al., 1988), partially dependent (Headrick & Berne, 1990; Moritoki, et al., 
1990; Rose’Meyer & Hope, 1990; Yen, et al., 1988) or not dependent on the presence 
of an intact endothelium (De Mey & Vanhoutte, 1981; Furchgott, 1983; Lewis, et al., 
1994a; Rubanyi & Vanhoutte, 1985). Adenosine vasodilation has also been linked to 
A1 and A2a receptor activation of endothelial production of NO and prostanoids (Ray & 
Marshall, 2006a), hyperpolarising factors (Mustafa, et al., 2009), and a complex 
interplay between endothelial and smooth muscle mitochondrial and sarcolemmal KATP 
channels (Headrick & Berne, 1990; Sato, et al., 2000; Taylor, et al., 1988), and Na+/K+ 
ATPase activation (Grbovic & Radenkovic, 2003; Mustafa, et al., 2009).  
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The aim of this chapter was to investigate adenosine relaxation in intact versus 
denuded rat thoracic aortic rings, and examine the effect of inhibitors of nitric oxide 
(NO), prostanoids, Kv channels, KATP channels, and adenosine A2a and A2b receptors. 
The rat thoracic aorta was chosen because of the ongoing debates about the 
mechanisms of adenosine relaxation, and its in vivo significance.  
3.2 MATERIALS AND METHODS 
3.2.1 Animals: 
Male Sprague Dawley rats (300-350g, n=47) were prepared as described in Chapter 
2.2.1. 
3.2.2 Aortic ring preparation and organ bath tension measurements:  
Rat thoracic aortic rings were prepared and tested as described in Chapter 2.2.2 and 
shown in Figure 2.3. 
3.2.3 Adenosine relaxation in intact and denuded rat aortic rings   
Adenosine was added into the oxygenated organ bath containing Krebs Henseleit 
solution to obtain 1, 5, 10, 50, 100, 500 and 1000 µM adenosine concentrations. The 
change in tension of pre-contracted intact or denuded rings was measured.  The 
inhibitors used in this study were incubated in an organ bath 20-30 min before NE was 
administered followed by incremental administration of adenosine. These included: 1) 
100 µM NG-nitro-L-arginine Methyl Ester (L-NAME) (nitric oxide synthetase inhibitor) 
and 10 µM indomethacin (cyclooxygenase or prostaglandin inhibitor e.g. prostacyclin). 
NO and prostacyclin are two major endothelial derived relaxation factors (EDRF), and 
the inhibitors were only applied in endothelium intact aortic rings, and 2) 1 mM 4-
aminopyridine (4-AP) (Non-selective voltage-dependent K+-channel blocker of the Kv1 
to Kv4 families rather than Kv7 channels) (Mackie & Byron, 2008; Novakovic, et al., 
2006; Rautureau, et al., 2002), 10 μM glibenclamide (Non-selective SarcKATP channel 
blocker) (O’rourke, 2000; Toyoda, et al., 2000) and 1 mM 5-hydroxydecanoate (5-HD) 
(MitoKATP channel blocker) (Gross & Gross, 2007), and Na+/K+-ATPase inhibitor (100 
μM ouabain) (Grbović & Radenković, 2003).  These inhibitors were applied to intact 
endothelium rings in the presence of L-NAME and indomethacin, and without the 
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presence of L-NAME and indomethacin in denuded aortic rings.  The adenosine A2a 
receptor inhibitor was 100 μM 8-(3-chlorostyryl) caffeine (CSC) (Allende & Acevedo, 
2011; Mathoôt, et al., 1996), and the A2b receptor inhibitor was 10 μM 8-(4-(4-(4-
chlorobenzyl)piperazine-1-sulfonyl)phenyl)-1-propylxanthine (PSB-0788) (Borrmann, 
et al., 2009). In rat striatal membranes, these antagonists have reported Ki values of 
24 nM for CSC (Van der Walt, et al., 2013) and 0.393 nM for PSB-0788 (Borrmann, et 
al., 2009), and the micromolar concentrations used in the present study were based 
on previous published studies (Kalkan, et al., 2007; Kataoka, et al., 2007; Schiedel, et 
al., 2013).  The inhibitors were applied in endothelium intact and denuded aortic rings 
in an oxygenated medium.  At the end of each experiment, the rings were tested for 
viability (or patency) by being maximally dilated with 100 µM papaverine, and 
relaxation was expressed as percentage of maximal relaxation to papaverine (Grbović 
& Radenković, 2003; Grbović, et al., 2000b). 
3.2.4 Statistics:  
Values are expressed as mean ± SEM. Eight animals (n=8) were used for each group 
for seven measurement points using ANOVA analysis, and the number of rats was 
selected from a priori G-power analysis to achieve a level of 1.0.  All data was tested 
for normality using Kolmogorov-Smirnov test. Relaxation responses to adenosine were 
analysed for homogeneity of variances followed by two-way ANOVA coupled with the 
Bonferroni post-hoc test for individual data point comparisons. The alpha level of 
significance for all experiments was set at p<0.05. 
3.3 RESULTS 
3.3.1 Intact versus Denuded Aortic Rings: 
In endothelium-intact rat aortic rings, adenosine led to 10%, 21%, 29%, 60% and 81% 
relaxation at 10, 50, 100, 500, and 1000 μM adenosine concentrations, respectively 
(Figure 3.1). Adenosine relaxation in intact rings occurred in three linear phases (log 
scale); 0.96% per μM from 1 to 10 μM adenosine (Phase 1), 0.2% per μM from 10 to 
100 μM adenosine (Phase 2), and 0.06% per μM from 100 to 1000 μM (Phase 3). After 
removing the endothelium, relaxation was reduced to 8%, 10%, 14%, 45% and 67% 
respectively, and was significant from 100 to 1000 μM. In denuded rings, adenosine 
relaxation was 0.72% per μM from 1 to 10 μM adenosine, 0.07% per μM from 10 to 
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100 μM adenosine (Phase 1), and 0.06% per μM in Phase 2 from 100 to 1000 μM.  
Thus, endothelial removal of rat aortic rings decreased the responsiveness (defined 
as % relaxation per μM) to around one-third between 10 and 100 μM, but not in the 
lower (Phase 1) or higher (Phase 3) ranges. (Figure 3.1).  
 
 
 
Figure 3.1 Concentration response curves to adenosine in intact and denuded isolated 
rat aortic rings. 
Relaxation is expressed as percent of maximal relaxation to 100 µM papaverine. Points 
represent mean ± S.E.M of aortic rings from a total of seven animals. *p<0.05 statistical 
difference in responses between the intact and denuded rings. Symbols (u) Intact rings (n) 
Denuded rings. 
 
3.3.2 Effect of L-NAME and Indomethacin in intact aortic rings 
Figure 3.2 shows that L-NAME and indomethacin significantly reduced adenosine 
relaxation at 50 to 1000 μM adenosine. At 50 μm, relaxation decreased from 26% to 
11% or 42% (11/26 x 100) of the relaxation of intact controls.   Thus at 50 μM adenosine 
59% of relaxation was linked to L-NAME and indomethacin inhibition.  At 100, 500 and 
1000 μM adenosine concentrations, L-NAME and indomethacin contribution to 
inhibition were 53, 33 and 19% (Figure 3.2). In addition, experiments with L-NAME 
alone showed a similar inhibition, indicating that indomethacin had little or no significant 
inhibition (Figure 3.2). However, at 500 uM and 1000 uM adenosine there was a small 
difference of indomethacin from L-NAME but this was not significant (Figure 3.2). 
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Figure 3.2 Concentration-response curves to adenosine with and without the presence 
of L-NAME alone and L-NAME + indomethacin in intact isolated rat aortic rings.   
Relaxation is expressed as percent of maximal relaxation to 100 µM papaverine. Points 
represent mean ± S.E.M of aortic rings from a total of eight animals. *p<0.05 statistically 
different in the presence of L-NAME alone (p) and L-NAME + indomethacin (n) compared to 
control on intact rings (u).  
 
 
The effect of Kv, sarcKATP, mitoKATP channels and Na+/K+-ATPase on adenosine 
relaxation in intact aortic rings is shown in Figure 3.3A-D. In order to eliminate the 
effect of NO- and prostacyclin-induced relaxation in intact rings, 100 μM L-NAME and 
10 μM indomethacin were included in the controls.  
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3.3.3 Effect of Kv, SarcKATP, MitoKATP Blockers and Ouabain on 
Adenosine Relaxation in intact aortic rings 
 
 
 
 
 
 
 
 
Figure 3.3 Concentration-response curves to adenosine with and without the presence 
of some specific ion channel blockers in intact isolated rat aortic rings. 
[A] In the presence of 1 mM 4-aminopyridine (n). [B] In the presence of 1 mM 5-
Hydroxydecanoate (n). [C] In the presence of 10 µM glibenclamide (n). [D] In the presence of 
100 µM ouabain (n) compared to controls intact rings (u). Relaxation is expressed as percent 
of maximal relaxation to 100 µM papaverine. Points represent mean ± S.E.M of aortic rings 
from a total of eight animals. *p<0.05 statistical difference in responses between the presence 
and the absence of inhibitors on intact rings. 
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Kv inhibition: The effect of pre-incubating intact rings with 1 mM 4-aminopyridine (4-
AP) on adenosine relaxation is shown in Fig 3.3A. Percentage relaxation was 2.4, 5.1, 
8.0, 32.1 and 52.5% for 10, 50, 100, 500 and 1000 μM adenosine, respectively. 
Expressed as a percentage contribution of adenosine relaxation relative to control 
intact rings, the Kv channel was responsible for 78%, 73%, 72%, 58.2% and 28% for 
10, 50, 100, 500 and 1000 μM adenosine respectively, with greater relaxation between 
10 to 100 μM (Figure 3.3A).  
 
SarcKATP and MitoKATP Inhibition: The effect of glibenclamide on adenosine 
relaxation is shown in Figure 3.3B.  Glibenclamide was not as striking as 4-AP but 
significantly decreased adenosine relaxation at 50 and 100 μM adenosine.   The 
contribution of sarcKATP channel to adenosine relaxation was 63%, 53% and 38% at 
10, 50 and 100 μM adenosine (Figure 3.3B).  MitoKATP inhibitor, 5-hydroxydecanoate 
(5-HD), significantly led to a wider range of inhibition of adenosine relaxation compared 
to glibenclamide from 10 to 1000 μM, but the differences between the two blockers 
were not significant (Figure 3.3 C).  The contribution of mitoKATP channel to adenosine 
relaxation was 70%, 63%, 65%, 40% and 27% at 10, 50, 100, 500 and 1000 μM 
adenosine level (Figure 3.3C). 
 
Na+/K+-ATPase Inhibition Figure 3.3D shows that ouabain did not significantly 
change the inhibition produced by L-NAME and indomethacin in adenosine-induced 
relaxation at any given concentration, indicating that Na+/K+-ATPase contributed little 
extra to adenosine relaxation in endothelium intact aortic rings.  
  
 65 
3.3.4 Effect of A2a and A2b Blockers in Intact and Denuded Aortic Ring 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 Concentration-response curves to adenosine with and without the presence 
of adenosine A2ab receptor blockers in intact (A) and denuded (B) isolated rat aortic 
rings.   
In the presence of 100 µM 8-(3-Chlorostyryl) caffeine (n) or 10 µM PSB 0788 (n). Controls 
(intact and denuded rings) (u).  Relaxation is expressed as percent of maximal relaxation to 
100 µM papaverine. Points represent mean ± S.E.M of aortic rings from a total of eight animals. 
*p<0.05 statistical difference in responses between the presence and the absence of inhibitors 
on intact rings. 
  
0
20
40
60
80
100
1 5 10 50 10
0
50
0
10
00
R
el
ax
at
io
n 
(%
)
Adenosine (Log μM)
*
*
0
20
40
60
80
100
1 5 10 50 10
0
50
0
10
00
Adenosine (Log μM)
 Adenosine A2a antagonist  Adenosine A2b antagonist 
A. INTACT RAT AORTIC RINGS  
+ PSB 0788 
+ CSC 
B. DENUDED RAT AORTIC RINGS  
0
20
40
60
80
100
1 5 10 50 10
0
50
0
10
00
R
el
ax
at
io
n 
(%
)
Adenosine (Log μM)
* *
*
*
0
20
40
60
80
100
1 5 10 50 10
0
50
0
10
00
Adenosine (Log μM)
+ PSB 0788 + CSC 
 Adenosine A2a antagonist  Adenosine A2b antagonist 
 66 
Intact Rings: 
L-NAME and indomethacin were not included in this experiment because it has been 
reported that NO or prostacyclin release are linked to adenosine A2a,b receptor 
activation (Hein, et al., 1999). In the absence of any inhibitors, adenosine induced a 
rate of relaxation of about 10% for every 50 μM adenosine up to 100 μM, and ~25% 
relaxation per 50 μM from 100 to 1000 μM until 90% full relaxation (Figure 3.4A). Pre-
incubating intact rings with adenosine A2a receptor inhibitor, CSC, significantly reduced 
adenosine relaxation between 50 to 100 μM (Figure 3.4A). Although greater 
percentage falls in relaxation occurred at lower adenosine levels (e.g. 5 to 10 μM) 
these were not significantly different from controls (Figure 3.4A). The A2a receptor was 
responsible for 71%, 66%, 59% and 47% adenosine relaxation at 5, 10, 50, and 100 
μM adenosine, respectively.  In direct contrast, adenosine A2b receptor inhibitor, PSB 
0788, did not change relaxation at any adenosine concentration studied (Figure 3.4B).  
 
Denuded Rings:  
In denuded rat aortic rings, incubation with A2a blocker, CSC, showed a significant 
reduction of adenosine relaxation from 5 to 100 μM (Figure 3.4B). At 5, 10, 50 and 100 
μM adenosine, the A2a receptor was responsible for 72, 79, 66 and 55% reduction in 
relaxation.  Similar to 4-AP and 5-HD, the A2a receptor blocker did not inhibit adenosine 
relaxation at 500 uM and 1000 uM.  In contrast, adenosine A2b blocker, PSB 0788, had 
no effect to reduce adenosine-induced relaxation (Figure 3.4B). 
  
 67 
3.3.5 Effect of Kv, SarcKATP, MitoKATP blockers and Ouabain on 
Adenosine Relaxation in Denuded Rings 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 Concentration-response curves to adenosine with and without the presence 
of some specific ion channel blockers in denuded isolated rat aortic rings. 
[A] In the presence of 1 mM 4-aminopyridine (n). [B] In the presence of 1 mM 5-
Hydroxydecanoate (n). [C] In the presence of 10 µM glibenclamide (n). [D] In the presence of 
100 µM ouabain (n). Control denuded rings (u). Relaxation is expressed as percent of maximal 
relaxation to 100 µM papaverine. Points represent mean ± S.E.M of aortic rings from a total of 
eight animals. *p<0.05 statistical difference in responses between the presence and the 
absence of inhibitors on denuded rings.  
-20
0
20
40
60
80
100
1 5 10 50 10
0
50
0
10
00
R
el
ax
at
io
n 
(%
)
Adenosine (Log μM)
* * *
*
*
*
0
20
40
60
80
100
1 5 10 50 10
0
50
0
10
00
Adenosine (Log μM)
*
*
*
-20
0
20
40
60
80
100
1 5 10 50 10
0
50
0
10
00
R
el
ax
at
io
n 
(%
)
Adenosine (Log μM)
*
*
*
*
0
20
40
60
80
100
1 5 10 50 10
0
50
0
10
00
Adenosine (Log μM)
A. 4-AP Voltage-dependent K+ (Kv) 
channel blocker 
C. 5HD (MitoKATP blocker)  
B. Glibenclamide (SarcKATP blocker)  
D. Ouabain Na+/K+-ATPase blocker  
DENUDED RAT AORTIC RINGS  
+ Glib 
+ 4-AP 
+ 5HD + Ouabain 
 68 
In the absence of endothelium and blockers, adenosine relaxed rat aortic rings in a 
dose-dependent manner reaching 78% relaxation at the highest 1000 μM adenosine 
concentration (Figure 3.5). Pre-treatment with 4-AP significantly reduced relaxation 
from 1 to 500 μM adenosine but not at 1000 μM (Figure 3.5A). 4-AP nearly completely 
abolished adenosine-induced relaxation up to 10 μM adenosine with over 95% 
inhibition.  At 50, 100 and 500 μM adenosine, the Kv channel was responsible for 74%, 
62%, 21% of adenosine relaxation (Figure 3.5A).  
 
The sarcKATP channel blocker, glibenclamide, also significantly reduced relaxation at 
10, 50 and 100 μM adenosine levels (Figure 3.5B) indicating that the SarcKATP channel 
was responsible for 41%, 38% and 22% of adenosine relaxation, respectively. 
Mitochondrial KATP blocker, 5-HD, significantly reduced relaxation over a wider range 
than glibenclamide similar to intact rings (Figures 3.3BC and 3.5BC).  The greatest 
effect of 5-HD was found at 10 to 100 μM. The contributions of the mitoKATP channel 
to adenosine relaxation were 51%, 48%, 44% and 14% at 10, 50, 100 and 500 uM 
adenosine levels, respectively. The Na+/K+-ATPase channel blocker ouabain, as in 
intact aortic rings, showed no significant effects to reduce adenosine-induced 
vasodilation at any given adenosine level (Figure 3.5D). 
3.4 DISCUSSION 
Despite decades of investigation, the mechanisms of adenosine relaxation in large 
elastic arteries such as the rat thoracic aorta, and smaller muscular resistance 
arterioles are not fully understood (Félétou & Vanhoutte, 2007; Furchgott, 1983; 
Headrick, et al., 2013; Jacobson & Gao, 2006; Mustafa, et al., 2009).  This Chapter 
reports in isolated rat thoracic rings that adenosine vasodilation was: 1) triphasic and 
partially dependent on an intact endothelium, 2) regulated predominately by 
endothelial NO, not prostanoids, 3) dependent on opening smooth muscle Kv, SarcKATP 
and MitoKATP channels, 4) ouabain-insensitive (Na+/K+ ATPase), and 5) activated by 
the A2a subtype, not A2b. The possible interplay between these potassium channels and 
adenosine relaxation in denuded and intact aortic rings, and the in vivo significance 
will now be discussed.  
3.4.1 Adenosine Relaxation involves an NO-Dependent Pathway 
This study showed that L-NAME significantly reduced relaxation in intact rings and 
contributed up to 59% of adenosine relaxation with little or no effect of indomethacin 
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(Figure 3.2). In the rat aorta, endothelial NO is believed to induce vasodilation via 
cGMP- and cAMP-dependent protein kinase mechanisms, and the inhibition of Rho-
kinase constrictor activity (Chitaley & Webb, 2002). The lack of a prostanoid effect in 
this study was surprising. In 2002, Ray and colleagues showed in an elegant series of 
studies, using a NO-sensitive electrode, that adenosine relaxation in the rat aorta 
produced a dose-dependent NO release from the endothelium (Ray, et al., 2002).  
They further showed that A1-receptor NO release was linked to endothelial prostacyclin 
release via a common cyclic AMP signaling pathway (Ray & Marshall, 2006a).  
 
In contrast to the current study, Ray and colleagues used halothane-O2 anaesthetized, 
hypoxic, male 200-250g Wistar rats, and aortic conduits of 10 mm in length which were 
longitudinally opened and the NO-sensitive electrode was directly in contact with the 
endothelial surface (Ray & Marshall, 2006a; Ray, et al., 2002). Systemic hypoxia in 
their study was induced using 8% O2 in N2 for 5 min prior to aorta harvest, but the 
group did not specify the pO2, pCO2 or temperature of their bathing media.  This is an 
interesting contrast, as in this thesis the thoracic aorta was harvested from normoxic, 
male 300-350g Sprague Dawley rats under thiopentone anaesthesia, and the isolated 
intact rings were 3-4 mm in length and fully oxygenated at all times. It is possible that 
prostanoid production in rat aortic rings is not activated during normoxia but during 
hypoxia. In 2001, Verma and colleagues also reported in healthy humans that COX-
2–selective inhibition did not result in significant changes in endothelial vasodilator 
responses (Verma, et al., 2001).  Further work is required to examine these differences 
in different models.   
3.4.2 Role of the Endothelium in Adenosine Relaxation  
In the present study, adenosine vasodilation was partially endothelium-dependent (Fig 
3.1), which is consistent with the earlier work of Yen and colleagues (Yen, et al., 1988), 
Moritoki et al., (Moritoki, et al., 1990), Headrick and Berne (Headrick & Berne, 1990) 
and Rose’Meyer and colleagues (Rose’Meyer & Hope, 1990) in rat and guinea pig 
thoracic aorta. However, in the present study adenosine relaxation was triphasic 
(Figure 3.1), and endothelial removal reduced ring relaxation ‘responsiveness’ 
between 10 to 100 μM adenosine (Phase 2) with little or no change to denuded ring 
sensitivity from 1 to 10 μM (Phase 1) or from 100 to 1000 μM (Phase 3) compared to 
intact rings (Figure 3.1). This triphasic nature of adenosine relaxation has not been 
reported before, and although the underlying mechanisms for the different sensitivities 
are not known, they appear to involve differential endothelial-smooth muscle 
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sensitivities to endothelial NO production, and smooth muscle A2a receptor and 
voltage-dependent Kv and KATP channels (see below).  
3.4.3 Role of Voltage-dependent Kv Channels in Adenosine Relaxation 
The 4-AP experiments (~70-95% inhibition at 5 to 100 μM adenosine) demonstrated 
that the Kv channel has the potential to be a potent activator of adenosine relaxation in 
rat aortic rings.  A similar change in intact and denuded rings (Figures 3.3A and 3.5A) 
suggests that the 4-AP effect was independent of endothelial NO production and was 
preferentially activated on vascular smooth muscle (Figure 3.3A).  This data supports 
the study of Tammaro and colleagues who reported the presence of smooth muscle 
Kv channels in rat aorta (Tammaro, et al., 2004), and that of Heaps and Bowles in 
swine coronary arteries who showed 4-AP-sensitive K+ channels in adenosine 
relaxation (Heaps & Bowles, 2002). In addition, Kv channels have also been widely 
reported in regulating tone in smaller resistance vessels of cerebral and mesenteric 
vascular beds (Albarwani, et al., 2003; Cole, et al., 1996; Coleman, et al., 2004; Mackie 
& Byron, 2008), and in vascular smooth muscle from larger rat pulmonary arteries 
(Archer, et al., 2004). In conclusion, this data indicates that adenosine relaxation in 
isolated NE-precontracted rat aortic rings involved Kv channels with higher sensitivities 
found at lower adenosine levels.  Further studies are required using more specific Kv 
channel isoform inhibitors (and agonists), and their membrane voltage dependence on 
relaxation (Smirnov, et al., 2003) at low and high adenosine levels.  
3.4.4 Contributions of SarcKATP and MitoKATP Channels to Adenosine 
Relaxation, and A2a Receptor Activation. 
The SarcKATP channel was shown to contribute to 14 to 63% of adenosine relaxation 
up to 100 μM adenosine (Figs 3.3B and 3.5B), and MitoKATP channels contributed to 
22 to 70% relaxation up to 1000 μM adenosine in intact and denuded aortic rings (Figs 
3.3C and 3.5C).  The wider range of adenosine inhibition with MitoKATP channel blocker 
5-HD indicates that it shifted the control relaxation curve more to the right than 
glibenclamide (Figs 3.3C and 3.5C).  For example, at 10 and 100 μM adenosine, 5-HD 
led to 50% more inhibition than glibenclamide in intact rings (Figures 3.3B and 3.3C), 
and 17% and 29% more inhibition in denuded rings (Figures 3.5C and 3.5B). This 
difference may indicate differential contributions of the MitoKATP and SarcKATP channel 
activation to adenosine relaxation, however, 5-HD has been shown to exert effects 
independent of MitoKATP channels (Li, et al., 2010) which may influence that 
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interpretation. 
 
The glibenclamide data showing significant relaxation reduction (Figures 3.3B and 
3.5B), albeit less potent than 5-HD (Figures 3.3C and 3.5C), is in contrast to the study 
of Husken and colleagues who reported no effect in rat aorta (Hüsken, et al., 1997). 
However, their rings were bathed in a hypoxic, low-glucose medium. Similarly, Kemp 
and Cocks reported lack of a glibenclamide effect in coronary artery rings prepared 
from cardiac surgery patients (Kemp & Cocks, 1999). It appears therefore that 
glibenclamide-sensitive KATP channel activation and adenosine relaxation is dependent 
on the state of tissue oxygenation, prior disease states and possibly ischaemia.  
 
Furthermore, Kemp and Cocks found that adenosine relaxation in their discarded 
human coronary artery rings was mediated largely by A2b receptors (Kemp & Cocks, 
1999), unlike A2a receptors found in isolated rat aortic rings in the present study (Figs 
3.4AB). Adenosine A2a receptor activation and relaxation in rat aortic rings is consistent 
with the majority of studies in rabbit aorta and mesenteric and coeliac arteries 
(Kleppisch & Nelson, 1995), mouse hearts (Zatta & Headrick, 2005), and guinea pig, 
porcine and bovine coronary arteries (Conti, et al., 1997; Lewis, et al., 1994a; Shryock 
& Belardinelli, 1997).  However, Lewis and colleagues reported in Wistar rat isolated 
aortic preparations that A2a adenosine relaxation was entirely endothelium-dependent 
(Lewis, et al., 1994a), not smooth muscle-dependent as was found in the present study 
(Figures 3.4A and 3.4B).  In rat renal artery, Grbović and colleagues also showed that 
removal of the endothelium abolished A2a adenosine relaxation, implicating endothelial 
relaxation factors such as NO for relaxation (Grbović, et al., 2000b).  These contrasting 
results may be due to differences in species, age, prior disease state, aortic ring 
preparation, presence of an endothelium and the bathing media. Another difference 
may be the type of artery; studying the larger arterial conduits versus smaller arteriolar 
resistance vessels which have very different functions (see below ‘Limitations of the 
Present Study and Future Studies’). It is noteworthy that Leal and colleagues found 
that A2a and A2b subtypes were abundant in all three layers of Wistar rat thoracic aorta 
wall (intima, media, and adventitia) (Leal, et al., 2008), again illustrating the deep 
complexity of receptor and channel expression in the thoracic aorta.  
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3.4.5 Adenosine Regulation of Relaxation in Rat Aortic Rings: A Working 
Hypothesis 
Although adenosine relaxation at different oxygenation states and pH, or from hypoxic 
animals, was not investigated in the current study, the results support the following 
scheme.  Adenosine-linked NO production appeared to be a major endothelium-
derived relaxing factor in intact rat aortic rings, not prostanoids, which sets the stage 
for endothelial-smooth muscle coupling. In denuded aortic rings, adenosine appears 
to activate A2a receptors and trigger downstream opening of Kv and KATP channels 
located on smooth muscle resulting in membrane hyperpolarization, and relaxation, 
which may have involved common protein kinase signalling transduction pathways and 
crosstalk (Berwick, et al., 2010; Brayden, 2002; Cole, et al., 1996; Kleppisch & Nelson, 
1995; Ko, et al., 2008; Maimon, et al., 2014; Quayle, et al., 1997). Membrane 
hyperpolarization of only a few millivolts can lower cytosolic Ca2+ via reduced activity 
of membrane voltage-operated Ca2+ channels and reduced myofilament Ca2+ 
sensitivity (Akata, 2007a), resulting in smooth muscle relaxation. Partial support for 
this hypothesis in denuded rings comes from reports showing adenosine activation of 
Kv channels in pig coronary arterioles occurs via cAMP-dependent protein kinase 
(PKA) activation and vasodilatation (Heaps, et al., 2008; Ko, et al., 2010), and from 
Kleppisch and Nelson who showed that adenosine A2a (not A2b) activation opens KATP 
channels via the cAMP/PKA pathway in isolated rabbit mesenteric vascular smooth 
muscle cells (Kleppisch & Nelson, 1995).  More recently, Maimon and colleagues 
showed in skeletal muscle arterioles that PKA signaling varies with pre-exposure to 
adenosine, and that PKA activation alone was not sufficient to dilate these arterioles, 
and required other Ca2+-dependent mechanisms to facilitate vasodilation to adenosine 
(Maimon, et al., 2014).  
 
Another possible mechanism coupling adenosine A2a receptor to opening Kv and KATP 
channels in rat denuded aorta rings may be via mitochondrial production of H2O2 
(Bonnet & Archer, 2007; Krenz, et al., 2002). H2O2 is a highly diffusible and signalling 
redox intermediate produced during mitochondrial phosphorylation of ADP to ATP, and 
is believed to trigger Ca2+ sparks that activate protein kinase pathways and adenosine 
relaxation (Dick, et al., 2008; Sharifi-Sanjani, et al., 2013). Dick and colleagues 
reported that H2O2 activated Kv channels and led to coronary vasodilation along with 
increases in myocardial metabolism (Dick, et al., 2008), and Sharifi-Saniani and 
colleagues showed that adenosine A2a receptor activation in mouse aorta during 
reactive hyperemia was coupled to smooth muscle KATP channels via the production of 
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H2O2 (Sharifi-Sanjani, et al., 2013). It is possible that mitochondrial H2O2 bursts may 
also facilitate crosstalk between mito- and sarc-KATP channels in our model.   
 
Lastly, activation of A2a in rat aortic rings may also have occurred from adenosine’s 
breakdown metabolite, inosine (via adenosine deaminase), which has recently been 
shown to be a functional agonist of the A2a receptor (Welihinda, et al., 2016). It is 
possible therefore that adenosine engages A2a receptor to generate initial relaxation 
followed by a dual agonist-mediated response from inosine to amplify or prolong A2a 
activation in vivo.  While inosine is known to relax aortic rings (Chinellato, et al., 1994), 
its dual action with adenosine has only been studied in inflammatory/immune cells 
(Welihinda, et al., 2016).  
3.4.6 Limitations of the Present Study and Future Studies 
While all four major types of K+ channels (Kv, KATP, KIR and KCa) appear to be present 
in vascular endothelial and smooth muscle cells (Bonnet & Archer, 2007; Chen, et al., 
2006; Cole, et al., 1996; Coleman, et al., 2004; Edwards, et al., 2010; Ko, et al., 2008), 
the current study was limited to KV and KATP channels in intact and denuded aortic 
rings.  Furthermore, aortic ring relaxation was investigated in a high pO2 environment 
and it would be of interest to investigate the effect of lowering pO2 and changing pH. 
In addition, adenosine receptor characterization may have been more robust with the 
use of more than one A2a and A2b antagonist at appropriate concentrations.  The 
isolated aortic ring preparation also lacks sympathetic neurohumoral innervations and 
the vasa vasorum, which makes translation to the intact vessel challenging. The in vivo 
significance of these results may relate to regulating compliance of the thoracic aorta 
as part of ventricular-arterial coupling (Jufri, et al., 2015; Sandoo, et al., 2010a; Triggle, 
et al., 2012a). The thoracic aorta and other large arteries are compliance vessels and 
are continually subjected to different hemodynamic forces such as mechanical stretch 
due to pulsatile blood flow, and may adjust vascular tone by changing the balance of 
vasodilating and vasoconstricting factors and neurohumoral mechanisms (Jufri, et al., 
2015; Sandoo, et al., 2010a; Triggle, et al., 2012a). In contrast, smaller peripheral and 
coronary arterioles supply vascular beds and regulate flow by changing resistance to 
maintain adequate tissue oxygenation. Further studies are required to investigate the 
possible role of adenosine (and possibly inosine) and its various receptor subtypes to 
regulate compliance versus resistance vessels (including venous capacitance vessels) 
in different regions and vascular beds in the body.   
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3.5 CONCLUSIONS 
This chapter showed that adenosine relaxation in NE-precontracted rat thoracic aortic 
rings was triphasic and partially endothelium-dependent and involved endothelial NO 
production with a complex interplay between smooth muscle A2a subtype and voltage-
dependent Kv, SarcKATP and MitoKATP channels, but not a prostanoid-dependent 
pathway.  
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CHAPTER 4. LIDOCAINE RELAXATION IN ISOLATED RAT AORTIC 
RINGS IS ENHANCED BY ENDOTHELIAL REMOVAL: POSSIBLE 
ROLE OF KV, KATP CHANNELS AND A2A RECEPTOR CROSSTALK 
Abstract:  
 
Introduction: Lidocaine is an approved local anaesthetic and Class 1B antiarrhythmic 
with a number of ancillary properties. The aim of this chapter was to investigate 
lidocaine’s vasoreactivity properties in intact versus denuded rat thoracic aortic rings, 
and the effect of inhibitors of nitric oxide (NO), prostenoids, voltage-dependent Kv and 
KATP channels, membrane Na+/K+ pump, and A2a and A2b receptors.  
 
Methods: Aortic rings were harvested from adult male Sprague Dawley rats and 
equilibrated in an organ bath containing oxygenated, modified Krebs-Henseleit 
solution, pH 7.4, 37°C. The rings were pre-contracted sub-maximally with 0.3 µM 
norepinephrine (NE), and the effect of increasing lidocaine concentrations was 
examined. Rings were tested for viability after each experiment with maximally dilating 
100 µM papaverine. The drugs 4-aminopyridine (4-AP), glibenclamide, 5-
hydroxydecanoate, ouabain, 8-(3-chlorostyryl) caffeine and PSB-0788 were 
examined. 
 
Results: All drugs tested had no significant effect on basal tension.  Lidocaine 
relaxation in intact rings was biphasic between 1 to 10 µM (Phase 1) and 10 to 1000 
µM (Phase 2). Mechanical removal of the endothelium resulted in further relaxation, 
and at lower concentrations ring sensitivity (% relaxation per µM lidocaine) significantly 
increased 3.5 times compared to intact rings.  The relaxing factor(s) responsible for 
enhancing ring relaxation did not appear to be NO- or prostacyclin-dependent, as L-
NAME and indomethacin had little or no effect on intact ring relaxation.  In denuded 
rings, lidocaine relaxation was completely abolished by Kv channel inhibition and 
significantly reduced by antagonists of the MitoKATP channel, and to a lesser extent the 
SarcKATP channel. Curiously, A2a subtype receptor antagonism significantly inhibited 
lidocaine relaxation above 100 µM, but not the A2b receptor. 
 
Conclusions: This chapter shows that lidocaine relaxation in rat thoracic aorta was 
biphasic and significantly enhanced by endothelial removal, which did not appear to 
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be NO or prostacyclin dependent. The unknown factor(s) responsible for enhanced 
relaxation was significantly reduced by Kv inhibition, 5-HD inhibition, and A2a subtype 
inhibition indicating a potential role for crosstalk in lidocaine’s vasoreactivity. 
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4.1 INTRODUCTION 
Lidocaine is a local amide-type cationic anaesthetic, which acts by blocking voltage-
dependent Na+ fast channels in excitable cells (EC50, 50-100 uM) (Opie & Gersh, 
2012). At lower concentrations, lidocaine is an approved Class 1B antiarrhythmic 
(Wyman, et al., 2004) and exerts anti-inflammatory (Hollmann, et al., 2004b), 
neuroprotective (Butterworth & Hammon, 2002), energy-lowering (Seyfried, et al., 
2005), anti-ischaemic (Cassuto, et al., 2006; Vinten-Johansen, 2004), anti-oxidant 
(Lee, et al., 2010; Tomoda, et al., 1990) and platelet-neutrophil interactive (Huang, et 
al., 2009; Schmidt, et al., 1997) properties.  
 
Lidocaine has also been shown to exert a number of vasomodulatory properties in 
isolated vessels including: 1) endothelium-independent relaxation (Shan, et al., 2004; 
Turan, et al., 2000), and 2) vascular smooth muscle relaxation (Evans, et al., 1997c; 
Johns, et al., 1985; Turan, et al., 2000) or contraction (Evans, et al., 1997c; Gherardini, 
et al., 1998a; Kinoshita, et al., 2001a; Kinoshita, et al., 2003a; Perlmutter, et al., 1990a) 
properties. The apparent paradoxical nature of lidocaine on vascular smooth muscle 
is often explained as being dose-dependent with vasoconstriction of peripheral blood 
vessels occurring at low concentrations of lidocaine (~5 uM) and vasodilation at higher 
levels (> 50 uM) (Abe, et al., 2000; Johns, et al., 1985; Perlmutter, et al., 1990a; Satoh, 
et al., 2015). In the rat carotid artery, Kinoshita further proposed that lidocaine may 
impair the vasodilator response via the activation of ATP-sensitive K+ channels which 
may be exacerbated by hypoxia (Kinoshita, et al., 2003a). Earlier the same group 
showed that in pre-contracted denuded rat aortic rings that acidification promoted 
lidocaine relaxation and alkalization led to vasoconstriction (Kinoshita, et al., 2001a). 
 
These confounding effects of lidocaine vasoreactivity appear to be linked to differential 
modulation of multiple channels including Na+ channels (Wyman, et al., 2004), 
inwardly-rectifying K+ channels (Josephson, 1988), Ca2+ channels (Shan, et al., 2004; 
Tanaka, et al., 2002) and/or KATP channels (Kinoshita, et al., 2001a; Kinoshita, et al., 
2003a). Vasodilation may involve nitric oxide (NO) (Newton, et al., 2007; Takaishi, et 
al., 2013; Toda, et al., 2007), redox regulation (Lee, et al., 2010) and possible 
convergence of a multitude of downstream cAMP and cGMP signaling cascades that 
lead to changes in cytosolic Ca2+ (Scholz, 2002). Hollmann and colleagues, for 
example, identified lidocaine and G-protein coupled receptor systems as potential 
intracellular signaling mechanisms, and the Gq protein subunit as a possible common 
target (Hollmann, et al., 2001b).  In 2003, Benkwitz et al., also showed that the Gi 
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protein subunit was enhanced by lidocaine, and that it was potentiated adenosine A1-
receptor signaling (Benkwitz, et al., 2003). The group proposed that lidocaine was not 
an A1-receptor agonist but enhanced adenosine-A1 receptor signaling separate from 
its local anaesthetic Na+ channel properties (Benkwitz, et al., 2003).  The aim of the 
present study was to investigate the nature of lidocaine relaxation in isolated rat 
thoracic aortic rings, and examine the effect of inhibitors of NO, prostanoids, Kv 
channels, KATP channels, and adenosine A2a and A2b receptors. Adenosine A2 receptors 
were chosen because they are widely known to modify vascular tone (Peart & 
Headrick, 2007), and may therefore be involved in possible crosstalk in lidocaine 
relaxation (Benkwitz, et al., 2003).  
4.2 MATERIALS AND METHODS 
4.2.1 Animals: 
Male Sprague Dawley rats (300-350g, n=72) were prepared as described in Chapter 
2.2.1. 
4.2.2 Aortic ring preparation and organ bath tension measurements:  
Rat thoracic aortic rings were prepared and tested as described in Chapter 2.2.2 and 
shown in Figure 2.3. 
4.2.3 Lidocaine relaxation in intact and denuded rat aortic rings: 
Experimental Protocol:   
Lidocaine-HCl was added into the oxygenated organ bath containing KH solution to 
obtain 1, 5, 10, 50, 100, 500 and 1000 µM lidocaine concentrations. The change in 
tension of pre-contracted intact or denuded rings was measured.  Responsiveness 
was defined as % relaxation per μM lidocaine. The inhibitors used in this study were 
incubated in organ bath 20-30 min before NE was administered followed by lidocaine 
incremental administration. These included 1) 100 µM NG-nitro-L-arginine Methyl Ester 
(L-NAME) (nitric oxide synthetase inhibitor) and 10 µM indomethacin (cyclooxygenase 
or prostaglandin inhibitor e.g. prostacyclin). NO and prostacyclin are two major 
endothelial derived relaxation factors (EDRF), and the inhibitors were only applied in 
endothelium intact aortic rings. 2) 1 mM 4-aminopyridine (4-AP) (Non-selective 
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voltage-dependent K+-channel blocker of the Kv1 to Kv4 families rather than Kv7 
channels) (Mackie & Byron, 2008; Novakovic, et al., 2006; Rautureau, et al., 2002), 10 
μM glibenclamide (Non-selective SarcKATP channel blocker) (O’rourke, 2000; Toyoda, 
et al., 2000) and 1 mM 5-hydroxydecanoate (5-HD) (Non-selective MitoKATP channel 
blocker) (Gross & Gross, 2007), and Na+/K+-ATPase inhibitor (100 μM ouabain) 
(Grbović & Radenković, 2003).  While 5-HD is commonly used in the literature as a 
specific MitoKATP channel blocker (Anastacio, et al., 2013), Hanley and colleagues 
have shown that 5-HD is not a selective inhibitor of mitochondrial KATP channels but 
can act a substrate for the mitochondrial outer membrane enzyme acyl-CoA 
synthetase in the beta-oxidation pathway (Hanley, et al., 2003), and it is also capable 
of playing a role as an inhibitor of sarcolemmal KATP channels in the presence of ATP 
(which was not the case in the current study) (Li, et al., 2010). These inhibitors were 
applied to intact endothelium rings in the presence of L-NAME and indomethacin, and 
without the presence of L-NAME and indomethacin in denuded aortic rings. 3) The 
adenosine A2a receptor inhibitor, 100 μM 8-(3-chlorostyryl) caffeine (CSC) (Allende & 
Acevedo, 2011; Jacobson, et al., 1993; Mathoôt, et al., 1996), and the A2b receptor 
inhibitor, 10 μM 8-(4-(4-(4-chlorobenzyl)piperazine-1-sulfonyl)phenyl)-1-
propylxanthine (PSB-0788) (Borrmann, et al., 2009). These high affinity antagonists 
have been used in rodent studies with reported Ki values of 24 nM for CSC (Van der 
Walt, et al., 2013) and 0.393 nM for PSB-0788 (Borrmann, et al., 2009). CSC has also 
been shown to be 520-fold selective for A2a-adenosine receptors in radioligand binding 
assays in the rat brain (Ki, 54 nM) with little or no effect on A1 receptors (Jacobson, et 
al., 1993). The inhibitors were applied to isolated rat aortic rings in an oxygenated 
medium.  At the end of each experiment, the rings were tested for viability (or patency) 
by being maximally dilated with 100 µM papaverine, and relaxation was expressed as 
percentage of maximal relaxation to papaverine [(Grbović & Radenković, 2003; 
Grbović, et al., 2000b).   
4.2.4 Statistics:  
Values are expressed as mean ± SEM. The number of rats was selected from a priori 
G-power analysis to achieve a level of 1.0. All data was tested for normality using 
Kolmogorov-Smirnov test. Relaxation responses to lidocaine were analysed for 
homogeneity of variances followed by two-way ANOVA coupled with the Bonferroni 
post-hoc test for individual data point comparisons. The alpha level of significance for 
all experiments was set at p<0.05. 
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4.3 RESULTS 
4.3.1 Effect of Increasing Lidocaine on Relaxation in Intact and Denuded 
Rings 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Concentration response curves to lidocaine in intact and denuded isolated rat 
aortic rings. 
Relaxation is expressed as percent of maximal relaxation to 100 µM papaverine. Points 
represent mean ± S.E.M of aortic rings. *p<0.05 statistical difference in responses between the 
intact and denuded rings.  Lidocaine concentrations are on a log scale. Total animals n=12 
 
 
Intact Rings: The gram tension produced with NE administration in endothelium intact 
rings was not significantly different from denuded aortic rings. Lidocaine produced a 
concentration-dependent, biphasic relaxation relationship in intact and denuded rat 
aortic rings (Figure 4.2). The percentage relaxation in intact rat aortic rings was 1.3, 
6.0, 8.6 and 41.7% at 1, 10, 100 and 1000 uM lidocaine respectively.  The first 
relaxation phase was between 1-10 uM (Phase 1) and the second phase was from 10 
to 1000 uM lidocaine (Phase 2) (log concentration scale) (Figure 4.2).  The percentage 
relaxation per μM lidocaine (ring responsiveness) was 0.47% from 1 to 10 μM, 0.029% 
between 10 and 100 μM, and 0.037% increase per μM between 100 and 1000 μM 
lidocaine. The maximum relaxation from 1 to 1000 μM lidocaine in intact rings was 
40.4%.  
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Denuded Rings: Removal of the endothelium significantly increased Phase 1 
relaxation responsiveness from 0.47% to 1.80% per μM lidocaine between 1 and 10 
μM (Figure 4.2). Interestingly, above 10 μM removing the endothelium had little or no 
significant effect on ring responsiveness to increasing lidocaine compared to intact 
rings. From 10 to 100 μM, % relaxation per μM was 0.033% and from 100 to 1000 μM 
was 0.028% (Figure 4.2).  However, despite this similar responsiveness, at each 
lidocaine concentration up to 100 μM, the absolute percentage relaxation was 
significantly higher in denuded rings than intact rings. The absolute % relaxation in 
denuded rings was 5.5, 14, 22, 24, 25, 36 and 50% at 1, 5, 10, 50, 100, 500 and 1000 
uM lidocaine, respectively (Figure 4.2).  Thus, the effect of removing the endothelium 
was to significantly enhance ring sensitivity or responsiveness at lower lidocaine 
concentrations (1 to 10 μM) but not in the higher range (10 to 1000 μM), even though 
absolute relaxation values were significantly higher at each lidocaine concentration (1 
to 1000 μM) in denuded versus intact rings (Figure 4.2). 
 
4.3.2 Effect of L-NAME and Indomethacin in intact aortic rings 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 Concentration-response curves to lidocaine with and without the presence of 
L-NAME + indomethacin in intact isolated rat aortic rings. 
Relaxation is expressed as percent of maximal relaxation to 100 µM papaverine. Points 
represent mean ± S.E.M of aortic rings. *p<0.05 statistically different in the presence of L-NAME 
+ indomethacin compared to control on intact rings. Lidocaine concentrations are on a log scale. 
Total animals n=12. 
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In intact aortic rings, pre-treatment with L-NAME and indomethacin did not significantly 
change lidocaine relaxation from 1 to 1000 μM, although there was a trend towards 
inhibition at higher concentrations (Figure 4.3). Between 1 and 10 μM, the change in 
relaxation was 0.44% per μM, 0002% per μM between 10-100 μM and 0.029% per μM 
from 100 to 1000 μM.  At 500 μM lidocaine, the % relaxation was 17% (32% lower than 
intact rings) and at 1000 μM lidocaine was 32% (24% lower than intact rings), but the 
differences were not significant (Figure 4.3).  
 
4.3.3 Effect of Kv, SarcKATP, MitoKATP and Na+/K+ ATPase Antagonists on 
Relaxation in Intact and Denuded Rings 
The effects of voltage-dependent Kv, SarcKATP, mitoKATP and Na+/K+-ATPase 
antagonists on lidocaine relaxation in intact rat aortic rings are shown in Figure 4.4. 
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Figure 4.4 Concentration-response curves to lidocaine with and without the presence of 
specific ion channel blockers in intact isolated rat aortic rings.   
[A] In the presence of 1 mM 4-aminopyridine. [B] In the presence of 1 mM 5-Hydroxydecanoate. 
[C] In the presence of 10 µM glibenclamide. [D] In the presence of 100 µM ouabain. Relaxation 
is expressed as percent of maximal relaxation to 100 µM papaverine. Points represent mean ± 
S.E.M of aortic rings in the presence of L-NAME and indomethacin. *p<0.05 statistical 
difference in responses between the presence and the absence of inhibitors on intact rings. 
Lidocaine concentrations are on a log scale.  Total animals n=16. 
  
-10
0
10
20
30
40
50
60
1 5 10 50 100 500 1000
R
el
ax
at
io
n 
(%
)
Lidocaine (μM)
L-NAME+indomethacin
L-NAME+indomethacin+4AP
-10
0
10
20
30
40
50
60
1 5 10 50 100 500 1000
Lidocaine (μM)
L-NAME+indomethacin
L-NAME+indomethacin+glibenclamide
-10
0
10
20
30
40
50
60
1 5 10 50 100 500 1000
R
el
ax
at
io
n 
(%
)
Lidocaine (μM)
L-NAME+indomethacin
L-NAME+indomethacin+5HD
-10
0
10
20
30
40
50
60
1 5 10 50 100 500 1000
Lidocaine (μM)
L-NAME+indomethacin
L-NAME+indomethacin+ouabain
A. 4-AP Voltage-dependent K+ (Kv) channel 
blocker 
B. Glibenclamide (SarcKATP blocker)  
C. 5HD (MitoKATP blocker)  D. Oubain Na+/K+-ATPase blocker  
INTACT RAT AORTIC RINGS  
+ Glib + 4-AP 
+ 5HD + Ouabain 
 84 
After pre-contracted with NE, ring basal tensions were 3.3 ± 0.09 g; 3.5 ± 0.17 g; 3.4 
± 0.09 g; 3.4 ± 0.14 g (n=8 each) for 4-AP, glibenclamide, 5-HD and ouabain groups, 
respectively; and not significantly different from NE with L-NAME and indomethacin 
controls (3.2 ± 0.19 g, n=8). In endothelial intact aortic rings, exposure of rings to these 
antagonists did not alter lidocaine-induced relaxation compared to controls (Figure 
4.4).  
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Figure 4.5 Concentration-response curves to lidocaine with and without the presence of 
specific ion channel blockers in denuded isolated rat aortic rings.   
[A] In the presence of 1 mM 4-aminopyridine. [B] In the presence of 1 mM 5-Hydroxydecanoate. 
[C] In the presence of 10 µM glibenclamide. [D] In the presence of 100 µM ouabain. Relaxation 
is expressed as percent of maximal relaxation to 100 µM papaverine. Points represent mean ± 
S.E.M of aortic rings in the presence of L-NAME and indomethacin. *p<0.05 statistical 
difference in responses between the presence and the absence of inhibitors on intact rings. 
Lidocaine concentrations are on a log scale.  Total animals n=16.  
D. Oubain Na+/K+-ATPase blocker  
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In denuded rings, the effect of 1 mM 4-AP was to totally abolish relaxation up to 500 
μM after which relaxation was 12 ± 5% (n=8) compared to 39 ± 5% in denuded controls 
(i.e. 4-AP led to a 70% decrease in relaxation) (Figure 4.5A). 4-AP inhibition was 
significant from 1 to 1000 μM lidocaine (p<0.0001).  The effect of glibenclamide (10 
μM) had little or no effect on relaxation up to 10 μM lidocaine compared to denuded 
controls (Figure 4. 5B) and was ~20% lower at higher lidocaine concentrations; 
however, the differences were not significant.  Exposure of denuded rings to 1 mM 5-
HD led to ~50% decrease in lidocaine relaxation at 5 to 1000 μM lidocaine which was 
significant >50 μM (Figure 4.5C). The presence of 100 μM ouabain, a Na+/K+-ATPase 
channel inhibitor, had little or no significant effect on lidocaine-induced relaxation 
(Figure 4.5D).  
4.3.4 Effect of A2a and A2b antagonists in intact and denuded rat aortic 
rings 
The basal tension of NE-precontracted CSC group was 3.1 ± 0.16 g and PSB-0788 
groups 3.7 ± 0.07 g (n=8 each) and not significantly different from controls (3.2 ± 0.19 
g, n=8). Adenosine A2a antagonist 8-(3-chlorostyryl) caffeine (CSC) significantly 
decreased lidocaine relaxation in the intact rat aorta at 100 to 1000 μM (Figure 4.6). 
Divergence began to occur at 50 μM lidocaine with relaxation values of 2, -2.8, -3.4 
and 7.6% at 50, 100, 500 and 1000 μM lidocaine respectively. In direct contrast, the 
incubation with PSB-0788, an adenosine A2b antagonist, did not modify lidocaine-
induced relaxation curve at any concentration used in NE pre-contracted aortic rings 
(Figure 4.6).  
 
In denuded rings, the basal tension of aortic rings with the presence of CSC (2.5 ± 0.15 
g) or PSB-0788 (3.1 ± 0.18 g) was not significantly different.  CSC had no effect on 
relaxation up to 10 uM lidocaine then strongly inhibited relaxation up to 500 μM (Figure 
4.6).  The maximum lidocaine relaxation was 13 ± 6%, which was significantly lower 
than control denuded rings (39 ± 5%, p<0.0001) (Figure 4.6).  The adenosine A2b 
receptor blocker PSB-0788 (10 μM) also decreased lidocaine relaxation by up to 50% 
but this effect was not significant (Figure 6). At 10, 100, and 1000 μM lidocaine, the 
relaxation percentages were 7 ± 1 %, 10 ± 2%, and 31 ± 3%, respectively compared 
to 16 ± 3%, 19 ± 4%, and 39 ± 5% in denuded controls (Figure 4.6).  
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Figure 4.6 Concentration-response curves to lidocaine with and without the presence of 
adenosine A2ab receptor blockers in intact and denuded isolated rat aortic rings.   
[A] In the presence of 100 µM 8-(3-Chlorostyryl) caffeine. [B] In the presence of 10 µM PSB-
0788. Relaxation is expressed as percent of maximal relaxation to 100 µM papaverine. Points 
represent mean ± S.E.M of aortic rings in the presence of L-NAME and indomethacin. *p<0.05 
statistical difference in responses between the presence and the absence of inhibitors on intact 
rings. Lidocaine concentrations are on a log scale. Total animals n=16. 
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4.4 DISCUSSION 
Despite decades of investigation, the mechanisms of lidocaine relaxation in the rat 
thoracic aorta, and muscular resistance arterioles are not fully understood (Abe, et al., 
2000; Evans, et al., 1984; Johns, et al., 1985; Perlmutter, et al., 1990a; Satoh, et al., 
2015; Turan, et al., 2000).  This chapter reports in isolated rat thoracic rings, pre-
contracted with NE, that lidocaine relaxation was: 1) biphasic from 1 to 10 μM and 10 
to 1000 μM, 2) significantly enhanced by endothelial removal, particularly from 1 to 100 
μM, 3) not significantly affected in the presence of L-NAME- and indomethacin in intact 
rings, 4) abolished by 4-AP in denuded rings and significantly reduced by 5-HD, and 
to a lesser extent glibenclamide, and 5) significantly reduced by A2a subtype antagonist 
from 100 to 1000 μM, but not A2b. The possible physiological significance of the 
biphasic nature of lidocaine relaxation, enhancement after endothelial removal, and 
potential role for crosstalk with the A2a subtype and voltage-dependent Kv and KATP 
channels will be discussed.  
4.4.1 Lidocaine Relaxation was Biphasic and Endothelial Dependent 
The results show in oxygenated, glucose-containing Krebs Henseleit buffer, pH 7.4 at 
37°C: 1) little or no change in relaxation in rat aortic rings at low lidocaine 
concentrations, and 2) a strong endothelial dependence which enhanced relaxation 
after its removal (Figure 4.2).  The data suggest that the presence of an intact 
endothelium acted like a “brake” to reduce lidocaine relaxation, and upon its removal 
activated some putative factor to enhance relaxation. These findings are in contrast 
with those reported in rat cremaster skeletal muscle (Johns, et al., 1985), epicardial 
porcine coronary arteries (Perlmutter, et al., 1990a), human radial arterial rings 
(Jernbeck & Samuelson, 1993), human mammary arteries (Gherardini, et al., 1995), 
and rabbit carotid arteries (Evans, et al., 1997c; Gherardini, et al., 1996), where 
lidocaine at low levels potentiated vasoconstriction, and at high concentrations led to 
relaxation. Jembeck and Samuelson further reported in isolated rings from radial 
arteries that lidocaine led to significantly stronger contractions after the endothelium 
was mechanically removed (Jernbeck & Samuelson, 1993). Reasons for the 
differences are not clear at present but may relate to species, age, mode of sacrifice, 
physiological state, pre-contractile conditions activating different channels and 
receptors (e.g. alteration of the membrane smooth muscle potential with high K+ versus 
NE or phenylephrine to pre-contract isolated rings), tissue preparation, different 
endothelial removal procedures and possible damage, buffer conditions, temperature, 
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pO2 availability, and the sequence of drug additions and concentrations. Another 
important difference is vessel type; the present study investigated the rat thoracic 
aorta, which is a large, highly elastic artery that normally offers little resistance to flow 
but assists in coupling the heart, as a pump and pressure-generator, to the arterial 
system by changing aortic compliance not resistance (Dobson, 2015a).  
 
That lidocaine relaxation occurred from 1 to 1000 uM is consistent with the study of 
Shan and colleagues who showed that lidocaine relaxed phenylephrine or KCl (60 mM) 
precontracted rat aortic rings in a concentration-dependent manner (Shan, et al., 
2004).  However, their study differed because they showed lidocaine relaxation was 
not significantly modified by endothelium removal, and their aortic rings were obtained 
from rats sacrificed by stunning and cervical dislocation, not anaesthesia (Shan, et al., 
2004). The present study also agreed with Turan and colleagues who showed 
lidocaine relaxed phenylephrine-precontracted rabbit thoracic aorta intact and 
denuded rings, however, when lidocaine (1 to 100 μM) was applied 15 min before the 
addition of phenylephrine it produced contractions at high concentrations (up to 10 
mM), and endothelium removal did not significantly affect contractile activity. This 
example demonstrates the dynamics of the pre-contractile state and the importance of 
specifying the sequence of drug administration, which can produce different results. 
Further studies are required to investigate these discrepancies in the thoracic aorta of 
rat and other species prepared from different modes of sacrifice, different 
precontracted states and basal tone. 
4.4.2 Lidocaine Relaxation Enhancement involves an Endothelium-
Smooth Muscle Coupling and possible activation of Kv and KATP 
channels 
Since lidocaine relaxation displayed a strong endothelial-dependence (Figure 4.2), it 
suggested a possible role for NO release or activation of the cyclo-oxygenase pathway 
and/or their interactions with the adrenoreceptors on vascular smooth muscle.  
Surprisingly, there was little or no effect of either L-NAME and indomethacin on 
lidocaine relaxation (Figure 4.3) indicating that the putative relaxing factor after 
endothelial removal was neither NO nor prostacyclin. Other unknown factor(s) must be 
released upon endothelial removal to enhance lidocaine relaxation. Another possibility 
is endothelial-dependent activation of smooth muscle voltage-dependent Kv channels 
and/or smooth muscle mitochondrial KATP channels since 4-AP completely abolished 
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relaxation (Figures 4.3A and 4.4A) and 5-HD led to ~50% inhibition in denuded rings 
(Figures 4.4C and 4.5C).  
 
Enhanced lidocaine relaxation may also have come from changing the cellular redox 
state and reactive oxygen species (ROS) derived from NAD(P)H oxidases (Hsieh, et 
al., 2014; Tsai & Jiang, 2010), as it has been reported that lidocaine at higher 
concentrations protects against ROS attack in rabbit abdominal aorta (Lee, et al., 
2010).  Rogers and colleagues further showed that 4-AP-sensitive Kv channels are 
redox sensitive and contribute to H2O2-induced coronary vasodilation (Rogers, et al., 
2007). In summary, enhanced lidocaine relaxation after endothelial removal does not 
appear to involve the direct activation of NO or prostanoid-linked pathways, and other 
relaxing factors and downstream signaling pathways, possibly involving Kv and/or 5-
HD sensitive KATP channels, are involved.  
 
4.4.3 Smooth Muscle Adenosine A2a modulation may also be involved in the 
Enhanced Lidocaine Relaxation  
 
The present study also suggests an intriguing possibility for enhancing lidocaine 
relaxation may be activation of the A2a receptor on vascular smooth muscle. A surprising 
result was that lidocaine relaxation above 50 μM in intact and denuded rat aortic rings 
was significantly inhibited by 75 to 100% in the presence of A2a blocker 8-(3-chlorostyryl) 
caffeine (CSC) (Figure 4.6). This implies that the A2a receptor may be involved in the 
presence or absence of an intact endothelium. Assuming CSC has high specificity for 
A2a receptors (Jacobson, et al., 1993), this antagonist may reduce lidocaine relaxation 
from one or more of the following mechanisms: 1) Directly or indirectly increasing Ca2+ 
influx from extracellular sources such as L-type Ca2+ channels (Amberg & Navedo, 
2013), 2) increasing the release of Ca2+ from intracellular stores (e.g. sarcoplasmic or 
endoplasmic) to increase cytosolic free Ca2+, and/or 3) increasing myofibrillar contractile 
sensitivity to existing free Ca2+ (signaled via the RhoA/Rho kinase pathway), increasing 
cross-bridge cycling and development of force (Tsai & Jiang, 2010; Webb, 2003). 
Possible crosstalk between A2a receptors and lidocaine may also involve 
transmembrane domains of adenyl cyclase and other downstream signaling pathways 
to alter intracellular free Ca2+ and/or myofibrillar sensitisation. 
 
Little or no data exist on adenosine and lidocaine interactions in intact rat aortic rings or 
endothelial-vascular smooth muscle interactions. Adenosine A2a and A2b receptors are 
present on vascular endothelium and smooth muscle of many vessels (Hein, et al., 2013; 
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Kemp & Cocks, 1999) and when activated can lead to vasodilation. A2a receptor 
vasodilation is thought to involve: 1) endothelial NO production which activates smooth 
muscle guanylyl cyclase via opening KIR channels (Hein, et al., 2013), and/or 2) more 
direct smooth muscle A2a receptor activation which in turn stimulates mostly Gs proteins 
(and Gq) and cAMP signaling pathways to reduce intracellular Ca2+ levels (Hein, et al., 
2013; Linden, 2001). In addition, adenosine A2a activation may activate sarcolemma 
Ca2+ channels and regulate influx in large elastic arteries and resistance vessels. Stella 
and colleagues showed that activation of A2 receptors stimulates protein kinase A to 
inhibit L-type Ca2+ channels in rod photoreceptors resulting in a decreased Ca2+ influx 
(Stella Jr, et al., 2002). Gubitz and colleagues have proposed dual A2a signaling 
involving the activation of both N- and P-type calcium channels by different G proteins 
and protein kinases in some nerve terminals (Gubitz, et al., 1996). Goncalves and 
colleagues showed that adenosine A2a receptors facilitated Ca2+ uptake through class A 
calcium channels in rat hippocampal CA3 region (Goncalves, et al., 1997).   
 
Interestingly, Benkwitz and colleagues also showed that higher concentrations of 
lidocaine (1000 uM) in hamster oocytes potentiated Gai-coupled A1 receptor signaling 
by reducing cyclic AMP production in a dose-dependent manner through an unidentified 
mechanism (Benkwitz, et al., 2003). The authors proposed that lidocaine was not an A1-
receptor agonist but enhanced adenosine-A1 receptor signaling. They argued that 
lidocaine interacted with a pool of already activated Gαi present in the cytoplasm and 
thereby facilitated its ability to inhibit adenylate cyclase leading to lower cAMP 
(Benkwitz, et al., 2003). The present study did not examine adenosine A1 receptor 
antagonism. It can be concluded from the current study that A2a receptor may have 
enhanced lidocaine relaxation activation by directly effecting vascular smooth muscle 
(Figure 6), and this may have occurred by reducing intracellular Ca2+ and/or myofibrillar 
contractile sensitization in intact isolated rat aortic rings, although the underlying 
mechanisms remain to be identified. Further studies are required to investigate the role 
of adenosine and lidocaine on membrane Ca2+ channel modulation in isolated rat aortic 
rings. 
 
4.4.4 Limitations of the Study and Possible Physiological Significance 
 
The present study examined lidocaine relaxation in isolated rat thoracic rings using 
length-tension experiments and a number of antagonists of NO, prostanoids, Kv, KATP 
and A2 receptors under normoxic and normal pH conditions from healthy rats. Before 
definitive conclusions can be drawn regarding the nature of unknown relaxation 
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factor(s), it would be important to examine separately and in combination other drug 
antagonists and agonists of NO, prostanoids, Kv, Sarc- and Mito-KATP channels and A2 
receptors on lidocaine relaxation in intact and denuded rings.  Furthermore, to gain 
greater mechanistic insight into the nature of voltage-dependent K+ channels and 
lidocaine vasorelaxation electrophysiological experiments would be essential. 
Leukotrienes, and leukotriene synthase inhibitors, may also be of interest because 
they have been shown to modulate rat aortic ring relaxation (Lawson, et al., 1989). 
Possible physiological significance of the present study relates to lidocaine's effect to 
regulate in vivo compliance such as ventricular-arterial coupling functions linking the 
heart as a pump to tissue perfusion (Bellien, et al., 2010; Marti, et al., 2012). However, 
further in vivo studies are required to test this hypothesis. This work may have clinical 
applicability on the ancillary properties of lidocaine at the site of injection during 
infiltration, nerve block, or epidural anaesthesia (Johns, et al., 1985), and on damaged 
endothelium such as in plaque formation, arterial and venous conduit protection for 
cardiopulmonary bypass grafting (Gur, et al., 2012a), prevention of vascular spasm 
during neurosurgery (Li, et al., 2012), lowering elevated intracranial pressure (Zeiler, 
et al., 2015), lidocaine cardioplegia (Baraka, et al., 1993; Dobson, et al., 2013a), and 
other surgical applications (Dobson, 2015a).  
 
 
4.5 CONCLUSIONS 
 
This chapter showed in isolated, oxygenated NE precontracted rat aortic rings that 
lidocaine relaxation was biphasic from 1 to 10 uM and 10 to 1000 uM. Furthermore, 
lidocaine relaxation was found to be significantly enhanced by endothelial removal, 
which did not appear to be NO or prostacyclin dependent.  The putative unknown 
factor(s) responsible for enhanced relaxation may involve activation of smooth muscle 
voltage-sensitive Kv and 5-HD sensitive channels or pathways, and possible crosstalk 
with A2a subtype receptor at higher lidocaine concentrations.  
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CHAPTER 5. ADENOSINE AND LIDOCAINE (AL) COMBINATION 
DILATES INTIMALLY DAMAGED RAT THORACIC AROTIC RINGS 
AND GUINEA PIG MESENTERIC ARTERIES: POSSIBLE 
SIGNIFICANCE TO CARDIAC SURGERY 
Abstract:   
 
Introduction: New pharmacotherapies are required to improve vessel graft protection 
and prevent vasoconstriction and spasm in CABG surgery. Chapters 3 and 4 studied 
adenosine (A) and lidocaine (L) relaxation in rat aortic rings and reported a possible 
crosstalk between L relaxation and adenosine A2a receptor inhibition. The aim of 
Chapter 5 was to examine the effect of AL combination compared to A and L alone on 
relaxation in intact and denuded rat aortic rings and in guinea-pig pressurized 
mesenteric arterial segments.   
 
Methods: Aortic rings were harvested from Sprague-Dawley rats and equilibrated in 
an organ bath containing modified Krebs Henseleit (KH) solution, pH 7.4, 37°C. Rings 
were pre-contracted sub-maximally with 0.3 µM norepinephrine, and the effects of 
increasing AL, A or L (up to 1.0 mM) were examined in intact and denuded rings. 
Mesenteric artery segments were isolated from guinea pigs and mounted in an 
arteriograph containing KH solution and pressurised to 60 mmHg. Arteries were 
preconstricted with 10-8 M vasopressin and AL, A, or L was administered luminally or 
abluminally. Diameters were measured using video-microscopy.  
 
Results: In intact rat aortic rings, AL increased relaxation from 21 to 100% (0.1-1.0 
mM) and relaxation was endothelium-independent. Adenosine alone was also a potent 
relaxant of aortic rings but, unlike AL relaxation, it was partially endothelium-
dependent.  In intact mesenteric artery segments, increasing luminal AL produced a 
potent endothelium-independent dilation (up to 90%). Adenosine dilation was 
endothelium-independent but not lidocaine, which produced 33% dilation only after 
endothelial removal.  Extra-luminal AL and A led to 76% and 80% dilation in intact 
segments respectively, whereas L resulted in constriction (10-17%).  
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Conclusions: AL can dilate aortic rings and mesenteric artery segments by up to 90% 
regardless of whether the endothelium is intact.  
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5.1 INTRODUCTION  
Endothelial damage is common after open surgical or endoscopic conduit harvesting, 
pressure-testing, storage and implantation in patients undergoing coronary artery bypass 
graft (CABG) surgery (Dobson, et al., 2013b; He, 2005; Kopjar & Dashwood, 2016).  
Endothelial dysfunction is a major factor responsible for loss of graft patency after one 
to five years (Fukui, et al., 2010; He & Taggart, 2016b; Ruel, et al., 2004).  Intimal 
damage is involved in the imbalance between endothelium-dependent and endothelium-
independent derived vasodilators and vasoconstrictors that can lead to endothelial-
smooth muscle decoupling, vasoconstriction, vasospasm, local inflammation/thrombosis 
and possible intimal hyperplasia/stenosis (Al-Sabti, et al., 2013 ; Cartier, et al., 1993b; 
Félétou, 2016; Goldman, et al., 2004a; He, 2005). The major vasodilators currently 
include nitric oxide, prostacyclin, bradykinin, adenosine and endothelium-derived 
hyperpolarising factor, and the major vasoconstrictors include endothelin-1, angiotensin 
II and reactive oxygen/nitrogen species (Félétou, 2016; He & Taggart, 2016b; Sandoo, 
et al., 2010b).  
 
An area of ongoing controversy is the role adenosine to regulate vascular tone in a 
number of vessel types, and their endothelial dependence (Arsyad & Dobson, 2016a). 
Chapter 3 showed that in rat aortic rings, adenosine relaxation was endothelium-
dependent above 10 μM, and involved endothelial nitric oxide production but not 
prostacyclin. Another vasoreactive modulator, lidocaine, has a number of paradoxical 
properties ranging from smooth muscle relaxation to constriction (Evans, et al., 1997b; 
Gherardini, et al., 1998b; Kinoshita, et al., 2001b; Kinoshita, et al., 2003b; Perlmutter, et 
al., 1990b). Chapter 4 showed that lidocaine relaxation in rat aortic rings was significantly 
enhanced by endothelial removal, which did not appear to be NO or prostacyclin-
dependent (Arsyad & Dobson, 2016b). That study identified an unknown factor(s) 
responsible for enhanced lidocaine relaxation, and implicated the involvement of the 
adenosine A2a receptor (Arsyad & Dobson, 2016b). Given the potential crosstalk 
between A and L, the aim of Chapter 5 was to examine the effect of AL combination 
compared to A and L alone on the relaxation properties of intact and denuded rat thoracic 
aortic rings and guinea-pig pressurized mesenteric arterial segments.  Mesenteric 
arterial segments were included because mesenteric vasoconstriction and gut ischemia-
reperfusion injury during major surgery can be particularly lethal with mortality rates of 
over 70% (Hasan, et al., 2004; Sastry, et al., 2014).   
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5.2 MATERIAL AND METHODS 
5.2.1 Animals 
Adult male Sprague-Dawley rats (300-350g) and guinea-pigs (250-300g) were 
prepared as described in Chapter 2.2.1 and 2.3.1, respectively.  
5.2.2 Aortic ring preparation and organ bath tension measurements  
Rat thoracic aortic rings were harvested and prepared as described in Chapter 2.2.2 
and shown in Figure 2.3. 
 
AL, A and L were added to the organ bath to obtain 1, 5, 10, 50, 100, 500 and 1000 
µM concentrations. At the end of each experiment, rings were tested for viability with 
100 µM papaverine using the method of Grbović and colleagues (Grbović, et al., 
2000a), and relaxation was expressed as a % maximal relaxation to papaverine.  
5.2.3 Guinea-pig mesenteric artery segments  
The arterial perfusion system coupled to microscopy and video monitoring is described 
by Sokoya and colleagues (Sokoya, et al., 2006b) and outlined in Chapter 2.3.2 and 
2.3.3. 
 
After 30 min equilibration in the pressure myograph, arterial segments were pre-
constricted with 10-8 M arginine vasopressin (AVP).  Some segments were left intact, 
and others denuded by pumping air into the vessel lumen at a flow rate 1ml/min for 10 
minutes (Sokoya, et al., 2006b). Removal of the endothelium was confirmed with 10-5 
M acetylcholine. After diameter stabilization, the arteries were exposed to AL, A or L 
luminally or abluminally (1 to 1000 µM) and the change in outer artery diameter was 
measured. At the end of each experiment, vessels were washed with calcium-free 
Krebs Henseleit solution containing 1 mM ethylene glycol tetraacetic acid (EGTA) to 
determine the maximal dilation of the vessels (Sokoya, et al., 2006b).  Preliminary 
experiments found that, unlike aortic rings, 100 µM of papaverine led to inconsistent 
maximum dilation in mesenteric segments. For mesenteric artery experiments, the 
effects of A, L and ALM on vasodilation (or relaxation) were expressed % maximal 
dilation to calcium-free Krebs Henseleit solution containing 1 mM EGTA. At each 
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concentration of ACh, the percentage dilation was calculated according to the following 
equation:    
 
Percentage Dilation = (DACh – Dbase)/(Dmax – Dbase) * 100  
 
where DACh is the diameter of the artery after luminal administration of ACh, Dbase is the 
baseline diameter of the artery before addition of ACh, Dmax is the maximal diameter 
of the artery in the presence of calcium-free Krebs Henseleit solution (containing 1 mM 
EGTA). 
5.2.4 Statistics  
Values are expressed as mean ± SEM. The number of rats and guinea-pigs were 
selected from a priori G-power analysis to achieve a level of 1.0. All data was tested 
for normality using Kolmogorov-Smirnov test. Relaxation responses to adenosine, 
lidocaine and AL were analysed for homogeneity of variances followed by two-way 
repeated measures ANOVA coupled with the Bonferroni post-hoc test for individual 
data point comparisons. The alpha level of significance for all experiments was set at 
p<0.05. 
5.3 RESULTS  
5.3.1 Effect of Increasing AL on Relaxation in Rat Aortic Rings 
AL produced a dose-dependent relationship in intact and denuded rat aortic rings 
(Figure 5.1A). In intact rings, AL had little effect below 100 μM (<5% relaxation) and 
increased relaxation to 76% above 100 μM.  Curiously, when the experiment was 
repeated but started at 100 μM (Figure 5.1B), rather than 1 μM, (Figure 1A), relaxation 
was higher (21% vs 3.7%), and maximum relaxation after 1000 μM was 98% compared 
to 76% after 1 to 1000 μM serial dilution (Figure 1A).  The data also show that serial 
additions of AL from 1 to 1000 μM vs. 100 to 1000 μM lead to different maximum 
relaxations at 100 μM (4 vs. 14% relaxation) and 1000 μM (76 versus 98% dilation), 
indicating a tachyphylaxis-like response in the first experiment (Figure 5.1A) but not in 
the latter (Figure 5.1B). Similar relaxation profiles were found in rings with the 
endothelium removed.  Another interesting feature of Figure 5.1B was that at the AL-
induced relaxation at the cardioplegic concentrations (250 to 1000 μM AL) (Figure 
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5.1B), showed a slight curvilinear effect that was more pronounced after removing the 
endothelium (greater dilation at a given AL concentration), but this was not significant.  
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Figure 5.1. Dose-response curves of adenosine-lidocaine (AL), adenosine (A) and 
lidocaine (L) in isolated intact and denuded rat thoracic aortic rings.   
A.  AL (1-1000 μM, log scale). B. AL (100-1000 μM, log scale). C. Adenosine (100-1000 μM) 
and D. Lidocaine (100-1000 μM). Values are mean ± S.E.M for aortic rings from 8 animals. 
*p<0.05 adenosine endothelium intact and denuded groups. 
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5.3.2 Effect of A and L Alone on Relaxation in Rat Aortic Rings 
 
Figure 5.2 Comparison of dose-response curves to AL, Adenosine and Lidocaine in 
isolated intact (A) and denuded (B) rat thoracic aortic rings.  
Values are mean ± S.E.M for aortic rings from 8 animals. *p<0.05 lidocaine group and other 
groups. # p<0.05 adenosine group and AL group.  
 
 
Increasing adenosine from 100 to 1000 μM significantly increased relaxation by 82% 
in intact rings, and by 81% in denuded rings from baseline (Figure 5.1C). The effect of 
removing the endothelium significantly reduced relaxation by 23 to 18% at 400 and 
600 μM respectively (Figure 5.1C). Lidocaine alone increased relaxation by 63% in 
intact and denuded rings, and endothelial removal significantly enhanced dilation 1.5 
times at 400 μM and 1.3 times at 600 μM lidocaine compared to intact rings (Figure 
5.1D).  Figures 5.2A and 5.2B represents the combined data in intact and denuded rat 
aortic rings. In intact rings, AL relaxation was not significantly different from adenosine, 
and both were significantly higher than lidocaine alone. In denuded rings, adenosine 
relaxation was significantly lower for a given concentration, lidocaine relaxation was 
significantly higher, and there was no change in AL relaxation after endothelial 
removal. 
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Guinea-Pig Mesenteric Artery 
5.3.3 Effect of luminal AL, A and L on endothelium intact and denuded 
segments 
For all mesenteric artery experiments, there was no significant difference in AVP-
stimulated constriction between the groups in either intact or denuded segments.  In 
intact arterial segments, increasing luminal AL or adenosine led to over a 10-fold 
increase in dilation from 8% to 84% (Figure 5.3A). The AL or A treatments were not 
significantly different from each other. In contrast, increasing intraluminal lidocaine 
concentration produced a 2.6 fold constriction, and was significantly different from all 
other groups (Figure 5.3A).  
 
In denuded segments, increasing luminal AL and adenosine followed a similar pattern 
to the intact artery with 90% dilation from 1 to 1000 μM (Figure 5.3B). Removal of the 
endothelium led to a dramatic and significant change in mesenteric arterial reactivity 
to lidocaine. Instead of modest constriction in intact segments, increasing lidocaine led 
to a 4.7-fold increase in dilation from 1 to 1000 μM (Figure 5.3B). Lidocaine’s maximum 
dilation response after denudation was 42% at 1000 μM compared to 9% at 1.0 μM 
(Figure 5.3B).  
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Figure 5.3 Effects of luminal AL, adenosine and lidocaine administration on guinea-pig 
intact (A) and denuded (B) mesenteric artery administered luminally, and (C) abluminal 
adminstration on intact mesenteric artery segments.  
A and B:  Drugs were delivered luminally (A and B) and abluminally (C) in a dose dependent 
manner. Values are mean ± S.E.M for mesenteric rings from 5-7 animals. *p<0.05 lidocaine 
and other groups. 
  
 103 
5.3.4 Effects of abluminal AL, A and L on intact mesenteric segments 
 
Figure 5.4 Luminal versus Abluminal Comparison between adenosine (A) and lidocaine 
(B) and AL (C) in intact guinea-pig mesenteric artery.   
Values represent mean ± S.E.M of mesenteric rings from 5-7 animals. *p<0.05 statistical 
difference in responses between luminal and abluminal adenosine administration. 
 
 
The effect of increasing abluminal AL produced 76% dilation from 1 to 1000 μM (Figure 
5.3C).  Similarly, adenosine led to a significant increase in dilation of 80% (Figure 
5.3C). The differences between AL and adenosine were not significant.  Increasing 
lidocaine from 1 to 10 μM produced an increase in constriction from 10% to 17% with 
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vessel diameter slowly dilating to baseline (Figure 5.3C).  The comparative effects of 
AL, adenosine or lidocaine on luminal verses abluminal administration in intact 
mesenteric segments are summarized in Figures 5.4A and 5.4C.  The data show that 
adenosine relaxation is significantly enhanced when administered abluminally (Figure 
5.4A), while no differences were found in lidocaine administration (Figure 5.4B). 
Abluminal versus luminal AL administration, like adenosine, produced up to 45% more 
dilation over a range of AL concentrations, however, the differences were not 
significant (Figure 5.4C). 
5.4 DISCUSSION  
New pharmacological strategies are required to improve autologous supplementary 
arterial and venous graft protection in CABG surgery (Kopjar & Dashwood, 2016). This 
chapter reports the following: 1) In rat aortic rings, AL combined produced a strong 
relaxation response that was endothelium-independent, 2) Adenosine relaxation in 
intact rings was similar to AL, but differed by being partially endothelium-dependent, 
3) Lidocaine relaxation was significantly less than AL and adenosine, but like 
adenosine was endothelium-dependent, 4) In intact mesenteric arterial segments, 
luminal administration of AL or adenosine produced a strong vasodilation (up to 90%) 
and was endothelium-independent, whereas lidocaine dilation was significantly less 
and occurred only after endothelial removal, and 5) Abluminal AL and adenosine 
produced 80% dilation, and lidocaine produced 10 to 17% constriction. These 
differences will now be discussed. 
5.4.1 AL relaxation was endothelial-independent 
Two interesting results of the present study were: 1) AL was a powerful dilator in 
isolated rat thoracic aortic rings and pressurized guinea-pig mesenteric segments, and 
2) relaxation/dilation was endothelium-independent.  The finding that AL was a strong 
relaxant in rat aorta, regardless of whether the intima was damaged or not, suggests 
that AL may find utility in harvesting and perfusing conduits for revascularisation. 
Harvest, storage and implantation are times when the conduit vessel is highly 
vulnerable to intimal damage and potential failure (Cartier, et al., 1993a; Chiavarelli, et 
al., 1982; Dashwood & Tsui, 2013).  Thus, maintaining optimal vascular tone in 
harvested vessels may lead to improved perfusion and reduce myocardial dysfunction.   
 
Interestingly, the relaxation effect of AL in aortic rings and mesenteric artery segments 
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was not a synergistic effect of adenosine and lidocaine but was dominated by 
adenosine and a complex dilation-contraction behavior from lidocaine (Figures 5.2 and 
5.3). Currently, the underlying mechanisms of AL's action are not known. It is important 
to recognize that the aortic ring experiments and pressurized artery experiments were 
different with regards to drug application. In the rings, drugs have access to both the 
endothelium and smooth muscle whereas in the pressurized vessels, they were 
applied to either the endothelium or smooth muscle. This may be particularly important 
for AL combination because it appears that there are receptors for both adenosine and 
lidocaine on both cell types (see below).  
5.4.2 Rat thoracic aortic rings  
In rat thoracic aorta, adenosine relaxation has been reported in the literature to be 
either fully endothelium dependent, partially dependent or have no dependency see 
(Arsyad & Dobson, 2016a). Adenosine vasodilation is believed to involve a complex 
interplay between endothelial A2a subtype receptor activation, nitric oxide (NO), 
prostanoids (e.g Prostaglandins and thromboxane A2), hyperpolarising factors, and 
voltage-dependent K+ channels (Headrick, et al., 2011). Chapter 3 revisited the 
question and found that relaxation in isolated rat thoracic aortic rings was endothelium-
dependent, and involved activation of smooth muscle A2a, endothelial NO production, 
and voltage-dependent Kv, KATP channels (sarcoplasmic and mitochondrial), but not 
prostanoid production (Arsyad & Dobson, 2016a).  The present study confirmed 
adenosine’s partial endothelium-dependency, but the focus was on the higher 
concentrations that appear in AL cardioplegia. 
 
Lidocaine reactivity in isolated rat thoracic rings is also controversial (Arsyad & 
Dobson, 2016b). The present study showed that by removing the endothelium it led to 
significant enhancement of lidocaine dilation (Figure 5.1D). In Chapter 4, a putative 
relaxation factor(s) was proposed to explain this anomalous effect, and showed it was 
not NO- or prostacyclin-dependent (Arsyad & Dobson, 2016b).  However, dilation was 
significantly reduced in the presence of Kv and MitoKATP inhibition in denuded rings 
(Arsyad & Dobson, 2016b), and interestingly by adenosine A2a subtype antagonism 
(above 100 μM lidocaine) in intact and denuded rings, indicating a potential role for 
voltage-dependent K+ channels and crosstalk with adenosine receptor activation 
(Arsyad & Dobson, 2016b).  Further studies are required to identify and understand 
the nature of this putative lidocaine relaxation factor, which appears to be activated 
upon denudation (Figure 5.1D).  
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5.4.3 Mesenteric artery segments 
In contrast to rat aortic rings, luminal adenosine relaxation was endothelium-
independent in mesenteric arterial segments (Figures 5.3A and 5.3B).  A possible 
reason for the difference is because adenosine in the isolated rat aortic rings was 
reaching receptors on both the endothelium and smooth muscle but not in the 
pressurized arteries.  That luminal infusion of adenosine elicits an endothelium-
independent dilation indicates the presence of smooth muscle adenosine receptors. 
This curious result supports the 2005 study of Radenković and colleagues in the rat 
mesenteric artery (Radenković, et al., 2005), who reported that dilation was partly 
induced by activation of smooth muscle A2a receptors and mediated via the opening a 
mixed population of smooth muscle K+ channels, and possibly the Na+/K+-ATPase 
pump (Radenković, et al., 2005). Unfortunately, there appear to be only a handful of 
studies on the effect of adenosine on mesenteric artery vasoreactivity.   
 
In the current study, increasing luminal lidocaine concentration also resulted in 
complex behaviour (Figures 5.3A and 5.3B).  In intact mesenteric artery segments, 
lidocaine produced a constriction (~10%), and denudation produced an opposite effect 
i.e. a significant dilation (42% relaxation at 1000 μM) (Figure 5.3B), which was similar 
to what was found in rat aortic rings.  It appears that the lidocaine-induced 'constricting' 
factor(s) originated from the intact endothelium, and the 'dilation' factor(s) from 
vascular smooth muscle.  In the abluminal lidocaine experiments, it is also possible 
that lipid-soluble lidocaine diffuses through to the endothelium, and the only way to 
remove the 'constricting' factor(s) is to remove the endothelium. Further, the addition 
of AL suggests that the effect of the lidocaine-mediated 'constricting' factor is overcome 
by the adenosine-mediated dilation.  
 
Complex lidocaine vasoreactivity has also been reported in human internal mammary 
artery (IMA), radial artery (RA) and saphenous vein segments (Gur, et al., 2012b). Gur 
and colleagues reported that lidocaine at low concentrations (10-9 to 10-7.5 M resulted 
in ~40% dilation in IMA and RA segments isolated from 20 patients, and constriction 
at higher concentrations (>10-7.5 M) (Gur, et al., 2012b).  In saphenous vein segments, 
the group also reported a 24% dilation at 10-9 to 10-7 M lidocaine, and a dose 
dependent constriction above 10-7 M (Gur, et al., 2012b). Unfortunately, there are only 
a few studies on the effect of lidocaine on the mesenteric artery.  In 1975, Sovac and 
colleagues found that intra-arterial injection of lidocaine was a poor mesenteric dilator 
in dogs (Sovak, et al., 1975), which is consistent with the current study’s data (Figure 
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5.3A).  Lastly, abluminal AL and A administration produced greater dilation than luminal 
delivery (Figures 5.4A and 5.4C) with no change in lidocaine reactivity (Figure 5.4B). 
Unfortunately, this experiment was not performed on denuded mesenteric segments.  
5.4.4 Possible clinical translational significance 
The findings of the present study have the potential to translate and improve graft 
protection in patients undergoing CABG surgery (Al-Sabti, et al., 2013 ; Dashwood & 
Tsui, 2013; Magee, et al., 2008b; Wallitt, et al., 2007b). AL solution at cardioplegia 
concentrations (0.25 to 1 mM) may further improve protection of the heart and conduits 
during reperfusion when vessels are susceptible to spasm, particularly radial arterial 
conduits (Ruel, et al., 2004). Translation may be achievable because the AL 
cardioplegia is in clinical use in the USA and Italy, and two prospective randomized 
trials have shown superiority over high potassium solutions (Onorati, et al., 2016b; 
Onorati, et al., 2013a). The uniqueness of the AL cardioplegia resides in arresting the 
heart at its natural or resting membrane potential (5 mM K+), not unnatural depolarizing 
potentials from high potassium solutions (>15 mM K+) (Dobson, et al., 2013b).  Thus, 
the AL cardioplegic solution may not only arrest and protect the heart but may protect 
the newly implanted grafts with the potential to improve graft patency.  
 
AL solution may also find clinical utility as a topical (abluminal) or intravenous 
antispasmotic agent for the internal mammary artery (IMA), which is commonly used 
in situ for CABG surgery (Harskamp, et al., 2008b; He & Taggart, 2016b).  Similar 
techniques may also apply to the in situ protection of the gastro-epiploic artery (a 
branch of celiac trunk), which is less commonly used today because it is particularly 
prone to vasospasm (He & Taggart, 2016b). AL topical use could also be used in 
neurosurgery where cerebral arterial spasm can lead to ischemic neurological deficits.  
Lastly, the finding that AL dilates mesenteric artery segments helps explain recent 
trauma work which showed that small-volume intravenous infusion of AL and 
magnesium (ALM) led to increased blood flow and local pO2 to the gut after non-
compressible haemorrhage and shock in the rat (Dobson & Letson, 2016a; Letson & 
Dobson, 2017a).  Protecting the gut is important during trauma or major surgery 
because it is the "motor of multiple organ failure" and responsible for triggering, 
heightening, and perpetuating the systemic inflammatory response (Dobson, 2015b; 
Patel, et al., 2016).   
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5.4.5 Limitations and future studies 
A major limitation of the present study was that the arterial rings and mesenteric 
segments were from healthy rats and guinea-pigs, and it would be clinically important 
to investigate segments from human conduit arteries and saphenous veins used in 
cardiac surgery, and the underlying pathogenesis of vasospasm. Another limitation is 
that rat thoracic aorta was used, which is a large, highly elastic compliance vessel that 
normally offers little resistance to flow in contrast to smaller peripheral and coronary 
arterioles (Arsyad & Dobson, 2016a).  From a mechanistic viewpoint, studies are 
required to investigate the possible cross-talk between A and L that leads to relaxation 
in the presence and absence of an intact endothelium, and include the effect of key 
modulators, ion channel activators and inhibitors and protein/mRNA analysis of 
candidate receptors. Since the net effect of this dynamic system is to regulate vascular 
reactivity via intracellular Ca2+, A and L crosstalk may be revealed from 
electrophysiological, immune-histochemical and qRT-PCR techniques targeting 
microdomain Ca2+ signaling receptor sites and pathways in denuded and intact arterial 
segments (Earley & Brayden, 2015). It would also be important to investigate the effect 
of AL on changing the membrane potential of endothelial and smooth muscle cells 
during relaxation because the cardioplegia confers its superior protection by keeping 
the heart at its resting membrane potential (Dobson, et al., 2013b; Sloots & Dobson, 
2010a).   
5.5 CONCLUSIONS 
Chapter 5 concludes that AL solution above 100 μM produced a concentration-
dependent relaxation/dilation in rat aorta and guinea-pig mesenteric artery segments 
with or without an intact endothelium. AL may find translational utility to improve 
conduit protection in CABG surgery, and other major surgeries, where varying degrees 
of endothelial damage, vasoconstriction or vasospasm are known to occur.  
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CHAPTER 6. DEVELOPING A PRESERVATION SOLUTION FOR 
VESSEL STORAGE WITH ADENOSINE AND LIDOCAINE 
COMBINATION 
Abstract:   
 
Introduction: Current methods of cold storage protection on vessel function remains 
unsatisfactory. Cold storage with traditionally used preservation solutions, such as 
University of Wisconsin (UW), EuroCollins (EC), and histidine-tryptophan-
ketoglutarate (HTK) solution, can result in dramatic losses of vascular contractility and 
relaxation after 72 hours of storage. Therefore, new pharmacotherapies are required 
for vessel graft protection and to prevent vasoconstriction and spasm of the graft. 
 
Methods: Thoracic aortic vessels were harvested from 300-350 g Sprague Dawley 
rats and transferred to a container with pre-cooled KH solution. Thoracic aortic rings 
(n=40) were then assigned to one of the following groups: 1. Fresh preparation 
(controls), 2. Krebs Henseleit (KH),  3. Modified KH (low Ca2+/high Mg2+), 4. Modified 
KH + adenosine + lidocaine (KH+AL),  5. Modified KH + adenosine + lidocaine + 
melatonin + insulin (KH+ALMI). With the exception of controls that were immediately 
subjected to vessel function analysis after harvesting, other groups were kept in the 
assigned preservation solutions at 4°C for six days. After 6-day storage, the vessel 
rings were then transferred to an organ bath filled with KH solution, gently warmed to 
37°C, and then subjected to vessel function analysis.  
Contraction responses to potassium chloride (KCl; 60 mM), norepinephrine (NE; 0.3 
μM), and relaxation responses to acetylcholine (ACh; 10-6-10-3 M) and sodium 
nitroprusside (SNP; 10-6-10-3 M) were evaluated using an isometric force transducer. 
At the end of each experiment, rings were maximally dilated with 100 μM papaverine 
to confirm viability of the vessels and the relaxation value would be used as a 
comparison to ACh and SNP-induced relaxation. 
 
Results: Following 6-day storage (4oC) in KH solution, the aortic rings only recovered 
46% and 34% of their contractility responses to NE and KCl, respectively. Modified KH 
with low Ca2+/high Mg2+ improved recovery of contractile function with 89% and 76% 
return with NE and KCl use, respectively. Meanwhile, AL storage in modified KH 
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recovered 100% of NE contractile function, but there was no further recovery in the 
KCl response compared to modified KH alone (76% recovery). Similar results were 
found with ALMI in modified KH, which led to 100% and 86% of contractile function 
recovery in response to NE and KCl, respectively. 
After 6-day storage in standard KH, aortic rings only recovered 42 % of ACh relaxation 
function, while modified KH storage led to 79% relaxation recovery. AL addition in 
modified KH significantly improved relaxation function, with 93% recovery after six 
days. In contrast, ALMI addition did not improve relaxation response to ACh compared 
to modified KH alone, and led to 70% of aortic recovery after six days in cold storage. 
Maximal SNP relaxation following 6-day cold storage with KH solution was only 63% 
compared to controls. Modified KH, with AL or with ALMI returned 100% of maximal 
SNP relaxation. 
 
Conclusions: After 6-day cold storage in standard KH, vascular contractile and 
relaxation functions were considerably impaired and lowering Ca2+/Mg2+ ratio (modified 
KH) was shown to improve vascular preservation of isolated rat aortic rings. The 
addition of AL in modified KH further increased protection, especially in response to 
NE. Melatonin and insulin added to AL conferred no additional protection. 
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6.1 INTRODUCTION 
CABG or vascular injury sometimes requires preservation of vessels for 
revascularization or replacement of infected vessels for longer than a few hours 
(Bisdas, et al., 2010; Fahner, et al., 2006). The preserved vessels are often stored in 
cold medium for up to several days (Wille, et al., 2008). However, current methods of 
cold storage protection on vessel function after 24-48 hours remains unsatisfactory 
(Zatschler, et al., 2009). Cold storage with traditionally used preservation solutions, 
such as University of Wisconsin (UW), EuroCollins (EC), and histidine-tryptophan-
ketoglutarate (HTK) solution, can result in dramatic losses of vascular contractility and 
relaxation after 72 hours of storage (Corner, et al., 2003), and Krebs Henseleit solution 
alone results in 86% loss of endothelial-induced relaxation after 36 hour of cold storage 
(Ingemansson, et al., 1995).   
 
Adenosine and lidocaine (AL) combination solution has been studied in the isolated rat 
heart preservation model, and it was shown that AL addition in low Ca2+/high Mg2+ 
Krebs Henseleit solution (modified KH), with or without melatonin and insulin, resulted 
in recovery of 78% cardiac output following 6-8 hours of static cold storage (Rudd & 
Dobson, 2011a, 2011b). This was significantly greater compared to traditional 
preservation solution, such as Celsior and HTK which could only recover 25% and 4% 
respectively (Rudd & Dobson, 2011b).  
 
The aim of Chapter 6 was to investigate the preservation effects of AL in Krebs 
Henseleit (KH), modified KH, and modified KH, with and without antioxidants melatonin 
and insulin, on rat aorta physiological function after 6-day cold static storage. 
 112 
6.2 EXPERIMENTAL DESIGN   
6.2.1 Animal preparation: 
Thoracic aortic vessels were harvested from 300-350 g Sprague Dawley rats as 
outlined in Chapter 2.2.1 and 2.4.2 and transferred to a container with pre-cooled KH 
solution. Thoracic aortic rings (n=40) were then assigned to one of the following 
groups:  
1. Fresh preparation (controls) 
2. Krebs Henseleit (KH)  
3. Modified KH (low Ca2+/high Mg2+)  
4. Modified KH + adenosine + lidocaine (KH+AL)  
5. Modified KH + adenosine + lidocaine + melatonin + insulin (KH+ALMI)  
With the exception of controls that were immediately subjected to vessel function 
analysis after harvesting, other groups were kept in the assigned preservation 
solutions at 4°C for six days. After 6-day storage, the vessel rings were then transferred 
to an organ bath filled with KH solution, gently warmed to 37°C, and then subjected to 
vessel function analysis. The contraction and relaxation responses of preserved aortic 
rings were compared with those of controls.  
6.2.2 Vessel physiological function testing   
Vessel physiological function testing has been described in detail in Chapter 2. Briefly, 
at the end of cold storage, preserved rings were then mounted and stretched to an 
optimal resting tension in oxygenated KH solution at 37°C. Contraction responses to 
potassium chloride (KCl; 60 mM), norepinephrine (NE; 0.3 μM), and relaxation 
responses to acetylcholine (ACh; 10-6-10-3 M) and sodium nitroprusside (SNP; 10-6-10-
3 M) were evaluated using an isometric force transducer (PANLAB, distributed by 
ADInstruments as MLT 0201/RAD, NSW, AUS) coupled to a computer-based data 
acquisition system (PowerLab, ADInstruments) and data recording software LabChart 
7 (ADInstruments Pty Ltd., Castle Hill, Australia). At the end of each experiment, rings 
were maximally dilated with 100 μM papaverine to confirm viability of the vessels and 
the relaxation value would be used as a comparison to ACh and SNP-induced 
relaxation. ACh is believed to act on muscarinic receptors which are G-protein-coupled 
receptors to produce relaxation via endothelial-derived NO production (Chataigneau, 
et al., 1999), whereas SNP is an NO donor that induces vascular smooth muscle 
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relaxation mainly through the activation of soluble guanylate cyclase (sGC), and an 
increase in cyclic GMP (cGMP), although cGMP-independent mechanisms have also 
been reported (Cogolludo, et al., 2001) 
6.2.3 Statistical analysis 
Values are reported as mean ± SEM. NE and KCl-induced contraction were expressed 
as the mean of gram tension results from the number of animals in each group, while 
ACh and SNP-induced relaxation responses were expressed as percentage of 
maximal relaxation to 100 µM papaverine. All data was tested for normality using 
Kolmogorov-Smirnov test. Contraction responses to NE and KCl, and relaxation 
responses to ACh and SNP were analysed for homogeneity of variances followed by 
one-way ANOVA and coupled with Bonferroni post hoc test for individual data point 
comparisons.  
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6.3 RESULTS  
6.3.1 Vasoconstrictive response to norepinephrine (NE) and potassium 
chloride (KCl) with different preservation solutions 
 
  
 
Figure 6.1. Isolated rat aortic ring contraction response to norepinephrine or KCl after 6-
day storage compared to fresh preparation (control).  
All values are expressed as mean ± S.E.M of aortic ring relaxation from 8 animals. *p<0.05 
statistical difference between KH and control groups. 
 
 
Contractile function of cold preserved rat aortic rings was tested in response to NE and 
KCl precontracted rings to indicate the receptor and non-receptor-stimulated 
constriction, respectively. In freshly harvested aortic rings NE and KCl (both controls) 
increased aortic ring tension to 1.27 ± 0.07 and 0.87 ± 0.08 g tension, respectively 
(Figure 6.1). Following 6-day storage (4oC) in KH solution, the aortic rings only 
produced 0.58 ± 0.24 and 0.30 ± 0.12 g tension in response to NE and KCl, 
respectively, indicating 46% and 34% recovery of their contractility responses. Low 
Ca2+/high Mg2+ (modified KH) improved recovery of contractile function with 89% and 
76% return with NE and KCl use, respectively. Meanwhile, AL storage in modified KH 
recovered 100% of NE contractile function, but no further recovery in the KCl response 
compared to modified KH alone (76% recovery). Similar results were found with ALMI 
in modified KH, which led to 100% and 86% of contractile function recovery in response 
to NE and KCl, respectively (Figure 6.1).  
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6.3.2 Vasorelaxation response to acetylcholine (ACh) and sodium 
nitroprusside (SNP) with different preservation solutions 
Relaxation function of preserved aortic rings was tested in response to ACh and SNP 
to measure the endothelium-dependent and endothelium-independent relaxation 
function, respectively.  
 
Freshly prepared aortic rings (controls) produced a relaxation in response to ACh in a 
concentration-dependent manner. Percentages of relaxation were 4.8 ± 1.36%, 10.3 ± 
2.57%, 38.8 ± 13.58%, 62.2 ± 11.67%, 76.6 ± 8.24%, 79.2 ± 6.67%, and 68.0 ± 9.47% 
after the administration of ACh at concentration of 10-9, 10-8, 10-7, 10-6, 10-5, 10-4, and 
10-3 M, respectively (Figure 6.2A). After 6-day storage in KH solution, aortic relaxation 
responses were reduced to 28.8 ± 12.61%, 33.5 ± 13.38%, 25.6 ± 11.79%, and 28.6 
± 11.18% at ACh concentration of 10-6 to 10-3 M but the reduction was only significant 
at concentrations 10-5 and 10-4 M. Compared to standard KH, modified KH (with low 
Ca2+ and high Mg2+) improved relaxation to 58 ± 10.06%, 62 ± 10.32%, 47 ± 9.21%, 
and 37 ± 10.79% at ACh concentration of 10-6 to 10-3 M; however, this was not 
statistically significant. The addition of AL in modified KH further improved relaxation 
at ACh concentration of 10-6 to 10-5 M to 71 ± 3.78% and 75 ± 3.34%, respectively, and 
this was significantly different from standard KH (p<0.05). Interestingly, ALMI addition 
did not improve relaxation response compared to modified KH alone, and resulted in 
51 ± 6.35%, 52 ± 7.42%, 45 ± 7.74% and 41 ± 8.20% relaxation at ACh concentration 
of 10-6, 10-5, 10-4 and 10-3 M (Figure 6.2A). 
 
When comparing maximum relaxation from ACh (endothelial NO-induced) relaxation, 
a value of 81.5 ± 7.1% was found in fresh prepared aortic rings (controls) following 
precontraction with NE. After 6-day storage in standard KH, aortic rings only recovered 
42 ± 13.68% of ACh relaxation function (Figure 6.2B), while modified KH storage led 
to 79 ± 9.97% relaxation recovery. AL addition in modified KH significantly improved 
relaxation function compared to standard KH, with 93 ± 3.59% recovery after six days. 
In contrast, ALMI addition in modified KH did not improve relaxation response to ACh 
compared to modified KH alone, and led to 70 ± 6.28% of aortic recovery after six days 
in cold storage (Figure 6.2B). 
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Figure 6.2. Isolated rat aortic ring relaxation response to acetylcholine (endothelial NO-
induced relaxation) after 6 day storage compared to control.  
(A) Concentration-response curve for ACh-induced relaxation in aortic rings. Relaxation is 
expressed as percent of relaxation to 100 μM papaverine. (B) ACh-induced maximal relaxation 
in KH solution group compare to the one in modified KH solution group. Relaxation is expressed 
as percent of control group maximal relaxation. Points represent mean ± S.E.M of aortic ring 
relaxation from 8 animals. *p<0.05 statistical difference between KH and modified KH + AL 
group. #p<0.05 statistical difference between KH and control group. 
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Figure 6.3. Concentration-response curve for SNP (smooth muscle NO-induced 
relaxation) after six day storage compared to control.  
(A) Concentration-response curve for SNP-induced relaxation in aortic rings. Relaxation is 
expressed as percent of relaxation to 100 μM papaverine. (B) SNP-induced maximal relaxation 
in different groups compare to maximal relaxation of control group. Relaxation is expressed as 
percent of control group maximal relaxation. Points represent mean ± S.E.M of aortic ring 
relaxation from 8 animals. *p<0.05 statistical differences between KH and the other groups. # 
p<0.05 KH group statistically differ from control and modified KH + AL groups 
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In response to SNP, control aortic rings relaxed in a concentration-dependent manner 
from 5.6 ± 1.39% relaxation at SNP concentration of 10-9 M, 48.4 ± 2.32% at 10-8 M, 
96.2 ± 0.90% at 10-7 M, and reached 100% at 10-6 -10-3 M (Figure 6.3A). After 6-day 
preservation in KH solution, aortic relaxation to SNP was significantly attenuated, with 
maximum relaxation of 63 ± 18.07% at concentration 10-6 to 10-3 M. In contrast, the use 
of modified KH with or without AL produced relaxation response to SNP similar to that 
of control at any concentration regardless of prolonged (6-day) storage. Interestingly, 
the addition of ALMI slightly reduced relaxation response compared to modified KH 
alone, but only at SNP concentration 10-8 to 10-7 M. All three modified KH solutions 
(with or without AL or ALMI) led to 100% relaxation starting at SNP concentration 10-6 
M (Figure 6.3A). Again, Figure 6.3B shows that maximal SNP relaxation following 6-
day cold storage with KH solution was only 63% compared to controls. Modified KH, 
with AL or with ALMI returned 100% of maximal SNP relaxation (Figure 6.3B).  
6.4 DISCUSSION 
Vessel graft preservation can alter the physiological and biochemical properties of the 
vascular wall which can affect vasoreactivity (Chow & Zhang, 2011). Thus, optimizing 
vascular response with the addition of certain physiological activities to preservation 
solutions is of particular clinical interest (Corner, et al., 2003; Garbe, et al., 2011; Wille, 
et al., 2008). After 6-day cold storage in standard KH solution, rat aortic rings recovered 
34-46% of contractile functions and 42-63% of relaxation responses. Modified KH with 
low Ca2+/high Mg2+ content increased contraction and relaxation functions of preserved 
aortic rings by almost twofold. The addition of AL and ALMI led to 100% recovery of 
NE-induced contraction with modified KH, but KCl contraction was not improved. AL 
addition in modified KH also led to a 16% increase in endothelium-dependent 
relaxation (ACh sensitive). These results will now be discussed. 
6.4.1 The effect of standard KH versus modified KH (low Ca2+ and high 
Mg2+ content) on aortic preservation 
The results show that after six days of cold storage, aortic rings preserved in standard 
KH (Ca2+=2.5 mM, Mg2+=1.2mM) recovered 46% and 34% of their contractility in 
response to NE and KCl, respectively (Figure 6.1). NE-induced vasoconstriction is 
obtained through alpha-adrenergic receptor stimulation (Young, et al., 1988), while 
KCl-induced vasoconstriction occurs via a receptor-independent Ca2+-dependent 
response on vascular tissue (Amerini, et al., 1995). Thus, the data suggests that 
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standard KH was insufficient to protect adrenergic-dependent and receptor 
independent-Ca2+ contractions of rat aorta, and resulted in greater than 54-66% loss 
of contractility after six days of cold storage. In addition to contraction loss, 6-day 
preservation with standard KH in the present study only led to 42% and 63% relaxation 
function in response to ACh and SNP, respectively (Figures 6.2B and 6.3B).  
 
Earlier studies of Ingemansson, et al. (1995) showed that standard KH solution was 
the only solution that could preserve 90-100% contractility of cold stored rat aorta after 
36 hours, compared to standard Euro-Collins, University of Wisconsin (UW), and 
Perfadex solutions. The contractile maintenance properties of KH were thought to be 
provided by its Ca2+ content (1.5 mM) (Ingemansson, et al., 1995). Ingemanson et al. 
further showed that adding Ca2+ content (1.5 mM) in UW, Perfadex and Euro-Collins 
solutions improved the maintenance of contractile function of rat infrarenal aorta after 
24-36 hours storage compared to the Ca2+-free solutions (Ingemansson, et al., 1997; 
Ingemansson, et al., 1996). However, Ingemansson (1997; 1995; 1996) also reported 
the opposite in rat infrarenal aortic rings and showed that the recovery response was 
poor (22% recovery) following 36 hours storage in KH solution, and significantly worse 
compared to those stored in Ca2+-free solution such as UW or Perfadex solution 
(Ingemansson, et al., 1995). Whether the Ca2+ content in KH solution negatively 
impacts vessel endothelial function is controversial because it depends on the other 
actives present in the preservation solution, and what vessel is being studied. Baker 
and Neely and colleagues addressed this issue in the isolated rat heart and found that 
the optimum concentration of Ca2+ for perfusion or cold storage was 0.015 to 0.3 mM 
for buffered KH solution to reduce reperfusion injury from Ca2+ loading in the cells 
(Baker, et al., 1991; Tani & Neely, 1990). 
 
In the present study, lowering Ca2+ and raising Mg2+ (Ca2+=0.22 mM, Mg2+=2.6 mM) 
showed a significant improvement on recovery in rat aortic rings after cold storage with 
76 - 89% recovery after six days (Figure 6.1). Furthermore, modified KH solution 
improved relaxation response to ACh and SNP; from 42% and 63% in standard KH, 
increased to 79% and 100% in modified KH. The concentration of Ca2+/Mg2+ in this 
study was also found to be highly protective in a number of studied such as the isolated 
rat heart preservation in Rudd & Dobson studies (2011b), the isolated heart of 
Foreman and colleagues after prolonged cold storage (Foreman, et al., 1985), and 
after cardioplegic arrest (Brown Jr, et al., 1991; Fukuhiro, et al., 2000; Robinson & 
Harwood, 1991). Fukuhiro, et al. (2000) further showed that lowering Ca2+ in addition 
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to high Mg 2+ in a cardioplegic solution was beneficial to reduce intracellular Ca2+ 
overloading, leading to significantly greater cardiac recovery.  
 
In summary, low Ca2+ and high Mg2+ modified KH solution used in the present study 
may have improved recovery after six days cold storage by: 1) reducing Ca2+ cell 
loading (Iseri & French, 1984), 2) improving endothelial function (Tiruppathi, et al., 
2002), and 3) maintaining vascular integrity (Tiruppathi, et al., 2002). Further 
functional, histological and electrophysiological studies are required to test these 
possibilities. 
 
6.4.2 The effect of AL or AL with melatonin and insulin (ALMI) in modified 
Krebs-Henseleit on preserved aortic rings 
Adenosine and lidocaine (AL) solution was first developed as a normokalaemic 
cardioplegia for human cardiac surgery (Dobson & Jones, 2004) and this polarized 
arrest concept was modified by lowering Ca2+, increasing Mg2+ and adding the 
antioxidants melatonin and insulin for cold static preservation (Rudd & Dobson, 
2011a). This chapter also examined if AL or AL plus melatonin and insulin in modified 
KH conferred extra protection to vascular preservation in cold static storage. 
 
AL in modified KH solution: In the present study, AL administration in modified KH 
solution was beneficial to slightly improve NE-induced contraction (from 89% to 100%), 
while the potassium-induced contraction remains unchanged (77% from baseline 
contraction) after 6-day cold storage (Figure 6.1). The vasorelaxation response to SNP 
was 100%, showing unaltered endothelium-independent vasodilation function (Figure 
6.3.), and this response was similar to that of modified KH without AL. However, AL 
addition increased vascular endothelial-induced vasorelaxation from 79% to 93% 
(Figure 6.2) and significantly greater than that of standard KH, indicating a significant 
improvement of endothelial function with AL treatment (with low Ca2+ and high Mg2+ 
KH) despite the prolonged cold storage. This result may be clinically important since 
endothelial cells are more vulnerable to ischaemic damage compared to smooth 
muscle (Mankad, et al., 1997). Previously, Hashimoto et al (1992) has shown that three 
days of cold anoxic storage obliterated endothelial function in porcine coronary 
arteries, while endothelial-independent vascular reactivity was less affected 
(Hashimoto, et al., 1992). In addition, impaired integrity of human vascular endothelial 
cells was observed only after three hours of hypoxic and hypothermic storage (Hidalgo, 
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et al., 1996). Apart from hypoxia, exposure to cold storage may also induce endothelial 
injury through increased intracellular calcium and/or iron accumulation (Haddad, et al., 
1999; Rauen & de Groot, 2002). Parolari (2002) also listed a number of other acute 
and chronic mechanisms responsible for impaired vessel wall vasoreactivity and cold 
storage. These include mitochondrial dysfunction and increased reliance on anaerobic 
metabolism with acidosis, activation of free radical production, oxidant damage and 
apoptosis (Parolari, et al., 2002). If prolonged, the hypoxic injury process becomes 
irreversible and consequent cellular death occurs (Stempien-Otero, et al., 1999). The 
present thesis did not examine the mechanism of improved contractility and/or 
relaxation in AL in Modified KH. However, further studies may include a histological 
and electrophysiological examination and/or biomarker analysis to confirm the 
presence/absence of functional endothelial or vascular smooth muscle damage 
compared to rings preserved in modified KH alone. 
6.5 CLINICAL SIGNIFICANCE 
A functional endothelium is critical for preservation of grafts and long-term patency 
after  surgery (Massa, et al., 1994). To date, methods for vascular preservation have 
not been standardized (Brockbank & Taylor, 2006) and generally rely on surgeon 
and/or clinical experience, which focuses on hypothermic storage with multiple 
additives to reduce vascular graft injury (Brockbank & Taylor, 2006). However, 
hypothermia itself is known to damage the vascular endothelium (Rauen & de Groot, 
2004). The design of any new hypothermic static storage solution needs to prevent the 
unwanted effects. Previously, AL has been demonstrated to maintain ionic balance 
near resting membrane voltage state during pharmacological arrest (Dobson & Jones, 
2004), prevent acidosis (Rudd & Dobson, 2011a), attenuate free radicals (Shi, et al., 
2012), and maintain high-energy compounds during ischaemia (Canyon & Dobson, 
2006). This chapter showed that AL in modified KH led to significant protection 
compared to modified KH alone and may be potentially useful for clinical translation of 
human vascular grafts for cardiac and other major vascular surgery.  
6.6 LIMITATIONS AND FUTURE STUDIES 
The major limitation of the present study was that the aortic rings used in the 
experiments are not normally used in clinical settings for grafts. It would be clinically 
important to investigate segments from human conduit arteries and saphenous veins 
used in cardiac surgery.  
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Future studies are require to further investigate AL preservation solution compared 
with other traditionally used preservation solutions, such as University of Wisconsin 
(UW), EuroCollins (EC), and histidine-tryptophan-ketoglutarate (HTK) solution. It 
would also be important to investigate histological changes of the vessels after the cold 
storage. 
6.7 CONCLUSION 
After 6-day cold storage in standard KH, vascular contractile and relaxation functions 
were considerably impaired and lowering Ca2+/Mg2+ ratio (modified KH) was shown to 
improve vascular preservation of isolated rat aortic rings. The addition of AL in modified 
KH further increased protection, especially in response to NE. Melatonin and insulin 
added to AL conferred no additional protection.  
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CHAPTER 7  
GENERAL DISCUSSION 
7.1 Restatement of the Problems and General Aims 
There are around one million coronary artery bypass graft (CABG) surgeries performed 
each year around the world (Mangiacapra, et al., 2011). An ongoing problem with 
CABG surgery is the patency of venous and arterial conduits (Goldman, 2004). 
Although arterial grafts may provide superior long-term patency, they tend to spasm 
from their thicker muscular walls during harvesting, preparation, grafting and in the 
post-operative period (Rehman, et al., 2013). Vasospasm can lead to post-operative 
myocardial infarction and mortality (Lanza, et al., 2011; Wakabayashi, et al., 2008). 
Vasodilators and anti-spasmodics are not standardized and may vary from surgeon to 
surgeon (Kitamura, et al., 2011). Therefore, there is a need for improved 
pharmacological strategies to protect the vessel and prevent spasm and to achieve 
optimal patency of arterial and/or venous grafts during and post-surgery (Goldman, et 
al., 2004b; Taggart, 2013; Wallitt, et al., 2007a).  
 
This thesis examined the effect of adenosine and lidocaine (AL) solution to relax and 
protect arterial conduits in rat and guinea pig models, and possible storage. AL was 
first developed as a non-depolarising cardioplegia (Dobson, 2010; Dobson, et al., 
2013a), and is currently used in adult and paediatric surgery (Jin, et al., 2008; Onorati, 
et al., 2016a; Onorati, et al., 2013b). AL has been found to possess anti-inflammatory 
(Shi, et al., 2012), anti ischaemic effects, and lowers energy demand (Canyon & 
Dobson, 2004, 2006). In addition, animal studies have observed improved coronary 
flow with AL cardioplegia (Sloots & Dobson, 2010b). In an attempt to begin to translate 
AL protection into cardiac surgery to anti-spasmodic and vessel preservation, the aims 
of this thesis were three-fold: 
1. To investigate the vasodilatory effects and possible mechanisms of adenosine 
(A), lidocaine (L) and adenosine-lidocaine (AL) relaxation on isolated rat 
thoracic aortic rings. 
2. To investigate the vasodilatory effects of A, L, and AL on segments of guinea 
pig second order mesenteric artery, with the future goal to reduce secondary 
complications from gut ischaemia during cardiac surgery. 
3. To investigate the effect of AL and AL solution with antioxidants on 6-day cold 
storage using rat thoracic aortic rings for future vessel banking. 
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7.2 Major Findings 
The main findings of this thesis were: 
1) In Chapter 3, adenosine was shown to induce concentration-dependent relaxation 
in NE-precontracted isolated rat aortic rings at 1-1000 μM. The maximum 
relaxation was >80% in endothelium-intact rat aortic rings at 1000 μM. 
Endothelium removal did not abolish adenosine relaxation but significantly 
attenuated it (p<0.05). The study further showed that adenosine-induced 
relaxation in intact rings was mediated by NO, prostacyclin, potassium channels 
(Kv, sarcKATP and mitoKATP), and adenosine A2a receptors were involved. However, 
in endothelium-denuded rings, adenosine relaxation involved potassium channels 
(Kv, sarcKATP and mitoKATP), and adenosine A2a receptors. In Chapter 4, lidocaine 
also elicited a concentration-dependent relaxation in isolated rat thoracic aorta 
with a maximum relaxation of 42% in endothelium-intact aortic rings (p<0.05), but 
less potent than adenosine. Interestingly, endothelium denudation significantly 
increased lidocaine relaxation at concentrations of 5-100 μM, although, the 
maximum relaxation was not significantly altered (50% at 1000 μM). Another 
interesting result from this study was that lidocaine relaxation in endothelium-intact 
aortic rings involved adenosine A2a receptor activation, implying crosstalk between 
adenosine receptor activation and lidocaine relaxation. In denuded rings, it was 
shown that increased lidocaine relaxation involved Kv channels, mitoKATP 
channels, and adenosine A2a receptors activation. In Chapter 5, the AL 
vasodilatory effect was compared to adenosine and lidocaine alone in rat aortic 
rings. It is found that AL and adenosine alone relaxed intact isolated rat aortic rings 
up to ~100% (p<0.05), compared to 65% relaxation with lidocaine. A most 
interesting finding was that the relaxation induced by AL was different to that of 
adenosine since it was not significantly reduced by endothelium removal. 
However, AL relaxation was distinguished from that of lidocaine alone (p<0.05), 
since AL relaxation is much more potent. In endothelium-denuded aortic rings, AL 
maximum relaxation was 100%, compared to 90% with adenosine (p<0.05) and 
65% with lidocaine (p<0.05).  
2) In Chapter 5, the vasodilatory effects of adenosine, lidocaine and AL were 
investigated in mesenteric artery of guinea pigs during intraluminal and abluminal 
administration. Intraluminal administration of adenosine and AL concentration    
10-6-10-3 M produced a marked vasodilation (>80%) on AVP-precontracted 
mesenteric arteries (p<0.05). Adenosine and AL relaxation was not attenuated 
with endothelium removal (Fig. 5.3 AB). Interestingly, luminal lidocaine produced 
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no relaxation in endothelium intact but 40% relaxation in endothelium denuded 
mesenteric arteries (Fig. 5.3AB), indicating lidocaine relaxation was endothelial-
dependent (i.e. removing endothelium increases relaxation). The maximal 
relaxation with lidocaine after endothelium removal was 42% (p<0.05). In the 
second part of the study, it was found that abluminal application of adenosine and 
AL produced ~90% relaxation (p<0.05), indicating that topical/intraperitoneal 
administration has a potent effect. Meanwhile, abluminal application of lidocaine 
led to no significant relaxation. 
3) In Chapter 6, the preservation effects of AL and AL with antioxidant melatonin and 
insulin (ALMI) in modified KH solution (low Ca2+/high Mg2+) were investigated in 
rat aortic rings after 6-day cold storage. This preservation cocktail was chosen 
after the isolated heart preservation studies of Rudd and Dobson (2011b). After 
six days of cold preservation, modified KH solution alone significantly improved 
return of contractility by a factor of two in both NE and KCl contracted aortic rings 
compared to standard KH solution. Cold AL and ALMI in modified KH solution fully 
recovered NE contractile function, but little or no further recovery was found in the 
KCl response over modified KH. Recovery of endothelium-dependent relaxation 
(ACh response) was 42% with cold standard KH alone. This study found that 
recovery was significantly improved with low Ca2+/high Mg2+ modified KH (80%), 
with AL (93%) and with ALMI (70% recovery). Meanwhile, smooth muscle 
dependent relaxation (SNP response) was 60% recovered with cold standard KH, 
while 100% recovery of SNP relaxation was obtained with Ca2+/high Mg2+ modified 
KH alone, with AL or with ALMI. 
 
The results of each chapter will now be discussed in detail. 
7.3 Adenosine relaxation on rat aortic rings and possible mechanisms 
Adenosine has become one of the most extensively studied vasodilators in vascular 
biology, including in isolated aorta (Headrick & Berne, 1990; Prentice, et al., 2001; 
Prentice & Hourani, 2000; Ray & Marshall, 2006b; Rose'Meyer & Hope, 1990). 
However, many aspects of the mechanisms by which adenosine induces relaxation 
are still controversial, including the role of endothelium (Headrick & Berne, 1990; 
Lewis, et al., 1994b; Newman, et al., 1988; Rose'Meyer & Hope, 1990), K+ channels 
(Grbović & Radenković, 2003; Ray & Marshall, 2006b), and adenosine receptor 
subtypes (Kemp & Cocks, 1999; Ponnoth, et al., 2009).  
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The present study supports the concept that adenosine relaxation in rat aorta is 
mediated predominately by A2a and not A2b receptors, since the A2a receptor blocker 
caused a significant (up to 50%) reduction in relaxation in endothelium-intact aortic 
rings (Fig. 3.4A). In addition, blocking A2a receptor in denuded rings led to a more 
pronounced (up to 79%) reduction in adenosine relaxation, suggesting a greater role 
of A2a receptor located in smooth muscle of isolated rat aorta (Fig. 3.4B). However, it 
must be noted that blocking the A2a receptors did not completely abolish adenosine 
relaxation, indicating other receptors/pathways, such as A1 or A3 subtypes may be 
involved in the isolated rat aorta. Notwithstanding these contributions, the presence of 
A2a receptors in both endothelial cells of rat aorta (Lewis, et al., 1994b) and vascular 
smooth muscle (McPherson, et al., 2001) attest to the importance of this receptor 
subtype in adenosine relaxation.  
 
A2a receptor vasodilation involves endothelial NO production, which activates smooth 
muscle guanylyl cyclase via opening Kir channels (Hein, et al., 2013). Another 
mechanism believed to be central in controlling relaxation is A2a activation of K+ 
channel opening, which inhibits Ca2+ influx through L-type Ca2+ channels, inactivates 
IP3 receptor in sarcoplasmic reticulum, and inhibits myosin light chain kinase to induce 
smooth muscle relaxation (Taylor, et al., 1999). MitoKATP channel activation is also 
thought to be involved and may also relax vascular smooth muscle cells via the 
generation of reactive oxygen species release (Krenz, et al., 2002), which 
subsequently stimulate KCa activation leading to hyperpolarization of smooth muscle 
cells (Xi, et al., 2005).  
 
Further examination with specific K+ channel inhibitors showed that in addition to L-
NAME and indomethacin, adenosine relaxation in endothelium intact aorta was 
significantly inhibited by 4-AP (Kv channel blocker) with ~20% reduction, glibenclamide 
(sarcKATP) with ~10% reduction, and 5-HD (mitoKATP) with ~20% reduction (Fig. 3.3). 
These specific inhibitors also significantly attenuated adenosine relaxation in 
endothelium denuded rat aortic rings (Fig.3.5). This indicates that activation of Kv, 
sarcKATP and mitoKATP channels plays an important role in endothelium dependent and 
independent relaxation of adenosine. The role of Kv and sarcKATP in adenosine-
induced relaxation has been implicated in earlier studies in swine coronary arteries 
(Heaps & Bowles, 2002; Hein & Kuo, 1999), perfused mouse cremaster arterioles 
(Maimon, et al., 2014) and isolated rat aorta (Ray & Marshall, 2006b). The new finding 
in this present study is that adenosine relaxation was also mediated by mitoKATP 
channels in both endothelium intact and denuded rat aorta. Although the underlying 
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mechanisms remain elusive, there is an implication that mitoKATP channel activation 
relaxes vascular smooth muscle cells through reactive oxygen species release (Krenz, 
et al., 2002), which subsequently stimulate KCa activation leading to hyperpolarization 
of smooth muscle cells (Xi, et al., 2005).  
 
The results of 4-AP studies indicated that, in addition to the opening of SarcKATP and 
mitoKATP channels, adenosine relaxation in denuded rat aortic rings also appeared to 
involve Kv channels (Fig.3.5). Kv channels have been implicated in relaxation in earlier 
studies in swine coronary arteries  (Heaps & Bowles, 2002; Hein & Kuo, 1999), 
perfused mouse cremaster arterioles (Maimon, et al., 2014) and rat aorta (Ray & 
Marshall, 2006b).  However, no study has reported that adenosine relaxation in intact 
rat aorta was also mediated by Kv, SarcKATP and mitoKATP channels (Figs 3.3), as well 
as in denuded rings (Fig. 3.5), which indicates adenosine may be useful if applied 
intraluminally or topically to protect and prevent an artery from spasm. Although the 
underlying mechanisms for smooth muscle and endothelium crosstalk remain elusive, 
relaxation appears to involve a complex interplay between endothelial NO dependent 
pathway(s) (not indomethacin-dependent) and smooth muscle A2a subtype, voltage-
dependent Kv , SarcKATP  and MitoKATP  channels. Further work needs to examine this 
crosstalk and linkages with KIR and KCa channels in both endothelium-intact and 
denuded rings.   
 
7.4 Lidocaine relaxation on rat aortic rings 
In the literature, lidocaine displays unusual properties including relaxation or 
constriction depending upon its concentration (Gherardini, et al., 1995; Johns, et al., 
1985; Perlmutter, et al., 1990a) and whether the vessel is pre-constricted or dilated 
(Turan, et al., 2000). In Chapter 4, lidocaine was found to elicit a biphasic concentration 
dependent relaxation in NE-preconstricted rat aortic rings, and that this relaxation was 
significantly augmented with the mechanical removal of the endothelium at lower 
concentrations of lidocaine (5–100 μM) (Fig. 4.2). The effect of denudation to increase 
relaxation suggests that relaxation was largely mediated by vascular smooth muscle 
activation, and that the intact endothelium appears to strongly inhibit this response. 
The factor responsible for keeping a brake on lidocaine vasoreactivity in the intact ring 
is unknown.  
 
In this thesis it was found that lidocaine relaxation does not appear to be NO- or 
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prostacyclin-dependent, as L-NAME and indomethacin had little or no effect on intact 
ring relaxation (Fig. 4.3). However, in denuded rings, relaxation was found to be 
completely abolished by Kv channel inhibition (p<0.05) and significantly reduced by 
antagonists of the MitoKATP channel, and to a lesser extent the SarcKATP channel. 
Lidocaine direct action on smooth muscle is generally believed to be mediated by its 
blockage on Ca2+ influx through L-type Ca2+ channels, resulting in smooth muscle 
relaxation (del Pozo, et al., 1997; Shan, et al., 2004; Tanaka, et al., 2002). However, 
based on this present result, the Ca2+ influx may be indirectly inhibited by smooth 
muscle K+ channel activation, most likely through Kv channels and mitoKATP to a lesser 
extent. Currently, most reports have implicated KATP channel modulation in lidocaine-
induced vasoaction (Kimoto, et al., 2005; Kinoshita, et al., 2001a; Kinoshita, et al., 
1999; Kinoshita, et al., 2003a). This present study revealed that only 5-HD sensitive 
(mitoKATP) but not glibenclamide-sensitive SarcKATP channel activation had a 
contribution in lidocaine relaxation (Fig. 4.5). The mechanism of Kv and mitoKATP 
channel activation mediating lidocaine-induced vasorelaxation warrants further 
investigation. 
 
In addition, the present study found that A2a subtype receptor antagonism significantly 
inhibited lidocaine relaxation above 100 μM (p<0.05) (Fig. 4.6A), but not the A2b 
receptor (Fig. 4.6B).  While this implicates A2a subtype receptor in lidocaine relaxation, 
other factors must be involved because the blocking A2a's effect was more pronounced 
in the higher range of lidocaine concentrations (Fig. 4.6A).  Nevertheless, this is a new 
finding, and it is possible that the relaxing factor is linked to multiple receptors and 
channels (e.g. Kv and mitoKATP), including a role for the A2a receptor subtype. It is also 
interesting that lidocaine (or its analogue) has been reportedly linked to G-protein 
coupled receptor (GPCR) activation (Hollmann, et al., 2004a; Nietgen, et al., 1998), 
and Xiong and colleagues in 1999 found that lidocaine binding to GPCRs modulates 
G-protein mediated K+ and Ca2+ currents in rat anterior pituitary cells (Hollmann, et al., 
2001a; Xiong, et al., 1999), which may have relevance to the present study.  Benkwitz 
and colleagues also showed that higher concentrations of lidocaine (1000 uM) in 
hamster oocytes potentiated Gai-coupled A1 receptor signaling by reducing cyclic AMP 
production through an unidentified mechanism (Benkwitz, et al., 2003).  They proposed 
that lidocaine interacted with a pool of already activated Gαi present in the cytoplasm, 
and thereby facilitated its ability to inhibit adenylate cyclase leading to lower cAMP 
(Benkwitz, et al., 2003). It would have been interesting to study A1 antagonism in the 
present rat aortic model. In summary, the A2a receptor subtype may have enhanced 
lidocaine relaxation activation by directly affecting vascular smooth muscle, and this 
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may have occurred by reducing intracellular Ca2+ and/or myofibrillar contractile 
sensitization in intact isolated rat aortic rings, although the underlying mechanisms 
remain to be identified.  
 
7.5 AL relaxation was endothelium-independent, and possible 
significance to cardiac surgery. 
In Chapter 5, one of the striking findings was that AL produced ~100% relaxation 
(p<0.05) of intact rat aortic rings at 1000 μM (Figs. 5.1B and 5.2A) compared to ~100% 
for adenosine (Figs. 5.1C and 5.2A) and 66% relaxation from lidocaine (Figs. 5.1D and 
5.2A). This potent relaxation with AL was maintained after the endothelium was 
physically removed while adenosine relaxation was significantly attenuated (Fig.5.1). 
In endothelium-denuded aortic rings, adenosine maximal relaxation was 90% (Figs. 
5.1C and 5.2B) while AL relaxation was 100% (p<0.05) (Figs. 5.1B and 5.2B). 
Lidocaine relaxation remained at around 66% in denuded aortic rings at maximum 
concentration (1000 μM) and was significantly less than A or AL (Figs. 5.1D and 5.2B).  
 
The finding that AL relaxation in rat aortic rings was endothelium-independent has 
possible clinical translation potential to protect arterial vessels and conduits from 
spasm in cardiac surgery. Endothelial damage and spasm are known to occur during 
harvest, pressure testing, storage and implantation, which can affect the clinical 
immediate and post-operative outcome such as ischaemia-reperfusion injury, 
arrhythmias and infarction (Goldman, et al., 2004b; Magee, et al., 2008a; Wallitt, et al., 
2007a) (Harskamp, et al., 2008a). As mentioned in the introduction there is no 
standardized strategy to prevent perioperative graft spasm (He, et al., 2008; Yildiz, et 
al., 2013). 
However, based on adenosine's ability to relax aortic rings makes it another candidate 
for reducing spasm in the clinical setting given that there was around 90% relaxation 
in denuded rings at its highest concentration (Figs. 5.1D and 5.2B).  There are however 
reasons why AL may be preferred in the clinical setting given that the combination has 
been shown to protect the human heart as a cardioplegia (Dobson, et al., 2013a; Jin, 
et al., 2008; Onorati, et al., 2013b), as well as AL's ability to reduce arrhythmias and 
ischaemia-reperfusion injury (Canyon & Dobson, 2004; Djabir & Dobson, 2013; Letson 
& Dobson, 2011a), AL's ability to reduce inflammation (Dobson & Letson, 2016b; Shi, 
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et al., 2012), AL's ability to protect the endothelium (Letson & Dobson, 2017b, 2018), 
and ALM's ability to lower energy demand (Dobson & Letson, 2016b). The mechanism 
for AL to reduce injury after trauma is not known but believed to involve improved 
central-cardiovascular and endothelial coupling (Dobson & Letson, 2016b), and the 
differential activation of tissue-specific master-genes of metabolism and mitochondrial 
health that control biological time (Dobson and Letson, unpublished data). Adenosine 
alone or lidocaine alone does not have these protective properties (Dobson & Letson, 
2016b).  
The mechanism of how AL can elicit a potent relaxation regardless of damaged 
endothelium is unknown. One can only speculate from the data in this thesis that AL 
relaxation appears to involve interactions between the adenosine A2a subtype and 
modulation of Kv and mitoKATP channels, although the mechanistic differences from 
adenosine alone or lidocaine alone are difficult to separate at this time (Chapter 3 and 
Chapter 4, respectively). However, the involvement of endothelium and EDRF 
(NO/PGI2) were only implicated in adenosine relaxation but not lidocaine relaxation, 
which raises the question if AL relaxation was also mediated partly by EDRF in intact 
rings, although not a dominant pathway because no loss of relaxation was found with 
AL (or A to a lesser extent) after the endothelium was physically removed. Future 
studies are required to elucidate AL relaxation in the presence of specific blockers, 
including EDRF, adenosine receptors subtypes (A1, A2a and A3) and K+ channel 
inhibitors.  
 
7.6 Adenosine and AL elicited an endothelium-independent relaxation in 
isolated guinea pig mesenteric artery, whereas lidocaine produced 
endothelium-dependent vasoconstriction 
Similar findings were found when AL, adenosine and lidocaine were examined in 
isolated mesenteric conduits of the guinea pig.  It was found that increasing luminal AL 
produced a significant and potent endothelium-independent dilation (up to 90%) (Figs. 
5.3A, and 5.3B). Similarly, adenosine dilation was endothelium-independent but not 
lidocaine, which produced 33% dilation only after endothelial removal (Figs. 5.3A and 
5.3B). Extra-luminal AL and adenosine led to 76% and 80% dilation in intact segments 
respectively, whereas lidocaine resulted in constriction (10-17%) (Fig. 5.3C).  
 
Although endothelium-dependent relaxation of adenosine has been reported in 
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mesenteric arteries (Hiley, et al., 1995; Tabrizchi & Lupichuk, 1995; Vuorinen, et al., 
1992), the majority of studies have failed to confirm the importance of an intact 
endothelium, including in rats (Prentice, et al., 1997; Radenkovic, 2005) and in rabbits 
(Mathieson & Burnstock, 1985).  This is consistent with the finding that EDRF (NO and 
PGI2) was not found to play a role in adenosine relaxation in mesentery beds (Hiley, 
et al., 1995; Hogan, et al., 1998; Radenkovic, 2005). Thus, it is generally agreed that 
adenosine relaxation in guinea pig mesenteric arteries largely depends on non-
endothelial process. This is different from adenosine relaxation in rat aortic rings 
(Chapter 3), which showed a partial dependency of adenosine relaxation on functional 
endothelium (Fig. 3.1), and a role of EDRFs (NO and PGI2) in adenosine vascular 
relaxation. The difference in endothelium dependence between aortic and mesenteric 
relaxation may derive from: 1) different functions of the vascular beds; i.e. conductance 
versus resistance vessels (Lüscher, et al., 1992), 2) different distribution of adenosine 
receptor subtypes (Shryock & Belardinelli, 1997), and 3) different cellular pathways, 
such as hyperpolarizing factors and specific ion channels (Lüscher, et al., 1992; 
Zygmunt, et al., 1995) 
 
Again these findings may have clinical relevance given the potential problem of acute 
gut hypoperfusion ischaemia, ileus, and potential infection during major surgery such 
as CABG surgery (Gabe, 2001). The mesenteric arterial system supplies the intestine 
from the lower part of the duodenum through two-thirds of the transverse colon and 
pancreas (Asfar, et al., 2003; Jacobson, 1982). Although the incidence of mesenteric 
ischaemia is rare (<3%), the mortality rate ranges from 46-100% (Nilsson, et al., 2013; 
Pang, et al., 2012).  Currently, the standard vasodilator used to prevent gut ischaemia 
is papaverine (Kahn, 2011; Oshikata, et al., 2013). However, the use of papaverine 
has been associated with side effects, one of the most common is cardiac 
tachyarrhythmias (Kahn, 2011). It should be noted that lidocaine infusion is known to 
significantly reduce ileus and hospital stay in a number of major surgeries (McCarthy, 
et al., 2010).  Future studies are required to investigate cardiac effects of adenosine 
and AL as potential vasodilators in in vivo models of non-occlusive mesenteric 
ischemia. For example, AL could protect arterial vessels and conduits in cardiac 
surgery, and possibly as an infusion during surgery to protect the gut from ilieus or 
ischaemic episodes. Recently, it was shown that AL(M) infusion led to increased blood 
flow to the gut in the rat model of haemorrhagic shock in vivo compared to controls 
(Letson & Dobson, 2017b), which would be wholly consistent with the vasodilatory 
properties of AL found in isolated mesentery segments in this thesis.   
 
 132 
7.7 Development of a low Ca2+/high Mg2+ AL addition for graft preservation  
Since there is no consensus on a graft storage solution for CABG and other types of 
vascular graft surgery, it was decided in Chapter 6 to examine if AL and AL plus 
antioxidants insulin and melatonin could provide protection in a low Ca2+/high Mg2+ 
(Ca2+=0.22 mM, Mg2+=2.6 mM) Krebs Henseleit (KH) modified solution.  One of the 
most commonly used physiological solutions is Krebs Henseleit, which partially mimics 
ionic contents of mammalian blood (Bailey & Ong, 1978; Lockwood, 1961). AL alone 
in modified KH produced the best recovery (ACh response) after six days storage, with 
no additional advantage of having melatonin and insulin present (Fig. 6.2).  
Interestingly, recovery of smooth muscle-dependent relaxation (assessed by SNP 
response) was 60% in cold standard KH compared to 100% recovery in Ca2+/high Mg2+ 
modified KH alone, with AL or with ALMI (all p<0.05), indicating low Ca2+/high Mg2+ 
was a key factor in protecting smooth muscle contraction and relaxation after six days 
storage at 4°C (Fig. 6.3).  Further functional, histological, biochemical and 
electrophysiological work is required in this area, but it appears that a graft harvest and 
storage solution with AL in a low Ca2+/high Mg2+ may have translational potential for 
CABG and possibly neurosurgery.  
 
7.8 Possible limitations and future studies 
The primary objective of this thesis was to develop a novel pharmacological vasodilator 
combination for cardiac surgery, and to understand the possible mechanisms of 
relaxation or dilation in the isolated rat aorta, and mesenteric segments. Originally the 
aim was to examine adenosine, lidocaine and AL on fresh discarded human left 
internal mammary artery (LIMA) or radial artery segments from cardiac surgeons but 
this failed to occur due to lack of conduit availability from the cardiovascular 
department.  The study therefore focused on rat aortic rings. The rat aorta was chosen 
because it was an established model to investigate the vasoactivity of drugs (Grbović 
& Radenković, 2003; Prentice & Hourani, 2000; Tawfik, et al., 2005). Although studies 
of this type may not translate to humans (Rosenfeldt, et al., 1999), the rat aortic model 
is relevant because it mimics many of the functional and morphological endothelial 
changes that occur in human grafting during excision, pressure testing, storage, 
implantation and after anastomoses (Andriambeloson, et al., 2001).  However, it must 
be appreciated in the translation process that the thoracic aorta is a large elastic 
 133 
conduit artery, which has different functional properties to smaller muscular arteries 
and arterioles (Dobson, et al., 2017).   
 
Despite these potential limitations, future studies based on the data in the present 
thesis may progress be to the clinical scenario and investigate the AL solution on 
vessel protection and spasm in cardiac surgery. This may include: 1) testing topical 
applications of the AL solution to the dissected LIMA in situ prior to grafting, a muscular 
vessel particularly prone to spasm during cardiac surgery, 2) infusing the AL solution 
through arterial conduits, and possibly venous conduits, prior to pressure testing, and 
storage, and 3) investigating AL in the storage graft solution to protect endothelium-
smooth muscle integrity prior to performing the bypass operation.  
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